HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
174373.0,234940,2181-10-15 07:38:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2181-10-14**] 09:11 AM
   rt upper quadrant
 URINE CULTURE - At [**2181-10-15**] 06:30 AM
   - high central venous sat
   - gave fluids for low BP's, still anuric; currently on two pressors
   (can add levophed as third pressor)
   - made DNR/DNI chemical code only
   - Got records from OSH re: previous CT abdomen (PO contrast)- nothing
   acute (records in chart)
   - has history of zosyn use at OSH (along with levaquin; full med list
   in chart). ? of intrahepatic cholestasis [**2-26**] drug effect as cause for
   obstructive picture
   - Echo not done today
   - RUQ u/s- fatty liver
   - hepatology recs: too sick for MRCP or liver biopsy, checking
   hepatitis A, B, C, CMV, iron, ferritin, other liver serologies
   -put on ARDsnet protocol based on CXR
   -trending DIC labs now
   - too unstable for CT abdomen overnight (wanted to get to evaluate for
   bowel origin)
   -[**1-28**] GPC's in blood (already on vanco)
   -Chronic intrahepatic cholestasis
 Drugs causing chronic intrahepatic
   cholestasis may produce a syndrome resembling primary biliary cirrhosis
   [36,41]. However, unlike primary biliary cirrhosis, serum
   antimitochondrial antibodies are usually not seen. Chronic cholestasis
   may evolve from acute drug-induced cholestasis. Most cases resolve with
   withdrawal of the offending [**Doctor Last Name **], but often require several months.
   However, some patients develop a vanishing bile duct syndrome and liver
   failure [67,68]. Drugs which have been reported to cause chronic
   intrahepatic cholestasis include amitriptyline, ampicillin,
   amoxicillin-clavulanate, carbamazepine, chlorpromazine, cyproheptadine,
   erythromycin estolate, haloperidol, imipramine, organic arsenicals,
   prochlorperazine, phenytoin, trimethoprim-sulfamethoxazole,
   thiabendazole, tolbutamide, tetracycline, oral contraceptives, and
   anabolic steroids [69-71]. Those drugs implicated in chronic
   intrahepatic cholestasis and also ductopenia include carbamazepine,
   chlorpromazine, chlorpropamide, co-trimoxazole, haloperidol,
   thiabendazole, and tricyclic antidepressants.
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-15**] 12:01 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl (Concentrate) - 50 mcg/hour
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Sodium Bicarbonate 8.4% (Amp) - [**2181-10-14**] 11:45 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-15**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.7
C (99.9
   Tcurrent: 36.4
C (97.6
   HR: 92 (92 - 126) bpm
   BP: 90/60(71) {82/51(64) - 128/85(102)} mmHg
   RR: 28 (20 - 32) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 12 (6 - 31)mmHg
   Mixed Venous O2% Sat: 75 - 75
   Total In:
                                                                  5,626 mL
                                                                    895 mL
   PO:
   TF:
   IVF:
                                                                  4,536 mL
                                                                    365 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                    164 mL
                                                                      6 mL
   Urine:
                                                                     14 mL
                                                                      6 mL
   NG:
                                                                    150 mL
   Stool:
   Drains:
   Balance:
                                                                  5,462 mL
                                                                    889 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: Hemodynamic Instability
   PIP: 23 cmH2O
   Plateau: 18 cmH2O
   Compliance: 25 cmH2O/mL
   SpO2: 95%
   ABG: 7.40/26/76.[**Numeric Identifier 126**]/15/-6
   Ve: 10 L/min
   PaO2 / FiO2: 152
   Physical Examination
   General Appearance: sedated
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: L>R)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   300 K/uL
   10.2 g/dL
   200 mg/dL
   1.8 mg/dL
   15 mEq/L
   3.3 mEq/L
   45 mg/dL
   105 mEq/L
   138 mEq/L
   31.0 %
   17.1 K/uL
        [image002.jpg]
                             [**2181-10-14**]  03:49 AM
                             [**2181-10-14**]  10:31 AM
                             [**2181-10-14**]  02:05 PM
                             [**2181-10-14**]  06:12 PM
                             [**2181-10-14**]  09:41 PM
                             [**2181-10-14**]  10:20 PM
                             [**2181-10-15**]  01:15 AM
                             [**2181-10-15**]  03:58 AM
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
   WBC
   16.0
   17.1
   Hct
   33.1
   31.0
   Plt
   319
   300
   Cr
   1.8
   1.8
   TCO2
   9
   9
   12
   15
   16
   15
   15
   17
   Glucose
   234
   200
   Other labs: PT / PTT / INR:33.3/46.3/3.4, CK / CKMB /
   Troponin-T:51//0.03, ALT / AST:2497/6244, Alk Phos / T Bili:1053/18.5,
   Amylase / Lipase:36/37, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:466 mg/dL, Lactic
   Acid:3.6 mmol/L, Albumin:2.0 g/dL, LDH:4500 IU/L, Ca++:7.3 mg/dL,
   Mg++:2.8 mg/dL, PO4:5.1 mg/dL
   Fluid analysis / Other labs: lactate=3.6
   IgG=909
   Imaging: ct abd/pelvis (wet read)
   moderate bilateral pleural effusions w/ right greater than left
   underlying
   atelectasis/consolidation. ascites. cholecystectomy clips. fluid or
   cystic
   lesion associated w/ pancreas, not well characterized on this
   noncontrast
   study (2:33, 301b:38). no free air, extraluminal contrast or
   pneumatosis. no bowel obstruction. fluid/stranding about tail of
   pancreas and thickening of anterior renal and left lateroconal fascia
   could indicate pancreatitis or may be related to ascites, anasarca.
   liver/gallbladder us
   Bilateral pleural effusions. Ascites.
   No intrahepatic or extrahepatic biliary ductal dilatation.
   Echogenic liver consistent with fatty infiltration. Other forms of
   liver
   disease and more advanced liver disease including significant hepatic
   fibrosis/cirrhosis cannot be excluded on this study.
   Microbiology: [**2181-10-15**]  URINE URINE CULTURE-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-PENDING; CMV IgM
   ANTIBODY-PENDING INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-PRELIMINARY INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY {GRAM
   POSITIVE COCCUS(COCCI)}; Aerobic Bottle Gram Stain-FINAL; Anaerobic
   Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-PENDING INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {GRAM NEGATIVE ROD(S)}
   INPATIENT
   urine cx:
      URINE CULTURE (Preliminary):
         GRAM NEGATIVE ROD(S).    >100,000 ORGANISMS/ML..
            ? OF TWO COLONIAL MORPHOLOGIES.
   blood cx:
      Blood Culture, Routine (Preliminary):
         GRAM POSITIVE COCCUS(COCCI).    IN CLUSTERS.
      Aerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN CLUSTERS.
         REPORTED BY PHONE TO DR [**First Name (STitle) **] ([**Numeric Identifier 10163**]) [**2181-10-14**] AT 2:30PM.
      Anaerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
   Assessment and Plan
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   This is an 81 yo female with progressive painless jaundice over the
   past two weeks now presenting with hypotension and hypothermia likely
   representing sepsis.
   .
   # Septic Shock: Pt presenting with hypotension, tachycardia and
   leukocytosis of [**Numeric Identifier 5728**] with bandemia. Pressures improved with NS bolus
   though MAPs remain in the mid-50's. Possible infectious sources include
   urosepsis especially given urine cx positive for ESBL E.Coli which she
   was not receiving abx. She Would certainly also consider cholangitis
   given cholestatic picture, but too unstable for ERCP. CXR with patchy
   opacity in the left mid lung may indicate a possible PNA. Also with
   GPC's in blood, raising concern for line infection.
   - continue Meropenem, Flagyl and Vanco; has been afebrile since.
   - Goal MAPS >65; currently on 2 pressors, able to wean phenylephrine
   when pH corrected
   - Cont IVF boluses with NS for CVP 15-20
   - Blood and urine cxs- pending speciation of GPC in blood and GNR in
   urine (need to verify speciation and sensitivities of GNR)
   - daily surveillance cultures; now with GPC in [**2-28**] bottles, might
   consider pulling lines, but also concern for enterococcus; will await
   to see if coag negative or positive
   - repeat RUQ u/s without any ductal abnormalities; just fatty liver. CT
   with PO contrast with no acute abdominal abnormalities
   - Follow CXR
   - lactate trending down from 5.8-->3.4; due to infection vs.
   hypotension (had SBP's in 70's to 80's at some points on admission).
   -not candidate for MRCP b/c has pacer. Does not seem stable enough for
   ERCP and likely not any obstruction/intervention
   #Hypoxic Respiratory failure - Patient with remarkable effusion;
   currently on ARDs net; ? PNA as component
   -somewhat [**Last Name (LF) 8601**], [**First Name3 (LF) **] try to come down on midazolam and see response
    -continue AC vent
   - f/u BAL
   -hold on tap of effusions
   -ARDS vent with Vt 300cc.
   -ABG stable, corrected with amps of bicarb
   .
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs; received 6amps total of bicarb yesterday
   - cont trend ABG
   - cont trend lactate
   - continue to maintain pH 7.2.5 for ideal pressor action
   - empiric ABX
   .
   #  Elevated LFTs/Cholestasis: Given recent abd ct and u/s with normal
   appearing biliary tree, pancreas and liver seems more likely that these
   LFT abnormalities represent intrhepatic biliary obstruction or
   intrahepatic etiology (primary biliary cirrhosis, drug induced
   cholestasis, infiltrative process, neoplasm(cholangiocarcinoma,
   lymphoma). For drug induced cholestasis, possible culprits include
   levaquin (?), remeron (?)
   - appreciate liver recs
   - likely component of shock liver superimposed
   - d/c remeron
   -f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
   -continue to trend coags and DIC labs; correct coagulopathy if bleeding
   .
   # Acute renal failure- likely hemodynamic in origin
   -renally dose all meds
   -f/u urine lytes this AM (previously unable to produce urine)
   .
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - thoracentesis if hypoxia worsens
   .
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP. Per OSH
   records coumadin being held in anticipation of possible procedure.
   - hold metoprolol for now
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes
   .
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   .
   # ? GERD: cont PPI
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 07:42 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: None (too much bruising with boots)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up
   Comments:
   Communication:  Comments:
   Code status: DNR (do not resuscitate)
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2181-10-14**] 09:11 AM
   rt upper quadrant
 URINE CULTURE - At [**2181-10-15**] 06:30 AM
   - high central venous sat
   - gave fluids for low BP's, still anuric; currently on two pressors
   (can add levophed as third pressor)
   - made DNR/DNI chemical code only
   - Got records from OSH re: previous CT abdomen (PO contrast)- nothing
   acute (records in chart)
   - has history of zosyn use at OSH (along with levaquin; full med list
   in chart). ? of intrahepatic cholestasis [**2-26**] drug effect as cause for
   obstructive picture
   - Echo not done today
   - RUQ u/s- fatty liver
   - hepatology recs: too sick for MRCP or liver biopsy, checking
   hepatitis A, B, C, CMV, iron, ferritin, other liver serologies
   -put on ARDsnet protocol based on CXR
   -trending DIC labs now
   - too unstable for CT abdomen overnight (wanted to get to evaluate for
   bowel origin)
   -[**1-28**] GPC's in blood (already on vanco)
   -Chronic intrahepatic cholestasis
 Drugs causing chronic intrahepatic
   cholestasis may produce a syndrome resembling primary biliary cirrhosis
   [36,41]. However, unlike primary biliary cirrhosis, serum
   antimitochondrial antibodies are usually not seen. Chronic cholestasis
   may evolve from acute drug-induced cholestasis. Most cases resolve with
   withdrawal of the offending [**Doctor Last Name **], but often require several months.
   However, some patients develop a vanishing bile duct syndrome and liver
   failure [67,68]. Drugs which have been reported to cause chronic
   intrahepatic cholestasis include amitriptyline, ampicillin,
   amoxicillin-clavulanate, carbamazepine, chlorpromazine, cyproheptadine,
   erythromycin estolate, haloperidol, imipramine, organic arsenicals,
   prochlorperazine, phenytoin, trimethoprim-sulfamethoxazole,
   thiabendazole, tolbutamide, tetracycline, oral contraceptives, and
   anabolic steroids [69-71]. Those drugs implicated in chronic
   intrahepatic cholestasis and also ductopenia include carbamazepine,
   chlorpromazine, chlorpropamide, co-trimoxazole, haloperidol,
   thiabendazole, and tricyclic antidepressants.
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-15**] 12:01 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl (Concentrate) - 50 mcg/hour
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Sodium Bicarbonate 8.4% (Amp) - [**2181-10-14**] 11:45 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-15**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.7
C (99.9
   Tcurrent: 36.4
C (97.6
   HR: 92 (92 - 126) bpm
   BP: 90/60(71) {82/51(64) - 128/85(102)} mmHg
   RR: 28 (20 - 32) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 12 (6 - 31)mmHg
   Mixed Venous O2% Sat: 75 - 75
   Total In:
                                                                  5,626 mL
                                                                    895 mL
   PO:
   TF:
   IVF:
                                                                  4,536 mL
                                                                    365 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                    164 mL
                                                                      6 mL
   Urine:
                                                                     14 mL
                                                                      6 mL
   NG:
                                                                    150 mL
   Stool:
   Drains:
   Balance:
                                                                  5,462 mL
                                                                    889 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: Hemodynamic Instability
   PIP: 23 cmH2O
   Plateau: 18 cmH2O
   Compliance: 25 cmH2O/mL
   SpO2: 95%
   ABG: 7.40/26/76.[**Numeric Identifier 126**]/15/-6
   Ve: 10 L/min
   PaO2 / FiO2: 152
   Physical Examination
   General Appearance: sedated
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: L>R)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   300 K/uL
   10.2 g/dL
   200 mg/dL
   1.8 mg/dL
   15 mEq/L
   3.3 mEq/L
   45 mg/dL
   105 mEq/L
   138 mEq/L
   31.0 %
   17.1 K/uL
        [image002.jpg]
                             [**2181-10-14**]  03:49 AM
                             [**2181-10-14**]  10:31 AM
                             [**2181-10-14**]  02:05 PM
                             [**2181-10-14**]  06:12 PM
                             [**2181-10-14**]  09:41 PM
                             [**2181-10-14**]  10:20 PM
                             [**2181-10-15**]  01:15 AM
                             [**2181-10-15**]  03:58 AM
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
   WBC
   16.0
   17.1
   Hct
   33.1
   31.0
   Plt
   319
   300
   Cr
   1.8
   1.8
   TCO2
   9
   9
   12
   15
   16
   15
   15
   17
   Glucose
   234
   200
   Other labs: PT / PTT / INR:33.3/46.3/3.4, CK / CKMB /
   Troponin-T:51//0.03, ALT / AST:2497/6244, Alk Phos / T Bili:1053/18.5,
   Amylase / Lipase:36/37, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:466 mg/dL, Lactic
   Acid:3.6 mmol/L, Albumin:2.0 g/dL, LDH:4500 IU/L, Ca++:7.3 mg/dL,
   Mg++:2.8 mg/dL, PO4:5.1 mg/dL
   Fluid analysis / Other labs: lactate=3.6
   IgG=909
   Imaging: ct abd/pelvis (wet read)
   moderate bilateral pleural effusions w/ right greater than left
   underlying
   atelectasis/consolidation. ascites. cholecystectomy clips. fluid or
   cystic
   lesion associated w/ pancreas, not well characterized on this
   noncontrast
   study (2:33, 301b:38). no free air, extraluminal contrast or
   pneumatosis. no bowel obstruction. fluid/stranding about tail of
   pancreas and thickening of anterior renal and left lateroconal fascia
   could indicate pancreatitis or may be related to ascites, anasarca.
   liver/gallbladder us
   Bilateral pleural effusions. Ascites.
   No intrahepatic or extrahepatic biliary ductal dilatation.
   Echogenic liver consistent with fatty infiltration. Other forms of
   liver
   disease and more advanced liver disease including significant hepatic
   fibrosis/cirrhosis cannot be excluded on this study.
   Microbiology: [**2181-10-15**]  URINE URINE CULTURE-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-PENDING; CMV IgM
   ANTIBODY-PENDING INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-PRELIMINARY INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY {GRAM
   POSITIVE COCCUS(COCCI)}; Aerobic Bottle Gram Stain-FINAL; Anaerobic
   Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-PENDING INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {GRAM NEGATIVE ROD(S)}
   INPATIENT
   urine cx:
      URINE CULTURE (Preliminary):
         GRAM NEGATIVE ROD(S).    >100,000 ORGANISMS/ML..
            ? OF TWO COLONIAL MORPHOLOGIES.
   blood cx:
      Blood Culture, Routine (Preliminary):
         GRAM POSITIVE COCCUS(COCCI).    IN CLUSTERS.
      Aerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN CLUSTERS.
         REPORTED BY PHONE TO DR [**First Name (STitle) **] ([**Numeric Identifier 10163**]) [**2181-10-14**] AT 2:30PM.
      Anaerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
   Assessment and Plan
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   This is an 81 yo female with progressive painless jaundice over the
   past two weeks now presenting with hypotension and hypothermia likely
   representing sepsis.
   .
   # Septic Shock: Pt presenting with hypotension, tachycardia and
   leukocytosis of [**Numeric Identifier 5728**] with bandemia. Pressures improved with NS bolus
   though MAPs remain in the mid-50's. Possible infectious sources include
   urosepsis especially given urine cx positive for ESBL E.Coli which she
   was not receiving abx. She Would certainly also consider cholangitis
   given cholestatic picture, but too unstable for ERCP. CXR with patchy
   opacity in the left mid lung may indicate a possible PNA. Also with
   GPC's in blood, raising concern for line infection.
   - continue Meropenem, Flagyl and Vanco; has been afebrile since.
   - Goal MAPS >65; currently on 2 pressors, able to wean phenylephrine
   when pH corrected
   - Cont IVF boluses with NS for CVP 15-20
   - Blood and urine cxs- pending speciation of GPC in blood and GNR in
   urine (need to verify speciation and sensitivities of GNR)
   - daily surveillance cultures; now with GPC in [**2-28**] bottles, might
   consider pulling lines, but also concern for enterococcus; will await
   to see if coag negative or positive
   - repeat RUQ u/s without any ductal abnormalities; just fatty liver. CT
   with PO contrast with no acute abdominal abnormalities
   - Follow CXR
   - lactate trending down from 5.8-->3.4; due to infection vs.
   hypotension (had SBP's in 70's to 80's at some points on admission).
   -not candidate for MRCP b/c has pacer. Does not seem stable enough for
   ERCP and likely not any obstruction/intervention
   #Hypoxic Respiratory failure - Patient with remarkable effusion;
   currently on ARDs net; ? PNA as component
   -somewhat [**Last Name (LF) 8601**], [**First Name3 (LF) **] try to come down on midazolam and see response
    -continue AC vent
   - f/u BAL
   -hold on tap of effusions
   -ARDS vent with Vt 300cc.
   -ABG stable, corrected with amps of bicarb
   .
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs; received 6amps total of bicarb yesterday
   - cont trend ABG
   - cont trend lactate
   - continue to maintain pH 7.2.5 for ideal pressor action
   - empiric ABX
   .
   #  Elevated LFTs/Cholestasis: Given recent abd ct and u/s with normal
   appearing biliary tree, pancreas and liver seems more likely that these
   LFT abnormalities represent intrhepatic biliary obstruction or
   intrahepatic etiology (primary biliary cirrhosis, drug induced
   cholestasis, infiltrative process, neoplasm(cholangiocarcinoma,
   lymphoma). For drug induced cholestasis, possible culprits include
   levaquin (?), remeron (?)
   - appreciate liver recs
   - likely component of shock liver superimposed
   - d/c remeron
   -f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
   -continue to trend coags and DIC labs; correct coagulopathy if bleeding
   .
   # Acute renal failure- likely hemodynamic in origin
   -renally dose all meds
   -f/u urine lytes this AM (previously unable to produce urine)
   .
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - thoracentesis if hypoxia worsens
   .
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP. Per OSH
   records coumadin being held in anticipation of possible procedure.
   - hold metoprolol for now
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes
   .
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   .
   # ? GERD: cont PPI
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 07:42 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: None (too much bruising with boots)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up
   Comments:
   Communication:  Comments:
   Code status: DNR (do not resuscitate)
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 81-year-old female who was admitted to the ICU with septic shock, hypotension, and hypothermia. The patient has a complex medical history, including chronic intrahepatic cholestasis, liver dysfunction, and potential liver failure.

The patient's laboratory results show elevated liver function tests (LFTs), including alkaline phosphatase, gamma-glutamyl transferase, and bilirubin. The patient also has a cholestatic picture, which may be caused by a variety of factors, including drug-induced cholestasis, primary biliary cirrhosis, or infiltrative processes.

The patient's imaging studies, including a computed tomography (CT) scan of the abdomen and pelvis, show moderate bilateral pleural effusions with right-sided predominance, ascites, and a fluid or cystic lesion associated with the pancreas. The CT scan also shows fatty infiltration of the liver.

The patient's urine culture is positive for extended-spectrum beta-lactamase (ESBL) Escherichia coli, which may be a source of sepsis. The patient's blood culture is also positive for Gram-positive cocci, which may be a secondary infection.

The patient's clinical condition is complex and requires careful management. The patient is at risk for further complications, including:

1. Sepsis and septic shock: The patient's septic shock is likely to be caused by a combination of factors, including the urinary tract infection, liver dysfunction, and potential liver failure.
2. Acute kidney injury: The patient's acute kidney injury is likely to be caused by hypotension, sepsis, and potential liver failure.
3. Respiratory failure: The patient's respiratory failure is likely to be caused by the bilateral pleural effusions, ascites, and potential pneumonia.
4. Coagulopathy: The patient's coagulopathy is likely to be caused by liver dysfunction and potential liver failure.
5. Gastrointestinal bleeding: The patient is at risk for gastrointestinal bleeding due to the potential liver failure and coagulopathy.

To manage the patient's condition, the following interventions are recommended:

1. Continue broad-spectrum antibiotics to treat the urinary tract infection and potential secondary infections.
2. Continue to monitor the patient's liver function and potential liver failure.
3. Consider liver transplantation if the patient's liver function does not improve with medical therapy.
4. Continue to monitor the patient's kidney function and potential acute kidney injury.
5. Consider dialysis if the patient's kidney function does not improve with medical therapy.
6. Continue to monitor the patient's respiratory function and potential respiratory failure.
7. Consider mechanical ventilation if the patient's respiratory function does not improve with medical therapy.
8. Continue to monitor the patient's coagulopathy and potential gastrointestinal bleeding.
9. Consider anticoagulation therapy if the patient's coagulopathy does not improve with medical therapy.

In conclusion, the patient's condition is complex and requires careful management. The patient is at risk for further complications, including sepsis, acute kidney injury, respiratory failure, coagulopathy, and gastrointestinal bleeding. The recommended interventions are designed to manage the patient's condition and prevent further complications."
174373.0,234940,2181-10-15 07:38:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2181-10-14**] 09:11 AM
   rt upper quadrant
 URINE CULTURE - At [**2181-10-15**] 06:30 AM
   - high central venous sat
   - gave fluids for low BP's, still anuric; currently on two pressors
   (can add levophed as third pressor)
   - made DNR/DNI chemical code only
   - Got records from OSH re: previous CT abdomen (PO contrast)- nothing
   acute (records in chart)
   - has history of zosyn use at OSH (along with levaquin; full med list
   in chart). ? of intrahepatic cholestasis [**2-26**] drug effect as cause for
   obstructive picture
   - Echo not done today
   - RUQ u/s- fatty liver
   - hepatology recs: too sick for MRCP or liver biopsy, checking
   hepatitis A, B, C, CMV, iron, ferritin, other liver serologies
   -put on ARDsnet protocol based on CXR
   -trending DIC labs now
   - too unstable for CT abdomen overnight (wanted to get to evaluate for
   bowel origin)
   -[**1-28**] GPC's in blood (already on vanco)
   -Chronic intrahepatic cholestasis
 Drugs causing chronic intrahepatic
   cholestasis may produce a syndrome resembling primary biliary cirrhosis
   [36,41]. However, unlike primary biliary cirrhosis, serum
   antimitochondrial antibodies are usually not seen. Chronic cholestasis
   may evolve from acute drug-induced cholestasis. Most cases resolve with
   withdrawal of the offending [**Doctor Last Name **], but often require several months.
   However, some patients develop a vanishing bile duct syndrome and liver
   failure [67,68]. Drugs which have been reported to cause chronic
   intrahepatic cholestasis include amitriptyline, ampicillin,
   amoxicillin-clavulanate, carbamazepine, chlorpromazine, cyproheptadine,
   erythromycin estolate, haloperidol, imipramine, organic arsenicals,
   prochlorperazine, phenytoin, trimethoprim-sulfamethoxazole,
   thiabendazole, tolbutamide, tetracycline, oral contraceptives, and
   anabolic steroids [69-71]. Those drugs implicated in chronic
   intrahepatic cholestasis and also ductopenia include carbamazepine,
   chlorpromazine, chlorpropamide, co-trimoxazole, haloperidol,
   thiabendazole, and tricyclic antidepressants.
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-15**] 12:01 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl (Concentrate) - 50 mcg/hour
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Sodium Bicarbonate 8.4% (Amp) - [**2181-10-14**] 11:45 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-15**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.7
C (99.9
   Tcurrent: 36.4
C (97.6
   HR: 92 (92 - 126) bpm
   BP: 90/60(71) {82/51(64) - 128/85(102)} mmHg
   RR: 28 (20 - 32) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 12 (6 - 31)mmHg
   Mixed Venous O2% Sat: 75 - 75
   Total In:
                                                                  5,626 mL
                                                                    895 mL
   PO:
   TF:
   IVF:
                                                                  4,536 mL
                                                                    365 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                    164 mL
                                                                      6 mL
   Urine:
                                                                     14 mL
                                                                      6 mL
   NG:
                                                                    150 mL
   Stool:
   Drains:
   Balance:
                                                                  5,462 mL
                                                                    889 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: Hemodynamic Instability
   PIP: 23 cmH2O
   Plateau: 18 cmH2O
   Compliance: 25 cmH2O/mL
   SpO2: 95%
   ABG: 7.40/26/76.[**Numeric Identifier 126**]/15/-6
   Ve: 10 L/min
   PaO2 / FiO2: 152
   Physical Examination
   General Appearance: sedated
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: L>R)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   300 K/uL
   10.2 g/dL
   200 mg/dL
   1.8 mg/dL
   15 mEq/L
   3.3 mEq/L
   45 mg/dL
   105 mEq/L
   138 mEq/L
   31.0 %
   17.1 K/uL
        [image002.jpg]
                             [**2181-10-14**]  03:49 AM
                             [**2181-10-14**]  10:31 AM
                             [**2181-10-14**]  02:05 PM
                             [**2181-10-14**]  06:12 PM
                             [**2181-10-14**]  09:41 PM
                             [**2181-10-14**]  10:20 PM
                             [**2181-10-15**]  01:15 AM
                             [**2181-10-15**]  03:58 AM
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
   WBC
   16.0
   17.1
   Hct
   33.1
   31.0
   Plt
   319
   300
   Cr
   1.8
   1.8
   TCO2
   9
   9
   12
   15
   16
   15
   15
   17
   Glucose
   234
   200
   Other labs: PT / PTT / INR:33.3/46.3/3.4, CK / CKMB /
   Troponin-T:51//0.03, ALT / AST:2497/6244, Alk Phos / T Bili:1053/18.5,
   Amylase / Lipase:36/37, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:466 mg/dL, Lactic
   Acid:3.6 mmol/L, Albumin:2.0 g/dL, LDH:4500 IU/L, Ca++:7.3 mg/dL,
   Mg++:2.8 mg/dL, PO4:5.1 mg/dL
   Fluid analysis / Other labs: lactate=3.6
   IgG=909
   Imaging: ct abd/pelvis (wet read)
   moderate bilateral pleural effusions w/ right greater than left
   underlying
   atelectasis/consolidation. ascites. cholecystectomy clips. fluid or
   cystic
   lesion associated w/ pancreas, not well characterized on this
   noncontrast
   study (2:33, 301b:38). no free air, extraluminal contrast or
   pneumatosis. no bowel obstruction. fluid/stranding about tail of
   pancreas and thickening of anterior renal and left lateroconal fascia
   could indicate pancreatitis or may be related to ascites, anasarca.
   liver/gallbladder us
   Bilateral pleural effusions. Ascites.
   No intrahepatic or extrahepatic biliary ductal dilatation.
   Echogenic liver consistent with fatty infiltration. Other forms of
   liver
   disease and more advanced liver disease including significant hepatic
   fibrosis/cirrhosis cannot be excluded on this study.
   Microbiology: [**2181-10-15**]  URINE URINE CULTURE-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-PENDING; CMV IgM
   ANTIBODY-PENDING INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-PRELIMINARY INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY {GRAM
   POSITIVE COCCUS(COCCI)}; Aerobic Bottle Gram Stain-FINAL; Anaerobic
   Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-PENDING INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {GRAM NEGATIVE ROD(S)}
   INPATIENT
   urine cx:
      URINE CULTURE (Preliminary):
         GRAM NEGATIVE ROD(S).    >100,000 ORGANISMS/ML..
            ? OF TWO COLONIAL MORPHOLOGIES.
   blood cx:
      Blood Culture, Routine (Preliminary):
         GRAM POSITIVE COCCUS(COCCI).    IN CLUSTERS.
      Aerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN CLUSTERS.
         REPORTED BY PHONE TO DR [**First Name (STitle) **] ([**Numeric Identifier 10163**]) [**2181-10-14**] AT 2:30PM.
      Anaerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
   Assessment and Plan
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   This is an 81 yo female with progressive painless jaundice over the
   past two weeks now presenting with hypotension and hypothermia likely
   representing sepsis.
   .
   # Septic Shock: Pt presenting with hypotension, tachycardia and
   leukocytosis of [**Numeric Identifier 5728**] with bandemia. Pressures improved with NS bolus
   though MAPs remain in the mid-50's. Possible infectious sources include
   urosepsis especially given urine cx positive for ESBL E.Coli which she
   was not receiving abx. She Would certainly also consider cholangitis
   given cholestatic picture, but too unstable for ERCP. CXR with patchy
   opacity in the left mid lung may indicate a possible PNA. Also with
   GPC's in blood, raising concern for line infection.
   - continue Meropenem, Flagyl and Vanco; has been afebrile since.
   - Goal MAPS >65; currently on 2 pressors, able to wean phenylephrine
   when pH corrected
   - Cont IVF boluses for CVP 15-20
   - Blood and urine cxs- pending speciation of GPC in blood and GNR in
   urine
   - daily surveillance cultures; now with GPC in [**2-28**] bottles, would
   consider pulling lines...
   - repeat RUQ u/s without any ductal abnormalities; just fatty liver. CT
   with PO contrast with no acute abdominal abnormalities
   - Follow CXR
   - lactate trending down from 5.8-->3.4; due to infection vs.
   hypotension (had SBP's in 70's to 80's at some points on admission).
   #Hypoxic Respiratory failure - Patient with remarkable effusion;
   currently on ARDs net; ? PNA as component
    -continue AC vent
   - f/u BAL
   -hold on tap of effusions
   -ARDS vent with Vt 300cc.
   -ABG stable, corrected with amps of bicarb
   .
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in these
   septic patient. Lactate trending down now with broad spectrum
   antibiotics and adequate MAPs; received 6amps total of bicarb yesterday
   - cont trend ABG
   - cont trend lactate
   - continue to maintain pH 7.3 for ideal pressor action
   - empiric ABX
   .
   #  Elevated LFTs/Cholestasis: Given recent abd ct and u/s with normal
   appearing biliary tree, pancreas and liver seems more likely that these
   LFT abnormalities represent intrhepatic biliary obstruction or
   intrahepatic etiology (primary biliary cirrhosis, drug induced
   cholestasis, infiltrative process, neoplasm(cholangiocarcinoma,
   lymphoma). For drug induced cholestasis, possible culprits include
   zosyn, levaquin (?), remeron (?)
   - appreciate liver recs
   - likely component of shock liver superimposed
   -consider d/c'ing remeron
   -f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
   -continue to trend coags and DIC labs
   .
   # Acute renal failure- likely hemodynamic in origin
   -renally dose all meds
   -f/u urine lytes this AM (previously unable to produce urine)
   .
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - thoracentesis if hypoxia worsens
   .
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP. Per OSH
   records coumadin being held in anticipation of possible procedure.
   - hold metoprolol for now
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes
   .
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   .
   # ? GERD: cont PPI
   ICU Care
   Nutrition:
   Glycemic Control: Blood sugar well controlled
   Lines:
   20 Gauge - [**2181-10-13**] 07:42 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: Boots, SQ UF Heparin
   Stress ulcer:
   VAP:
   Comments:
   Communication: ICU consent signed
   HCP: Daughter: [**Name (NI) 9831**]: (H)[**Telephone/Fax (1) 10126**], (C)[**Telephone/Fax (1) 10127**] and son [**Name (NI) **]
   [**Name (NI) 36**] status: Full code
   Disposition: ICU
   ------ Protected Section ------
   MICU ATTENDING ADDENDUM
   I saw and examined the patient, and was physically present with the ICU
   team for the key portions of the services provided. I agree with the
   note above, including the assessment and plan. I would emphasize and
   add the following points: 81F AF, dCHF, prior chole, recent ESBL klebs
   UTI p/w initial problem of obstructive LFTs / intrahepatic cholestasis
   at [**Hospital3 **]. On arrival to [**Hospital 19**] medical floor, found to be
   hypotensive, hypothermic and hypoxemic with metabolic acidosis on
   arrival. Intuibated, lined, bronched on arrival to MICU, now on broad
   spectrum antibiotics and max neo / VPA. Seen by ERCP - procedure
   deferred.
   Exam notable for Tm 99.3 BP 96/60 HR 110 RR 20 with sat on 450x20 5 0.5
   27/22 7.22/21/149. 3+ edema TBB +8L/LOS CVP 16. Labs notable for WBC
   16K, HCT 28, K+ 4, Cr 1.2, lactate 5.3, AP 1090, TB 16.3, ALT 609, AST
   1215, LDH 1277. CXR with R effusion, LLL ASD.
   81F smoldering intrahepatic cholestatic picture now p/w likely
   refractory septic shock d/t urosepsis and/or biliary sepsis c/b MOSF.
   Agree with plan to manage shock with ongoing IVF resuscitation, follow
   CVO2, check echo, and continue IVF boluses for CVP >16-18 range. Will
   check repeat RUQ USG, ERCP following, while continuing vanco / [**Last Name (un) 614**] /
   flagyl / HC. Suspect met acidosis is combined effect of ARF and
   elevated lactate, though ischemic bowel is a concern as a primary or
   secondary mechanism
 I- abd CT when stable. LFT abnormalities
   suggestive of drug-induced intrahepatic disease, await anti-SM Ab and
   liver eval; other infiltrative processes including PBC / PSC / lymphoma
   / amyloidosis possible but less likely. Respiratory failure  - continue
   AC vent, f/u BAL, hold on tap of effusions, transition to ARDS vent
   with Vt 300cc. ARF likely hemodynamic - RD meds, check lytes. NPO for
   now, HSC, [**Last Name (LF) 1618**], [**First Name3 (LF) **] line, full. Will meet with family today. Remainder
   of plan as outlined above.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 07:42 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up
   Comments:
   Communication:  Comments:
   Code status: DNR (do not resuscitate)
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2181-10-14**] 09:11 AM
   rt upper quadrant
 URINE CULTURE - At [**2181-10-15**] 06:30 AM
   - high central venous sat
   - gave fluids for low BP's, still anuric; currently on two pressors
   (can add levophed as third pressor)
   - made DNR/DNI chemical code only
   - Got records from OSH re: previous CT abdomen (PO contrast)- nothing
   acute (records in chart)
   - has history of zosyn use at OSH (along with levaquin; full med list
   in chart). ? of intrahepatic cholestasis [**2-26**] drug effect as cause for
   obstructive picture
   - Echo not done today
   - RUQ u/s- fatty liver
   - hepatology recs: too sick for MRCP or liver biopsy, checking
   hepatitis A, B, C, CMV, iron, ferritin, other liver serologies
   -put on ARDsnet protocol based on CXR
   -trending DIC labs now
   - too unstable for CT abdomen overnight (wanted to get to evaluate for
   bowel origin)
   -[**1-28**] GPC's in blood (already on vanco)
   -Chronic intrahepatic cholestasis
 Drugs causing chronic intrahepatic
   cholestasis may produce a syndrome resembling primary biliary cirrhosis
   [36,41]. However, unlike primary biliary cirrhosis, serum
   antimitochondrial antibodies are usually not seen. Chronic cholestasis
   may evolve from acute drug-induced cholestasis. Most cases resolve with
   withdrawal of the offending [**Doctor Last Name **], but often require several months.
   However, some patients develop a vanishing bile duct syndrome and liver
   failure [67,68]. Drugs which have been reported to cause chronic
   intrahepatic cholestasis include amitriptyline, ampicillin,
   amoxicillin-clavulanate, carbamazepine, chlorpromazine, cyproheptadine,
   erythromycin estolate, haloperidol, imipramine, organic arsenicals,
   prochlorperazine, phenytoin, trimethoprim-sulfamethoxazole,
   thiabendazole, tolbutamide, tetracycline, oral contraceptives, and
   anabolic steroids [69-71]. Those drugs implicated in chronic
   intrahepatic cholestasis and also ductopenia include carbamazepine,
   chlorpromazine, chlorpropamide, co-trimoxazole, haloperidol,
   thiabendazole, and tricyclic antidepressants.
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-15**] 12:01 AM
   Infusions:
   Midazolam (Versed) - 1 mg/hour
   Fentanyl (Concentrate) - 50 mcg/hour
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Sodium Bicarbonate 8.4% (Amp) - [**2181-10-14**] 11:45 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-15**] 07:38 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.7
C (99.9
   Tcurrent: 36.4
C (97.6
   HR: 92 (92 - 126) bpm
   BP: 90/60(71) {82/51(64) - 128/85(102)} mmHg
   RR: 28 (20 - 32) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 12 (6 - 31)mmHg
   Mixed Venous O2% Sat: 75 - 75
   Total In:
                                                                  5,626 mL
                                                                    895 mL
   PO:
   TF:
   IVF:
                                                                  4,536 mL
                                                                    365 mL
   Blood products:
                                                                    350 mL
   Total out:
                                                                    164 mL
                                                                      6 mL
   Urine:
                                                                     14 mL
                                                                      6 mL
   NG:
                                                                    150 mL
   Stool:
   Drains:
   Balance:
                                                                  5,462 mL
                                                                    889 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: Hemodynamic Instability
   PIP: 23 cmH2O
   Plateau: 18 cmH2O
   Compliance: 25 cmH2O/mL
   SpO2: 95%
   ABG: 7.40/26/76.[**Numeric Identifier 126**]/15/-6
   Ve: 10 L/min
   PaO2 / FiO2: 152
   Physical Examination
   General Appearance: sedated
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: L>R)
   Abdominal: Soft, Non-tender, Bowel sounds present
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   300 K/uL
   10.2 g/dL
   200 mg/dL
   1.8 mg/dL
   15 mEq/L
   3.3 mEq/L
   45 mg/dL
   105 mEq/L
   138 mEq/L
   31.0 %
   17.1 K/uL
        [image002.jpg]
                             [**2181-10-14**]  03:49 AM
                             [**2181-10-14**]  10:31 AM
                             [**2181-10-14**]  02:05 PM
                             [**2181-10-14**]  06:12 PM
                             [**2181-10-14**]  09:41 PM
                             [**2181-10-14**]  10:20 PM
                             [**2181-10-15**]  01:15 AM
                             [**2181-10-15**]  03:58 AM
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
   WBC
   16.0
   17.1
   Hct
   33.1
   31.0
   Plt
   319
   300
   Cr
   1.8
   1.8
   TCO2
   9
   9
   12
   15
   16
   15
   15
   17
   Glucose
   234
   200
   Other labs: PT / PTT / INR:33.3/46.3/3.4, CK / CKMB /
   Troponin-T:51//0.03, ALT / AST:2497/6244, Alk Phos / T Bili:1053/18.5,
   Amylase / Lipase:36/37, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:466 mg/dL, Lactic
   Acid:3.6 mmol/L, Albumin:2.0 g/dL, LDH:4500 IU/L, Ca++:7.3 mg/dL,
   Mg++:2.8 mg/dL, PO4:5.1 mg/dL
   Fluid analysis / Other labs: lactate=3.6
   IgG=909
   Imaging: ct abd/pelvis (wet read)
   moderate bilateral pleural effusions w/ right greater than left
   underlying
   atelectasis/consolidation. ascites. cholecystectomy clips. fluid or
   cystic
   lesion associated w/ pancreas, not well characterized on this
   noncontrast
   study (2:33, 301b:38). no free air, extraluminal contrast or
   pneumatosis. no bowel obstruction. fluid/stranding about tail of
   pancreas and thickening of anterior renal and left lateroconal fascia
   could indicate pancreatitis or may be related to ascites, anasarca.
   liver/gallbladder us
   Bilateral pleural effusions. Ascites.
   No intrahepatic or extrahepatic biliary ductal dilatation.
   Echogenic liver consistent with fatty infiltration. Other forms of
   liver
   disease and more advanced liver disease including significant hepatic
   fibrosis/cirrhosis cannot be excluded on this study.
   Microbiology: [**2181-10-15**]  URINE URINE CULTURE-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-PENDING; CMV IgM
   ANTIBODY-PENDING INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-PRELIMINARY INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY {GRAM
   POSITIVE COCCUS(COCCI)}; Aerobic Bottle Gram Stain-FINAL; Anaerobic
   Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-PENDING INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {GRAM NEGATIVE ROD(S)}
   INPATIENT
   urine cx:
      URINE CULTURE (Preliminary):
         GRAM NEGATIVE ROD(S).    >100,000 ORGANISMS/ML..
            ? OF TWO COLONIAL MORPHOLOGIES.
   blood cx:
      Blood Culture, Routine (Preliminary):
         GRAM POSITIVE COCCUS(COCCI).    IN CLUSTERS.
      Aerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN CLUSTERS.
         REPORTED BY PHONE TO DR [**First Name (STitle) **] ([**Numeric Identifier 10163**]) [**2181-10-14**] AT 2:30PM.
      Anaerobic Bottle Gram Stain (Final [**2181-10-14**]):
         GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
   Assessment and Plan
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   This is an 81 yo female with progressive painless jaundice over the
   past two weeks now presenting with hypotension and hypothermia likely
   representing sepsis.
   .
   # Septic Shock: Pt presenting with hypotension, tachycardia and
   leukocytosis of [**Numeric Identifier 5728**] with bandemia. Pressures improved with NS bolus
   though MAPs remain in the mid-50's. Possible infectious sources include
   urosepsis especially given urine cx positive for ESBL E.Coli which she
   was not receiving abx. She Would certainly also consider cholangitis
   given cholestatic picture, but too unstable for ERCP. CXR with patchy
   opacity in the left mid lung may indicate a possible PNA. Also with
   GPC's in blood, raising concern for line infection.
   - continue Meropenem, Flagyl and Vanco; has been afebrile since.
   - Goal MAPS >65; currently on 2 pressors, able to wean phenylephrine
   when pH corrected
   - Cont IVF boluses for CVP 15-20
   - Blood and urine cxs- pending speciation of GPC in blood and GNR in
   urine
   - daily surveillance cultures; now with GPC in [**2-28**] bottles, would
   consider pulling lines...
   - repeat RUQ u/s without any ductal abnormalities; just fatty liver. CT
   with PO contrast with no acute abdominal abnormalities
   - Follow CXR
   - lactate trending down from 5.8-->3.4; due to infection vs.
   hypotension (had SBP's in 70's to 80's at some points on admission).
   #Hypoxic Respiratory failure - Patient with remarkable effusion;
   currently on ARDs net; ? PNA as component
    -continue AC vent
   - f/u BAL
   -hold on tap of effusions
   -ARDS vent with Vt 300cc.
   -ABG stable, corrected with amps of bicarb
   .
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in these
   septic patient. Lactate trending down now with broad spectrum
   antibiotics and adequate MAPs; received 6amps total of bicarb yesterday
   - cont trend ABG
   - cont trend lactate
   - continue to maintain pH 7.3 for ideal pressor action
   - empiric ABX
   .
   #  Elevated LFTs/Cholestasis: Given recent abd ct and u/s with normal
   appearing biliary tree, pancreas and liver seems more likely that these
   LFT abnormalities represent intrhepatic biliary obstruction or
   intrahepatic etiology (primary biliary cirrhosis, drug induced
   cholestasis, infiltrative process, neoplasm(cholangiocarcinoma,
   lymphoma). For drug induced cholestasis, possible culprits include
   zosyn, levaquin (?), remeron (?)
   - appreciate liver recs
   - likely component of shock liver superimposed
   -consider d/c'ing remeron
   -f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
   -continue to trend coags and DIC labs
   .
   # Acute renal failure- likely hemodynamic in origin
   -renally dose all meds
   -f/u urine lytes this AM (previously unable to produce urine)
   .
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - thoracentesis if hypoxia worsens
   .
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP. Per OSH
   records coumadin being held in anticipation of possible procedure.
   - hold metoprolol for now
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes
   .
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   .
   # ? GERD: cont PPI
   ICU Care
   Nutrition:
   Glycemic Control: Blood sugar well controlled
   Lines:
   20 Gauge - [**2181-10-13**] 07:42 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: Boots, SQ UF Heparin
   Stress ulcer:
   VAP:
   Comments:
   Communication: ICU consent signed
   HCP: Daughter: [**Name (NI) 9831**]: (H)[**Telephone/Fax (1) 10126**], (C)[**Telephone/Fax (1) 10127**] and son [**Name (NI) **]
   [**Name (NI) 36**] status: Full code
   Disposition: ICU
   ------ Protected Section ------
   MICU ATTENDING ADDENDUM
   I saw and examined the patient, and was physically present with the ICU
   team for the key portions of the services provided. I agree with the
   note above, including the assessment and plan. I would emphasize and
   add the following points: 81F AF, dCHF, prior chole, recent ESBL klebs
   UTI p/w initial problem of obstructive LFTs / intrahepatic cholestasis
   at [**Hospital3 **]. On arrival to [**Hospital 19**] medical floor, found to be
   hypotensive, hypothermic and hypoxemic with metabolic acidosis on
   arrival. Intuibated, lined, bronched on arrival to MICU, now on broad
   spectrum antibiotics and max neo / VPA. Seen by ERCP - procedure
   deferred.
   Exam notable for Tm 99.3 BP 96/60 HR 110 RR 20 with sat on 450x20 5 0.5
   27/22 7.22/21/149. 3+ edema TBB +8L/LOS CVP 16. Labs notable for WBC
   16K, HCT 28, K+ 4, Cr 1.2, lactate 5.3, AP 1090, TB 16.3, ALT 609, AST
   1215, LDH 1277. CXR with R effusion, LLL ASD.
   81F smoldering intrahepatic cholestatic picture now p/w likely
   refractory septic shock d/t urosepsis and/or biliary sepsis c/b MOSF.
   Agree with plan to manage shock with ongoing IVF resuscitation, follow
   CVO2, check echo, and continue IVF boluses for CVP >16-18 range. Will
   check repeat RUQ USG, ERCP following, while continuing vanco / [**Last Name (un) 614**] /
   flagyl / HC. Suspect met acidosis is combined effect of ARF and
   elevated lactate, though ischemic bowel is a concern as a primary or
   secondary mechanism
 I- abd CT when stable. LFT abnormalities
   suggestive of drug-induced intrahepatic disease, await anti-SM Ab and
   liver eval; other infiltrative processes including PBC / PSC / lymphoma
   / amyloidosis possible but less likely. Respiratory failure  - continue
   AC vent, f/u BAL, hold on tap of effusions, transition to ARDS vent
   with Vt 300cc. ARF likely hemodynamic - RD meds, check lytes. NPO for
   now, HSC, [**Last Name (LF) 1618**], [**First Name3 (LF) **] line, full. Will meet with family today. Remainder
   of plan as outlined above.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 07:42 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up
   Comments:
   Communication:  Comments:
   Code status: DNR (do not resuscitate)
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following medical complications are potential concerns:

1. Sepsis: The patient is septic with a high white blood cell count, bandemia, and positive blood cultures. This increases the risk of organ dysfunction and death.
2. Acute Kidney Injury (AKI): The patient has an elevated creatinine level and is anuric, indicating acute kidney injury. This may be due to hemodynamic instability, sepsis, or other factors.
3. Metabolic Acidosis: The patient has a metabolic acidosis with a lactate level of 3.6 mmol/L, which may be related to sepsis, hypoperfusion, or other factors.
4. Respiratory Failure: The patient has bilateral pleural effusions and is on ARDS net, indicating respiratory failure. This may be due to sepsis, pneumonia, or other factors.
5. Coagulopathy: The patient has a prolonged PT and PTT, indicating coagulopathy. This may be related to liver dysfunction, sepsis, or other factors.
6. Liver Dysfunction: The patient has elevated liver enzymes and a fatty liver on ultrasound, indicating liver dysfunction. This may be related to sepsis, cholestasis, or other factors.
7. Pancreatitis: The patient has a thickening of the anterior renal and left lateroconal fascia on CT, which may indicate pancreatitis or other inflammatory processes.
8. Intrahepatic Biliary Obstruction: The patient has a cholestatic picture with elevated liver enzymes and a fatty liver on ultrasound, indicating intrahepatic biliary obstruction. This may be related to sepsis, cholestasis, or other factors.
9. Cardiac Complications: The patient has atrial fibrillation and may have diastolic heart failure, which may be related to sepsis, hypoperfusion, or other factors.
10. Gastrointestinal Complications: The patient has a history of gastroesophageal reflux disease (GERD) and may have gastrointestinal bleeding or other complications related to sepsis or other factors.

To address these potential complications, the patient requires close monitoring and management in the ICU. This includes:

1. Continued broad-spectrum antibiotics to treat sepsis.
2. Aggressive fluid resuscitation to manage shock and hypoperfusion.
3. Management of metabolic acidosis with bicarbonate therapy.
4. Respiratory support with mechanical ventilation and ARDS net.
5. Coagulation management with fresh frozen plasma and platelets.
6. Liver function monitoring and management of liver dysfunction.
7. Pancreatitis management with analgesics and fluids.
8. Intrahepatic biliary obstruction management with cholestyramine and other medications.
9. Cardiac management with rate control medications and diuretics.
10. Gastrointestinal management with antacids and proton pump inhibitors.

The patient's family should be informed of the potential complications and the plan for management. The patient's code status should be DNR (do not resuscitate) as indicated in the note."
174373.0,234940,2181-10-16 07:24:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - transthoracic echo performed: suboptimal image quality, normal LV
   cavity size with moderate global hypokinesis (LVEF 30-35 %) c/w diffuse
   process, moderate MR, moderate to severe TR, pulmonary a. systolic HTN
   - call renal for HD/CVVH consult pending d/w Dr. [**Last Name (STitle) 775**] and family
   - Doppler US of PV and HV per hepatology: results pending
   - ERCP consult: recommends MRCP
   - Troponin bump to 0.11 x 3 from initial baseline of 0.02 at admission
   - Multiple boluses with albumin for hypotension continued on 2 pressors
   - UTI and urine cultures from [**Hospital1 608**] on [**10-11**] and [**10-15**]
 E. Coli and
   Klebsiella
   sensitive to ertapenum and imipenum
   -need to call wound care consult in the am
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 01:21 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Lansoprazole (Prevacid) - [**2181-10-16**] 12:22 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-16**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98
   Tcurrent: 36.7
C (98
   HR: 121 (97 - 128) bpm
   BP: 99/73(83) {81/49(61) - 118/76(91)} mmHg
   RR: 28 (24 - 28) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (6 - 15)mmHg
   Total In:
                                                                  1,774 mL
                                                                  1,098 mL
   PO:
   TF:
   IVF:
                                                                  1,214 mL
                                                                    838 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     19 mL
                                                                      0 mL
   Urine:
                                                                     19 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,755 mL
                                                                  1,098 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 71
   PIP: 20 cmH2O
   Plateau: 19 cmH2O
   SpO2: 95%
   ABG: 7.35/29/75/15/-7
   Ve: 8.2 L/min
   PaO2 / FiO2: 150
   Physical Examination
   General: NAD, sedated and intubated, bare hugger in place
   HEENT: jaundice, scleral icterus, PERRL
   Heart: irregular, tachycardic, no MRG
   Lungs: CTA anterior fields, no WRR
   Abdomen: NTND, ABS, no palpable masses
   Extremities: WWP, CR < 2s
   Labs / Radiology
   334 K/uL
   11.7 g/dL
   113 mg/dL
   2.8 mg/dL
   15 mEq/L
   4.3 mEq/L
   51 mg/dL
   106 mEq/L
   137 mEq/L
   36.3 %
   20.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
                             [**2181-10-15**]  08:43 AM
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
   WBC
   17.1
   20.7
   Hct
   31.0
   36.3
   Plt
   300
   334
   Cr
   1.8
   2.4
   2.8
   TropT
   0.11
   0.11
   0.11
   TCO2
   17
   17
   17
   17
   17
   16
   17
   Glucose
   200
   133
   118
   113
   Other labs: PT / PTT / INR:37.3/51.0/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:1862/2292, Alk Phos / T
   Bili:1043/18.0, Amylase / Lipase:243/383, Differential-Neuts:90.0 %,
   Band:2.0 %, Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL,
   Lactic Acid:3.0 mmol/L, Albumin:2.0 g/dL, LDH:849 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.3 mg/dL
   Micro:
   - urine culture [**10-13**]
 e. coli
   - MRSA [**10-13**]
 pos.
   - BAL [**10-13**]
 staph aureus
   - blood culture [**10-14**]
 coagulase neg. staph
   - blood culture [**10-15**]
 [**10-16**]
 pending
   - urine culture [**10-15**]
 pending
   Imaging:
   - CT Abd-Pelvis
 moderate bilateral pleural effusion with underlying
   consolidation / atelectasis, fluid stranding about pancreatic tail c/w
   pancreatitis, ascites or anasarca
   - CXR
 small bilateral pleural effusion right > left, heterogenous
   opacification of left lower lobe concerning for pneumonia and
   progressing since [**10-14**]
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Septic Shock: continued hypotension on pressors (vasopressin and
   phenylephrine), possible infectious sources include urosepsis,
   pneumonia, cholangitis, line infection
    - continue broad spectrum meropenum and vancomycin considering e.coli
   and klebsiella, MRSA + and s. aureus on BAL and discontinue flagyl
    - continue pressors to maintain MAP > 65
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos.
   - f/u RUQ Doppler of PV and HV
   - continue to trend lacate now 3.0 from peak of 5.8 on [**10-14**]
   #Hypoxic: patient with large effusion and likely underlying pneumonia
    -continue AC vent
 attempt transition to pressure support with goal
   TVol 300
   - f/u sensitivies of S. aureus + BAL, already being treated with
   vancomycin
   - continue to follow ABG
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u urine lytes
 urine OSM 277, Cr 49, Urea 68, Na 85
   - consider HD vs. CVVH given anuric renal failure, will f/u renal
   consult
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - consider therapeutic thoracentesis if hypoxia continues
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes with digoxin to improve
   atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:  [**Last Name (LF) **], [**First Name3 (LF) **]
   Stress ulcer: lansoprazole
   VAP:  HOB elevation
   Comments:
   Communication:  Comments:
   Code status: chemical  code
   Disposition: ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - transthoracic echo performed: suboptimal image quality, normal LV
   cavity size with moderate global hypokinesis (LVEF 30-35 %) c/w diffuse
   process, moderate MR, moderate to severe TR, pulmonary a. systolic HTN
   - call renal for HD/CVVH consult pending d/w Dr. [**Last Name (STitle) 775**] and family
   - Doppler US of PV and HV per hepatology: results pending
   - ERCP consult: recommends MRCP
   - Troponin bump to 0.11 x 3 from initial baseline of 0.02 at admission
   - Multiple boluses with albumin for hypotension continued on 2 pressors
   - UTI and urine cultures from [**Hospital1 608**] on [**10-11**] and [**10-15**]
 E. Coli and
   Klebsiella
   sensitive to ertapenum and imipenum
   -need to call wound care consult in the am
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 01:21 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Lansoprazole (Prevacid) - [**2181-10-16**] 12:22 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-16**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98
   Tcurrent: 36.7
C (98
   HR: 121 (97 - 128) bpm
   BP: 99/73(83) {81/49(61) - 118/76(91)} mmHg
   RR: 28 (24 - 28) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (6 - 15)mmHg
   Total In:
                                                                  1,774 mL
                                                                  1,098 mL
   PO:
   TF:
   IVF:
                                                                  1,214 mL
                                                                    838 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     19 mL
                                                                      0 mL
   Urine:
                                                                     19 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,755 mL
                                                                  1,098 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 71
   PIP: 20 cmH2O
   Plateau: 19 cmH2O
   SpO2: 95%
   ABG: 7.35/29/75/15/-7
   Ve: 8.2 L/min
   PaO2 / FiO2: 150
   Physical Examination
   General: NAD, sedated and intubated, bare hugger in place
   HEENT: jaundice, scleral icterus, PERRL
   Heart: irregular, tachycardic, no MRG
   Lungs: CTA anterior fields, no WRR
   Abdomen: NTND, ABS, no palpable masses
   Extremities: WWP, CR < 2s
   Labs / Radiology
   334 K/uL
   11.7 g/dL
   113 mg/dL
   2.8 mg/dL
   15 mEq/L
   4.3 mEq/L
   51 mg/dL
   106 mEq/L
   137 mEq/L
   36.3 %
   20.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
                             [**2181-10-15**]  08:43 AM
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
   WBC
   17.1
   20.7
   Hct
   31.0
   36.3
   Plt
   300
   334
   Cr
   1.8
   2.4
   2.8
   TropT
   0.11
   0.11
   0.11
   TCO2
   17
   17
   17
   17
   17
   16
   17
   Glucose
   200
   133
   118
   113
   Other labs: PT / PTT / INR:37.3/51.0/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:1862/2292, Alk Phos / T
   Bili:1043/18.0, Amylase / Lipase:243/383, Differential-Neuts:90.0 %,
   Band:2.0 %, Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL,
   Lactic Acid:3.0 mmol/L, Albumin:2.0 g/dL, LDH:849 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.3 mg/dL
   Micro:
   - urine culture [**10-13**]
 e. coli
   - MRSA [**10-13**]
 pos.
   - BAL [**10-13**]
 staph aureus
   - blood culture [**10-14**]
 coagulase neg. staph
   - blood culture [**10-15**]
 [**10-16**]
 pending
   - urine culture [**10-15**]
 pending
   Imaging:
   - CT Abd-Pelvis
 moderate bilateral pleural effusion with underlying
   consolidation / atelectasis, fluid stranding about pancreatic tail c/w
   pancreatitis, ascites or anasarca
   - CXR
 small bilateral pleural effusion right > left, heterogenous
   opacification of left lower lobe concerning for pneumonia and
   progressing since [**10-14**]
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Septic Shock: continued hypotension on pressors (vasopressin and
   phenylephrine), possible infectious sources include urosepsis,
   pneumonia, cholangitis, line infection
    - continue broad spectrum meropenum and vancomycin considering e.coli
   and klebsiella, MRSA + and s. aureus on BAL and discontinue flagyl
    - continue pressors to maintain MAP > 65
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos.
   - f/u RUQ Doppler of PV and HV
   - continue to trend lacate now 3.0 from peak of 5.8 on [**10-14**]
   #Hypoxic: patient with large effusion and likely underlying pneumonia
    -continue AC vent
 attempt transition to pressure support with goal
   TVol 300
   - f/u sensitivies of S. aureus + BAL, already being treated with
   vancomycin
   - continue to follow ABG
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u urine lytes
 urine OSM 277, Cr 49, Urea 68, Na 85
   - consider HD vs. CVVH given anuric renal failure, will f/u renal
   consult
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - consider therapeutic thoracentesis if hypoxia continues
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes with digoxin to improve
   atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:  [**Last Name (LF) **], [**First Name3 (LF) **]
   Stress ulcer: lansoprazole
   VAP:  HOB elevation
   Comments:
   Communication:  Comments:
   Code status: chemical  code
   Disposition: ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old woman admitted with progressive painless jaundice, hypotension, and hypothermia, likely representing sepsis. The patient has multiple medical conditions, including:

1. Septic Shock: The patient has continued hypotension on pressors (vasopressin and phenylephrine), and possible infectious sources include urosepsis, pneumonia, cholangitis, and line infection. The patient is being treated with broad-spectrum antibiotics, including meropenem and vancomycin.
2. Hypoxic: The patient has a large effusion and likely underlying pneumonia, which is being treated with AC vent and pressure support with a goal TVol of 300.
3. Metabolic Acidosis: The patient has lactic acidosis, which is likely due to sepsis and is being treated with broad-spectrum antibiotics and adequate MAPs.
4. Elevated LFT: The patient's liver function tests (LFTs) are elevated, likely representing component of superimposed shock liver given poor distal perfusion.
5. Acute Renal Failure: The patient has anuric renal failure, likely hemodynamic in origin due to poor perfusion, and is being treated with renally dosed medications and considering HD vs. CVVH.
6. Bilateral Pleural Effusions: The patient has left-sided pleural effusion, which is likely contributing to hypoxia.
7. Atrial Fibrillation: The patient is currently in afib with RVR and will be monitored for rate control if BP stabilizes with digoxin to improve atrial kick.
8. Diastolic Heart Failure: The patient is being held on beta blockers and lasix due to hemodynamic instability.

Potential medical complications that can arise include:

1. Worsening septic shock and organ dysfunction
2. Progression of pneumonia and respiratory failure
3. Development of acute respiratory distress syndrome (ARDS)
4. Increased risk of bleeding due to coagulopathy and platelet dysfunction
5. Worsening liver dysfunction and potential development of liver failure
6. Progression of acute renal failure to chronic kidney disease
7. Development of electrolyte imbalances and acid-base disorders
8. Increased risk of cardiovascular complications, such as arrhythmias and heart failure, due to atrial fibrillation and diastolic heart failure.

The patient requires close monitoring and management of these conditions to prevent complications and improve outcomes."
174373.0,234940,2181-10-16 07:24:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - transthoracic echo performed: suboptimal image quality, normal LV
   cavity size with moderate global hypokinesis (LVEF 30-35 %) c/w diffuse
   process, moderate MR, moderate to severe TR, pulmonary a. systolic HTN
   - call renal for HD/CVVH consult pending d/w Dr. [**Last Name (STitle) 775**] and family
   - Doppler US of PV and HV per hepatology: results pending
   - ERCP consult: recommends MRCP
   - Troponin bump to 0.11 x 3 from initial baseline of 0.02 at admission
   - Multiple boluses with albumin for hypotension continued on 2 pressors
   - UTI and urine cultures from [**Hospital1 608**] on [**10-11**] and [**10-15**]
 E. Coli and
   Klebsiella
   sensitive to ertapenum and imipenum
   -need to call wound care consult in the am
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 01:21 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Lansoprazole (Prevacid) - [**2181-10-16**] 12:22 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-16**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98
   Tcurrent: 36.7
C (98
   HR: 121 (97 - 128) bpm
   BP: 99/73(83) {81/49(61) - 118/76(91)} mmHg
   RR: 28 (24 - 28) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (6 - 15)mmHg
   Total In:
                                                                  1,774 mL
                                                                  1,098 mL
   PO:
   TF:
   IVF:
                                                                  1,214 mL
                                                                    838 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     19 mL
                                                                      0 mL
   Urine:
                                                                     19 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,755 mL
                                                                  1,098 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 71
   PIP: 20 cmH2O
   Plateau: 19 cmH2O
   SpO2: 95%
   ABG: 7.35/29/75/15/-7
   Ve: 8.2 L/min
   PaO2 / FiO2: 150
   Physical Examination
   General: NAD, sedated and intubated, bare hugger in place
   HEENT: jaundice, scleral icterus, PERRL
   Heart: irregular, tachycardic, no MRG
   Lungs: CTA anterior fields, no WRR
   Abdomen: NTND, ABS, no palpable masses
   Extremities: WWP, CR < 2s
   Labs / Radiology
   334 K/uL
   11.7 g/dL
   113 mg/dL
   2.8 mg/dL
   15 mEq/L
   4.3 mEq/L
   51 mg/dL
   106 mEq/L
   137 mEq/L
   36.3 %
   20.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
                             [**2181-10-15**]  08:43 AM
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
   WBC
   17.1
   20.7
   Hct
   31.0
   36.3
   Plt
   300
   334
   Cr
   1.8
   2.4
   2.8
   TropT
   0.11
   0.11
   0.11
   TCO2
   17
   17
   17
   17
   17
   16
   17
   Glucose
   200
   133
   118
   113
   Other labs: PT / PTT / INR:37.3/51.0/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:1862/2292, Alk Phos / T
   Bili:1043/18.0, Amylase / Lipase:243/383, Differential-Neuts:90.0 %,
   Band:2.0 %, Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL,
   Lactic Acid:3.0 mmol/L, Albumin:2.0 g/dL, LDH:849 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.3 mg/dL
   Micro:
   - urine culture [**10-13**]
 e. coli
   - MRSA [**10-13**]
 pos.
   - BAL [**10-13**]
 staph aureus
   - blood culture [**10-14**]
 coagulase neg. staph
   - blood culture [**10-15**]
 [**10-16**]
 pending
   - urine culture [**10-15**]
 pending
   Imaging:
   - CT Abd-Pelvis
 moderate bilateral pleural effusion with underlying
   consolidation / atelectasis, fluid stranding about pancreatic tail c/w
   pancreatitis, ascites or anasarca
   - CXR
 small bilateral pleural effusion right > left, heterogenous
   opacification of left lower lobe concerning for pneumonia and
   progressing since [**10-14**]
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Septic Shock: continued hypotension on pressors (vasopressin and
   phenylephrine), possible infectious sources include urosepsis,
   pneumonia, cholangitis, line infection
    - continue broad spectrum meropenum, flagyl and vancomycin considering
   e.coli and klebsiella, MRSA + and s. aureus on BAL
    - continue pressors to maintain MAP > 65
    - continue IVF boluses to maintain CVP 15-20
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines in setting of + blood Cx
   - f/u RUQ Doppler of PV and HV
   - f/u CXR
   - continue to trend lacate now 3.0 from peak of 5.8 on [**10-14**]
   #Hypoxic: patient with large effusion and currently ventilated on ARDs
   net protocol, possible underlying pneumonia
    -continue AC vent
   - f/u sensitivies of S. aureus + BAL, already being treated with
   vancomycin
   - consider tap of effusions
 maybe therapeutic given their size
   - continue to follow ABG
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors and fluid boluses to improve distal perfusion
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u urine lytes
 urine OSM 277, Cr 49, Urea 68, Na 85
   - consider HD vs. CVVH given anuric renal failure, will f/u renal
   consult
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - consider therapeutic thoracentesis if hypoxia continues
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes to improve atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: chemical  code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - transthoracic echo performed: suboptimal image quality, normal LV
   cavity size with moderate global hypokinesis (LVEF 30-35 %) c/w diffuse
   process, moderate MR, moderate to severe TR, pulmonary a. systolic HTN
   - call renal for HD/CVVH consult pending d/w Dr. [**Last Name (STitle) 775**] and family
   - Doppler US of PV and HV per hepatology: results pending
   - ERCP consult: recommends MRCP
   - Troponin bump to 0.11 x 3 from initial baseline of 0.02 at admission
   - Multiple boluses with albumin for hypotension continued on 2 pressors
   - UTI and urine cultures from [**Hospital1 608**] on [**10-11**] and [**10-15**]
 E. Coli and
   Klebsiella
   sensitive to ertapenum and imipenum
   -need to call wound care consult in the am
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 01:21 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Lansoprazole (Prevacid) - [**2181-10-16**] 12:22 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-16**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98
   Tcurrent: 36.7
C (98
   HR: 121 (97 - 128) bpm
   BP: 99/73(83) {81/49(61) - 118/76(91)} mmHg
   RR: 28 (24 - 28) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (6 - 15)mmHg
   Total In:
                                                                  1,774 mL
                                                                  1,098 mL
   PO:
   TF:
   IVF:
                                                                  1,214 mL
                                                                    838 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     19 mL
                                                                      0 mL
   Urine:
                                                                     19 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,755 mL
                                                                  1,098 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 71
   PIP: 20 cmH2O
   Plateau: 19 cmH2O
   SpO2: 95%
   ABG: 7.35/29/75/15/-7
   Ve: 8.2 L/min
   PaO2 / FiO2: 150
   Physical Examination
   General: NAD, sedated and intubated, bare hugger in place
   HEENT: jaundice, scleral icterus, PERRL
   Heart: irregular, tachycardic, no MRG
   Lungs: CTA anterior fields, no WRR
   Abdomen: NTND, ABS, no palpable masses
   Extremities: WWP, CR < 2s
   Labs / Radiology
   334 K/uL
   11.7 g/dL
   113 mg/dL
   2.8 mg/dL
   15 mEq/L
   4.3 mEq/L
   51 mg/dL
   106 mEq/L
   137 mEq/L
   36.3 %
   20.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
                             [**2181-10-15**]  08:43 AM
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
   WBC
   17.1
   20.7
   Hct
   31.0
   36.3
   Plt
   300
   334
   Cr
   1.8
   2.4
   2.8
   TropT
   0.11
   0.11
   0.11
   TCO2
   17
   17
   17
   17
   17
   16
   17
   Glucose
   200
   133
   118
   113
   Other labs: PT / PTT / INR:37.3/51.0/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:1862/2292, Alk Phos / T
   Bili:1043/18.0, Amylase / Lipase:243/383, Differential-Neuts:90.0 %,
   Band:2.0 %, Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL,
   Lactic Acid:3.0 mmol/L, Albumin:2.0 g/dL, LDH:849 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.3 mg/dL
   Micro:
   - urine culture [**10-13**]
 e. coli
   - MRSA [**10-13**]
 pos.
   - BAL [**10-13**]
 staph aureus
   - blood culture [**10-14**]
 coagulase neg. staph
   - blood culture [**10-15**]
 [**10-16**]
 pending
   - urine culture [**10-15**]
 pending
   Imaging:
   - CT Abd-Pelvis
 moderate bilateral pleural effusion with underlying
   consolidation / atelectasis, fluid stranding about pancreatic tail c/w
   pancreatitis, ascites or anasarca
   - CXR
 small bilateral pleural effusion right > left, heterogenous
   opacification of left lower lobe concerning for pneumonia and
   progressing since [**10-14**]
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Septic Shock: continued hypotension on pressors (vasopressin and
   phenylephrine), possible infectious sources include urosepsis,
   pneumonia, cholangitis, line infection
    - continue broad spectrum meropenum, flagyl and vancomycin considering
   e.coli and klebsiella, MRSA + and s. aureus on BAL
    - continue pressors to maintain MAP > 65
    - continue IVF boluses to maintain CVP 15-20
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines in setting of + blood Cx
   - f/u RUQ Doppler of PV and HV
   - f/u CXR
   - continue to trend lacate now 3.0 from peak of 5.8 on [**10-14**]
   #Hypoxic: patient with large effusion and currently ventilated on ARDs
   net protocol, possible underlying pneumonia
    -continue AC vent
   - f/u sensitivies of S. aureus + BAL, already being treated with
   vancomycin
   - consider tap of effusions
 maybe therapeutic given their size
   - continue to follow ABG
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors and fluid boluses to improve distal perfusion
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u urine lytes
 urine OSM 277, Cr 49, Urea 68, Na 85
   - consider HD vs. CVVH given anuric renal failure, will f/u renal
   consult
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - consider therapeutic thoracentesis if hypoxia continues
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes to improve atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: chemical  code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the progress note, the patient is a 81-year-old female admitted with progressive painless jaundice, hypotension, and hypothermia, likely representing sepsis. The patient is currently in the ICU and is being treated for septic shock, hypoxia, metabolic acidosis, elevated liver function tests, acute renal failure, bilateral pleural effusions, atrial fibrillation, and diastolic heart failure.

The patient has undergone several diagnostic tests, including a transthoracic echo, Doppler US of PV and HV, ERCP consult, and imaging studies such as CT Abd-Pelvis and CXR. The results of these tests suggest moderate bilateral pleural effusion, underlying consolidation/atelectasis, fluid stranding about pancreatic tail c/w pancreatitis, ascites or anasarca, and small bilateral pleural effusion right > left, heterogenous opacification of left lower lobe concerning for pneumonia.

The patient's laboratory results show elevated white blood cell count, lactate levels, and liver function tests, as well as abnormal electrolyte levels. The patient's blood cultures have grown coagulase-negative Staphylococcus, Staphylococcus aureus, and E. coli.

The patient is being treated with broad-spectrum antibiotics, including meropenem, flagyl, and vancomycin, and is receiving vasopressin and phenylephrine to maintain mean arterial pressure above 65. The patient is also receiving IVF boluses to maintain central venous pressure between 15-20.

The patient's potential medical complications include:

1. Sepsis-related organ dysfunction: The patient's septic shock, hypoxia, and metabolic acidosis are all potential complications of sepsis.
2. Infection-related complications: The patient's positive blood cultures and urine culture results suggest the presence of infection, which could lead to further complications such as septic shock, organ failure, and death.
3. Respiratory failure: The patient's bilateral pleural effusions and pneumonia could lead to respiratory failure, which could be exacerbated by the patient's atrial fibrillation and diastolic heart failure.
4. Cardiac complications: The patient's atrial fibrillation and diastolic heart failure could lead to further cardiac complications, such as heart failure, arrhythmias, and cardiac arrest.
5. Renal failure: The patient's acute renal failure could worsen if not managed appropriately, leading to further complications such as electrolyte imbalances and acidosis.
6. Liver failure: The patient's elevated liver function tests and coagulopathy could lead to liver failure, which could be exacerbated by the patient's sepsis and other medical complications.
7. Nutritional deficiencies: The patient's inability to eat and drink could lead to nutritional deficiencies, which could exacerbate the patient's medical complications.

Overall, the patient is at high risk for further complications and requires close monitoring and management to prevent and treat these complications."
174373.0,234940,2181-10-16 07:24:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - blood cultures sent
   - transthoracic echo performed: suboptimal image quality, normal LV
   cavity size with moderate global hypokinesis (LVEF 30-35 %) c/w diffuse
   process, moderate MR, moderate to severe TR, pulmonary a. systolic HTN
   - call renal for HD/CVVH consult pending d/w Dr. [**Last Name (STitle) 775**] and family
   - Doppler US of PV and HV per hepatology: results pending
   - ERCP consult: recommends MRCP
   - Troponin bump to 0.11 x 3 from initial baseline of 0.02 at admission
   - Multiple boluses with albumin for hypotension
   - UTI and urine cultures from [**Hospital1 608**] on [**10-11**] and [**10-15**]
 E. Coli and
   Klebsiella
   sensitive to ertapenum and imipenum
   -need to call wound care consult in the am
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 01:21 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Lansoprazole (Prevacid) - [**2181-10-16**] 12:22 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-16**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98
   Tcurrent: 36.7
C (98
   HR: 121 (97 - 128) bpm
   BP: 99/73(83) {81/49(61) - 118/76(91)} mmHg
   RR: 28 (24 - 28) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (6 - 15)mmHg
   Total In:
                                                                  1,774 mL
                                                                  1,098 mL
   PO:
   TF:
   IVF:
                                                                  1,214 mL
                                                                    838 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     19 mL
                                                                      0 mL
   Urine:
                                                                     19 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,755 mL
                                                                  1,098 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 71
   PIP: 20 cmH2O
   Plateau: 19 cmH2O
   SpO2: 95%
   ABG: 7.35/29/75/15/-7
   Ve: 8.2 L/min
   PaO2 / FiO2: 150
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   334 K/uL
   11.7 g/dL
   113 mg/dL
   2.8 mg/dL
   15 mEq/L
   4.3 mEq/L
   51 mg/dL
   106 mEq/L
   137 mEq/L
   36.3 %
   20.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
                             [**2181-10-15**]  08:43 AM
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
   WBC
   17.1
   20.7
   Hct
   31.0
   36.3
   Plt
   300
   334
   Cr
   1.8
   2.4
   2.8
   TropT
   0.11
   0.11
   0.11
   TCO2
   17
   17
   17
   17
   17
   16
   17
   Glucose
   200
   133
   118
   113
   Other labs: PT / PTT / INR:37.3/51.0/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:1862/2292, Alk Phos / T
   Bili:1043/18.0, Amylase / Lipase:243/383, Differential-Neuts:90.0 %,
   Band:2.0 %, Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL,
   Lactic Acid:3.0 mmol/L, Albumin:2.0 g/dL, LDH:849 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.3 mg/dL
   Micro:
   - urine culture [**10-13**]
 e. coli
   - MRSA [**10-13**]
 pos.
   - BAL [**10-13**]
 staph aureus
   - blood culture [**10-14**]
 coagulase neg. staph
   - blood culture [**10-15**]
 [**10-16**]
 pending
   - urine culture [**10-15**]
 pending
   Imaging:
   - CT Abd-Pelvis
 moderate bilateral pleural effusion with underlying
   consolidation / atelectasis, fluid stranding about pancreatic tail c/w
   pancreatitis, ascites or anasarca
   - CXR
 small bilateral pleural effusion right > left, heterogenous
   opacification of left lower lobe concerning for pneumonia and
   progressing since [**10-14**]
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Septic Shock: continued hypotension on pressors, possible infectious
   sources include urosepsis, pneumonia, cholangitis, line infection
    - continue broad spectrum meropenum, flagyl and vancomycin considering
   e.coli and klebsiella, MRSA + and s. aureus on BAL
    - continue pressors to maintain MAP > 65
    - continue IVF boluses to maintain CVP 15-20
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines in setting of + blood Cx
   - f/u RUQ Doppler of PV and HV
   - f/u CXR
   - continue to trend lacate now 3.0 from peak of 5.8 on [**10-14**]
   #Hypoxic: patient with large effusion and currently ventilated on ARDs
   net protocol, possible underlying pneumonia
    -continue AC vent
   - f/u sensitivies of S. aureus + BAL, already being treated with
   vancomycin
   - consider tap of effusions
 maybe therapeutic given their size
   - continue to follow ABG
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors and fluid boluses to improve distal perfusion
   - empiric ABX
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u urine lytes
 urine OSM 277, Cr 49, Urea 68, Na 85
   - consider HD vs. CVVH given anuric renal failure
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - consider therapeutic thoracentesis if hypoxia continues
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes to improve atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: chemical  code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - blood cultures sent
   - transthoracic echo performed: suboptimal image quality, normal LV
   cavity size with moderate global hypokinesis (LVEF 30-35 %) c/w diffuse
   process, moderate MR, moderate to severe TR, pulmonary a. systolic HTN
   - call renal for HD/CVVH consult pending d/w Dr. [**Last Name (STitle) 775**] and family
   - Doppler US of PV and HV per hepatology: results pending
   - ERCP consult: recommends MRCP
   - Troponin bump to 0.11 x 3 from initial baseline of 0.02 at admission
   - Multiple boluses with albumin for hypotension
   - UTI and urine cultures from [**Hospital1 608**] on [**10-11**] and [**10-15**]
 E. Coli and
   Klebsiella
   sensitive to ertapenum and imipenum
   -need to call wound care consult in the am
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 01:21 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Lansoprazole (Prevacid) - [**2181-10-16**] 12:22 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-16**] 06:37 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98
   Tcurrent: 36.7
C (98
   HR: 121 (97 - 128) bpm
   BP: 99/73(83) {81/49(61) - 118/76(91)} mmHg
   RR: 28 (24 - 28) insp/min
   SpO2: 95%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (6 - 15)mmHg
   Total In:
                                                                  1,774 mL
                                                                  1,098 mL
   PO:
   TF:
   IVF:
                                                                  1,214 mL
                                                                    838 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     19 mL
                                                                      0 mL
   Urine:
                                                                     19 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,755 mL
                                                                  1,098 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 300 (300 - 300) mL
   RR (Set): 28
   RR (Spontaneous): 0
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 71
   PIP: 20 cmH2O
   Plateau: 19 cmH2O
   SpO2: 95%
   ABG: 7.35/29/75/15/-7
   Ve: 8.2 L/min
   PaO2 / FiO2: 150
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   334 K/uL
   11.7 g/dL
   113 mg/dL
   2.8 mg/dL
   15 mEq/L
   4.3 mEq/L
   51 mg/dL
   106 mEq/L
   137 mEq/L
   36.3 %
   20.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  03:59 AM
                             [**2181-10-15**]  06:32 AM
                             [**2181-10-15**]  08:43 AM
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
   WBC
   17.1
   20.7
   Hct
   31.0
   36.3
   Plt
   300
   334
   Cr
   1.8
   2.4
   2.8
   TropT
   0.11
   0.11
   0.11
   TCO2
   17
   17
   17
   17
   17
   16
   17
   Glucose
   200
   133
   118
   113
   Other labs: PT / PTT / INR:37.3/51.0/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:1862/2292, Alk Phos / T
   Bili:1043/18.0, Amylase / Lipase:243/383, Differential-Neuts:90.0 %,
   Band:2.0 %, Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL,
   Lactic Acid:3.0 mmol/L, Albumin:2.0 g/dL, LDH:849 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.3 mg/dL
   Micro:
   - urine culture [**10-13**]
 e. coli
   - MRSA [**10-13**]
 pos.
   - BAL [**10-13**]
 staph aureus
   - blood culture [**10-14**]
 coagulase neg. staph
   - blood culture [**10-15**]
 [**10-16**]
 pending
   - urine culture [**10-15**]
 pending
   Imaging:
   - CT Abd-Pelvis
 moderate bilateral pleural effusion with underlying
   consolidation / atelectasis, fluid stranding about pancreatic tail c/w
   pancreatitis, ascites or anasarca
   - CXR
 small bilateral pleural effusion right > left, heterogenous
   opacification of left lower lobe concerning for pneumonia and
   progressing since [**10-14**]
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Septic Shock: continued hypotension on pressors, possible infectious
   sources include urosepsis, pneumonia, cholangitis, line infection
    - continue broad spectrum meropenum, flagyl and vancomycin considering
   e.coli and klebsiella, MRSA + and s. aureus on BAL
    - continue pressors to maintain MAP > 65
    - continue IVF boluses to maintain CVP 15-20
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines in setting of + blood Cx
   - f/u RUQ Doppler of PV and HV
   - f/u CXR
   - continue to trend lacate now 3.0 from peak of 5.8 on [**10-14**]
   #Hypoxic: patient with large effusion and currently ventilated on ARDs
   net protocol, possible underlying pneumonia
    -continue AC vent
   - f/u sensitivies of S. aureus + BAL, already being treated with
   vancomycin
   - consider tap of effusions
 maybe therapeutic given their size
   - continue to follow ABG
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors and fluid boluses to improve distal perfusion
   - empiric ABX
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u urine lytes
 urine OSM 277, Cr 49, Urea 68, Na 85
   - consider HD vs. CVVH given anuric renal failure
   # Bilateral Pleural Effusions: Left sided pleural effusion sig
   increased compared to last CXR from [**10-12**] at OSH. Per records these have
   been attributed to heart failure and have been transudative. Likely
   these effusions contributing to hypoxia.
   - cont to follow on CXR
   - consider therapeutic thoracentesis if hypoxia continues
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes to improve atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: chemical  code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided medical progress note, the patient is a 81-year-old female admitted with progressive painless jaundice, hypotension, and hypothermia, likely representing sepsis. The patient has multiple comorbidities, including atrial fibrillation, diastolic heart failure, and acute renal failure.

The patient's vital signs are stable, with a temperature of 36.7C, heart rate of 121 bpm, and blood pressure of 99/73 mmHg. The patient is intubated and receiving mechanical ventilation.

The patient has multiple laboratory abnormalities, including:

* Elevated white blood cell count (17.1 x 10^9/L)
* Elevated lactate level (3.0 mmol/L)
* Elevated liver enzymes (ALT 1862 U/L, AST 2292 U/L)
* Elevated bilirubin level (51 mg/dL)
* Elevated creatinine level (2.4 mg/dL)
* Anemia (Hct 31.0%)
* Thrombocytopenia (Platelet count 300 x 10^9/L)

The patient has multiple potential sources of sepsis, including urosepsis, pneumonia, cholangitis, and line infection. The patient is receiving broad-spectrum antibiotics, including meropenem, flagyl, and vancomycin.

The patient has multiple potential complications, including:

* Septic shock: The patient's hypotension is likely due to septic shock, and the patient is receiving vasopressors to maintain a mean arterial pressure of greater than 65 mmHg.
* Acute respiratory distress syndrome (ARDS): The patient's hypoxia is likely due to ARDS, and the patient is receiving mechanical ventilation.
* Metabolic acidosis: The patient's lactic acidosis is likely due to sepsis, and the patient is receiving broad-spectrum antibiotics and vasopressors to improve distal perfusion.
* Elevated liver enzymes: The patient's liver enzymes are elevated, likely due to superimposed shock liver or hepatic injury.
* Acute renal failure: The patient's creatinine level is elevated, likely due to hemodynamic in origin.
* Bilateral pleural effusions: The patient's pleural effusions are likely due to heart failure and are contributing to hypoxia.
* Atrial fibrillation: The patient is in atrial fibrillation, which is likely contributing to the patient's hypotension and hypoxia.

The patient requires close monitoring and management of her multiple comorbidities and potential complications. The patient's treatment plan should include:

* Continued broad-spectrum antibiotics to cover potential sources of sepsis
* Vasopressors to maintain a mean arterial pressure of greater than 65 mmHg
* Mechanical ventilation to manage ARDS
* Fluid management to prevent fluid overload and improve distal perfusion
* Renal replacement therapy to manage acute renal failure
* Management of the patient's liver enzymes and potential liver dysfunction
* Management of the patient's atrial fibrillation and potential heart failure
* Close monitoring of the patient's pleural effusions and potential need for therapeutic thoracentesis."
174373.0,234940,2181-10-17 07:27:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Nutrition Consult: continue current tube feeds and decrease goal rate
   to 30 cc/hr
   - Renal consult: patient is not a good candidate for CVVH given poor
   prognosis, multiple critical issues and pressor requirements
   - Flagyl discontinued
   -BAL grew MRSA
   -blood cx coag negative staph
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.6 mcg/Kg/min
   Other ICU medications:
   Fentanyl - [**2181-10-17**] 03:19 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-17**] 07:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 37.1
C (98.8
   HR: 133 (112 - 133) bpm
   BP: 98/65(77) {81/59(67) - 126/85(98)} mmHg
   RR: 15 (14 - 28) insp/min
   SpO2: 96%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (5 - 21)mmHg
   Total In:
                                                                  1,966 mL
                                                                    340 mL
   PO:
   TF:
                                                                    150 mL
                                                                    211 mL
   IVF:
                                                                  1,496 mL
                                                                    129 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     55 mL
                                                                    390 mL
   Urine:
                                                                     55 mL
                                                                     20 mL
   NG:
   Stool:
   Drains:
                                                                     70 mL
   Balance:
                                                                  1,911 mL
                                                                    -50 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 300 (300 - 300) mL
   Vt (Spontaneous): 412 (410 - 492) mL
   PS : 14 cmH2O
   RR (Set): 28
   RR (Spontaneous): 13
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   SpO2: 96%
   ABG: 7.32/28/106/15/-10
   Ve: 5.1 L/min
   PaO2 / FiO2: 212
   Physical Examination
   General Appearance: No acute distress
   Eyes / Conjunctiva: icteric
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: No(t) Normal), (S2: No(t) Normal), irregularly
   irregular, tachycardic
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: )
   Abdominal: Soft, No(t) Non-tender, No(t) Bowel sounds present,
   hypoactive bowel sounds
   Extremities: Right lower extremity edema: 3+, Left lower extremity
   edema: 3+
   Skin:  Not assessed, Jaundice
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   159 K/uL
   9.8 g/dL
   152 mg/dL
   3.1 mg/dL
   15 mEq/L
   3.9 mEq/L
   57 mg/dL
   107 mEq/L
   137 mEq/L
   29.9 %
   18.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
   WBC
   20.7
   18.7
   Hct
   36.3
   29.9
   Plt
   334
   159
   Cr
   2.4
   2.8
   3.1
   TropT
   0.11
   0.11
   TCO2
   17
   17
   17
   16
   17
   15
   15
   Glucose
   133
   118
   113
   152
   Other labs: PT / PTT / INR:37.9/51.1/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:912/880, Alk Phos / T Bili:693/20.2,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:486 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.4 mg/dL
   Imaging: U/S liver/gallbladder:
   IMPRESSION:
   Patent flow identified within the portal vein and hepatic veins on
   doppler
   son[**Name (NI) **].
   CXR ([**10-16**]):
   In comparison with the study of [**10-15**], there is continued
   enlargement of the cardiac silhouette with bibasilar opacification
   consistent
   with volume loss and pleural effusions. Patchy opacification in the
   left mid
   lung zone is again seen, worrisome for pneumonia. Monitoring support
   devices
   remain in place.
   Microbiology:    URINE CULTURE (Preliminary):
         ESCHERICHIA COLI.    >100,000 ORGANISMS/ML..
            PRESUMPTIVE IDENTIFICATION OF TWO COLONIAL MORPHOLOGIES.
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                ESCHERICHIA COLI
                                |
   AMPICILLIN------------  =>32 R
   AMPICILLIN/SULBACTAM--  =>32 R
   CEFAZOLIN-------------    16 I
   CEFEPIME--------------   <=1 S
   CEFTAZIDIME-----------   <=1 S
   CEFTRIAXONE-----------   <=1 S
   CEFUROXIME------------    16 I
   CIPROFLOXACIN---------   =>4 R
   GENTAMICIN------------   <=1 S
   MEROPENEM-------------<=0.25 S
   NITROFURANTOIN--------  <=16 S
   PIPERACILLIN---------- =>128 R
   PIPERACILLIN/TAZO-----     8 S
   TOBRAMYCIN------------   <=1 S
   TRIMETHOPRIM/SULFA----   <=1 S
   Blood culture:
         STAPHYLOCOCCUS, COAGULASE NEGATIVE.
   _________________________________________________________
                                STAPHYLOCOCCUS, COAGULASE NEGATIVE
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------<=0.25 S
   TETRACYCLINE----------     4 S
   VANCOMYCIN------------   <=1 S
   BAL culture:
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                STAPH AUREUS COAG +
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------   =>4 R
   RIFAMPIN-------------- <=0.5 S
   TETRACYCLINE----------   <=1 S
   TRIMETHOPRIM/SULFA---- <=0.5 S
   VANCOMYCIN------------   <=1 S
   [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY
   {STAPHYLOCOCCUS, COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE
   NEGATIVE}; Aerobic Bottle Gram Stain-FINAL; Anaerobic Bottle Gram
   Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {ESCHERICHIA COLI}
   INPATIENT
   Assessment and Plan
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: likely SIRS/septic shock, continued hypotension on pressors
   (vasopressin and phenylephrine), infectious source likely MRSA
   pneumonia vs urosepsis
    -urine growing e.coli and enterococcus (no sensitivties yet, <10,000
   growing). BAL growing MRSA.
    - currently on meropenem and vancomycin. Vancomycin seems appropriate
   for MRSA (day 1 = [**10-14**]). E.coli in urine most sensitive to [**Last Name (un) 614**], also
   quite sensitive to ceftriaxone and ceftazidime. Could consider
   switching to ceftriaxone pending enterococcus sensitivities..
    - continue pressors to maintain MAP > 65
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   - continue to trend lacate now 2.8 from peak of 5.8 on [**10-14**]
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    -continue AC vent
 attempt transition to pressure support with goal
   TVol 300
   - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction (too sick for ERCP, has pacer and can
t get MRCP)
 LFT
s now trending down likely representing component of superimposed
   shock liver given poor distal perfusion- INR and tbili continue to
   trend up.
   - appreciate liver and ERCP recs
   - liver workup negative
negative hepatitis, AMA, [**Doctor First Name **], etc.
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - as per renal, not a great candidate for CVVH b/c multiple pressors
   and critically ill. Patient had expressed that she would not want to be
   on HD longterm. Will discuss with family option of dialysis, but
   unlikely to be of great utility
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - will start dig today (renally dosed)
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - Nutrition Consult: continue current tube feeds and decrease goal rate
   to 30 cc/hr
   - Renal consult: patient is not a good candidate for CVVH given poor
   prognosis, multiple critical issues and pressor requirements
   - Flagyl discontinued
   -BAL grew MRSA
   -blood cx coag negative staph
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.6 mcg/Kg/min
   Other ICU medications:
   Fentanyl - [**2181-10-17**] 03:19 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-17**] 07:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 37.1
C (98.8
   HR: 133 (112 - 133) bpm
   BP: 98/65(77) {81/59(67) - 126/85(98)} mmHg
   RR: 15 (14 - 28) insp/min
   SpO2: 96%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (5 - 21)mmHg
   Total In:
                                                                  1,966 mL
                                                                    340 mL
   PO:
   TF:
                                                                    150 mL
                                                                    211 mL
   IVF:
                                                                  1,496 mL
                                                                    129 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     55 mL
                                                                    390 mL
   Urine:
                                                                     55 mL
                                                                     20 mL
   NG:
   Stool:
   Drains:
                                                                     70 mL
   Balance:
                                                                  1,911 mL
                                                                    -50 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 300 (300 - 300) mL
   Vt (Spontaneous): 412 (410 - 492) mL
   PS : 14 cmH2O
   RR (Set): 28
   RR (Spontaneous): 13
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   SpO2: 96%
   ABG: 7.32/28/106/15/-10
   Ve: 5.1 L/min
   PaO2 / FiO2: 212
   Physical Examination
   General Appearance: No acute distress
   Eyes / Conjunctiva: icteric
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: No(t) Normal), (S2: No(t) Normal), irregularly
   irregular, tachycardic
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: )
   Abdominal: Soft, No(t) Non-tender, No(t) Bowel sounds present,
   hypoactive bowel sounds
   Extremities: Right lower extremity edema: 3+, Left lower extremity
   edema: 3+
   Skin:  Not assessed, Jaundice
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   159 K/uL
   9.8 g/dL
   152 mg/dL
   3.1 mg/dL
   15 mEq/L
   3.9 mEq/L
   57 mg/dL
   107 mEq/L
   137 mEq/L
   29.9 %
   18.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
   WBC
   20.7
   18.7
   Hct
   36.3
   29.9
   Plt
   334
   159
   Cr
   2.4
   2.8
   3.1
   TropT
   0.11
   0.11
   TCO2
   17
   17
   17
   16
   17
   15
   15
   Glucose
   133
   118
   113
   152
   Other labs: PT / PTT / INR:37.9/51.1/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:912/880, Alk Phos / T Bili:693/20.2,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:486 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.4 mg/dL
   Imaging: U/S liver/gallbladder:
   IMPRESSION:
   Patent flow identified within the portal vein and hepatic veins on
   doppler
   son[**Name (NI) **].
   CXR ([**10-16**]):
   In comparison with the study of [**10-15**], there is continued
   enlargement of the cardiac silhouette with bibasilar opacification
   consistent
   with volume loss and pleural effusions. Patchy opacification in the
   left mid
   lung zone is again seen, worrisome for pneumonia. Monitoring support
   devices
   remain in place.
   Microbiology:    URINE CULTURE (Preliminary):
         ESCHERICHIA COLI.    >100,000 ORGANISMS/ML..
            PRESUMPTIVE IDENTIFICATION OF TWO COLONIAL MORPHOLOGIES.
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                ESCHERICHIA COLI
                                |
   AMPICILLIN------------  =>32 R
   AMPICILLIN/SULBACTAM--  =>32 R
   CEFAZOLIN-------------    16 I
   CEFEPIME--------------   <=1 S
   CEFTAZIDIME-----------   <=1 S
   CEFTRIAXONE-----------   <=1 S
   CEFUROXIME------------    16 I
   CIPROFLOXACIN---------   =>4 R
   GENTAMICIN------------   <=1 S
   MEROPENEM-------------<=0.25 S
   NITROFURANTOIN--------  <=16 S
   PIPERACILLIN---------- =>128 R
   PIPERACILLIN/TAZO-----     8 S
   TOBRAMYCIN------------   <=1 S
   TRIMETHOPRIM/SULFA----   <=1 S
   Blood culture:
         STAPHYLOCOCCUS, COAGULASE NEGATIVE.
   _________________________________________________________
                                STAPHYLOCOCCUS, COAGULASE NEGATIVE
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------<=0.25 S
   TETRACYCLINE----------     4 S
   VANCOMYCIN------------   <=1 S
   BAL culture:
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                STAPH AUREUS COAG +
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------   =>4 R
   RIFAMPIN-------------- <=0.5 S
   TETRACYCLINE----------   <=1 S
   TRIMETHOPRIM/SULFA---- <=0.5 S
   VANCOMYCIN------------   <=1 S
   [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY
   {STAPHYLOCOCCUS, COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE
   NEGATIVE}; Aerobic Bottle Gram Stain-FINAL; Anaerobic Bottle Gram
   Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {ESCHERICHIA COLI}
   INPATIENT
   Assessment and Plan
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: likely SIRS/septic shock, continued hypotension on pressors
   (vasopressin and phenylephrine), infectious source likely MRSA
   pneumonia vs urosepsis
    -urine growing e.coli and enterococcus (no sensitivties yet, <10,000
   growing). BAL growing MRSA.
    - currently on meropenem and vancomycin. Vancomycin seems appropriate
   for MRSA (day 1 = [**10-14**]). E.coli in urine most sensitive to [**Last Name (un) 614**], also
   quite sensitive to ceftriaxone and ceftazidime. Could consider
   switching to ceftriaxone pending enterococcus sensitivities..
    - continue pressors to maintain MAP > 65
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   - continue to trend lacate now 2.8 from peak of 5.8 on [**10-14**]
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    -continue AC vent
 attempt transition to pressure support with goal
   TVol 300
   - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction (too sick for ERCP, has pacer and can
t get MRCP)
 LFT
s now trending down likely representing component of superimposed
   shock liver given poor distal perfusion- INR and tbili continue to
   trend up.
   - appreciate liver and ERCP recs
   - liver workup negative
negative hepatitis, AMA, [**Doctor First Name **], etc.
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - as per renal, not a great candidate for CVVH b/c multiple pressors
   and critically ill. Patient had expressed that she would not want to be
   on HD longterm. Will discuss with family option of dialysis, but
   unlikely to be of great utility
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - will start dig today (renally dosed)
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old woman admitted to the ICU with progressive jaundice, hypotension, and hypothermia, likely representing sepsis. She has multiple comorbidities, including respiratory failure, acute kidney injury, metabolic acidosis, and atrial fibrillation. The patient is currently on broad-spectrum antibiotics, vasopressors, and respiratory support.

Potential Medical Complications:

1. Sepsis-related organ dysfunction: The patient's sepsis may lead to further organ dysfunction, such as acute kidney injury, respiratory failure, or liver failure.
2. Antimicrobial resistance: The patient's MRSA pneumonia and urinary tract infection may develop antimicrobial resistance, making treatment more challenging.
3. Hemodynamic instability: The patient's hypotension and tachycardia may worsen, leading to further organ dysfunction and increased risk of cardiac arrest.
4. Respiratory failure: The patient's respiratory failure may progress, requiring more aggressive respiratory support or mechanical ventilation.
5. Acute kidney injury: The patient's acute kidney injury may worsen, leading to the need for dialysis or further renal support.
6. Metabolic acidosis: The patient's metabolic acidosis may worsen, leading to further organ dysfunction and increased risk of cardiac arrest.
7. Liver failure: The patient's liver dysfunction may worsen, leading to coagulopathy, jaundice, and further organ dysfunction.
8. Cardiovascular instability: The patient's atrial fibrillation may worsen, leading to further cardiovascular instability and increased risk of cardiac arrest.
9. Infection control: The patient's multiple infections may lead to further complications, such as septic shock, organ failure, or death.
10. Nutritional deficiencies: The patient's malnutrition may worsen, leading to further organ dysfunction and increased risk of complications.

Recommendations:

1. Continue broad-spectrum antibiotics to cover MRSA and E. coli.
2. Monitor the patient's hemodynamic status closely and adjust vasopressors as necessary.
3. Continue respiratory support and consider increasing pressure support.
4. Monitor the patient's kidney function and consider dialysis if necessary.
5. Monitor the patient's liver function and consider further evaluation with MRCP/ERCP if necessary.
6. Monitor the patient's metabolic acidosis and adjust treatment as necessary.
7. Consider adding an anti-coagulant to prevent thrombosis.
8. Monitor the patient's cardiovascular status and adjust treatment as necessary.
9. Continue to monitor the patient's infection control and consider further evaluation if necessary.
10. Consider nutritional support to prevent malnutrition and further organ dysfunction."
174373.0,234940,2181-10-17 07:27:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Nutrition Consult: continue current tube feeds and decrease goal rate
   to 30 cc/hr
   - Renal consult: patient is not a good candidate for CVVH given poor
   prognosis, multiple critical issues and pressor requirements
   - Flagyl discontinued
   -BAL grew MRSA
   -blood cx coag negative staph
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.6 mcg/Kg/min
   Other ICU medications:
   Fentanyl - [**2181-10-17**] 03:19 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-17**] 07:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 37.1
C (98.8
   HR: 133 (112 - 133) bpm
   BP: 98/65(77) {81/59(67) - 126/85(98)} mmHg
   RR: 15 (14 - 28) insp/min
   SpO2: 96%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (5 - 21)mmHg
   Total In:
                                                                  1,966 mL
                                                                    340 mL
   PO:
   TF:
                                                                    150 mL
                                                                    211 mL
   IVF:
                                                                  1,496 mL
                                                                    129 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     55 mL
                                                                    390 mL
   Urine:
                                                                     55 mL
                                                                     20 mL
   NG:
   Stool:
   Drains:
                                                                     70 mL
   Balance:
                                                                  1,911 mL
                                                                    -50 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 300 (300 - 300) mL
   Vt (Spontaneous): 412 (410 - 492) mL
   PS : 14 cmH2O
   RR (Set): 28
   RR (Spontaneous): 13
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   SpO2: 96%
   ABG: 7.32/28/106/15/-10
   Ve: 5.1 L/min
   PaO2 / FiO2: 212
   Physical Examination
   General Appearance: No acute distress
   Eyes / Conjunctiva: icteric
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: No(t) Normal), (S2: No(t) Normal), irregularly
   irregular, tachycardic
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: )
   Abdominal: Soft, No(t) Non-tender, No(t) Bowel sounds present,
   hypoactive bowel sounds
   Extremities: Right lower extremity edema: 3+, Left lower extremity
   edema: 3+
   Skin:  Not assessed, Jaundice
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   159 K/uL
   9.8 g/dL
   152 mg/dL
   3.1 mg/dL
   15 mEq/L
   3.9 mEq/L
   57 mg/dL
   107 mEq/L
   137 mEq/L
   29.9 %
   18.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
   WBC
   20.7
   18.7
   Hct
   36.3
   29.9
   Plt
   334
   159
   Cr
   2.4
   2.8
   3.1
   TropT
   0.11
   0.11
   TCO2
   17
   17
   17
   16
   17
   15
   15
   Glucose
   133
   118
   113
   152
   Other labs: PT / PTT / INR:37.9/51.1/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:912/880, Alk Phos / T Bili:693/20.2,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:486 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.4 mg/dL
   Imaging: U/S liver/gallbladder:
   IMPRESSION:
   Patent flow identified within the portal vein and hepatic veins on
   doppler
   son[**Name (NI) **].
   CXR ([**10-16**]):
   In comparison with the study of [**10-15**], there is continued
   enlargement of the cardiac silhouette with bibasilar opacification
   consistent
   with volume loss and pleural effusions. Patchy opacification in the
   left mid
   lung zone is again seen, worrisome for pneumonia. Monitoring support
   devices
   remain in place.
   Microbiology:    URINE CULTURE (Preliminary):
         ESCHERICHIA COLI.    >100,000 ORGANISMS/ML..
            PRESUMPTIVE IDENTIFICATION OF TWO COLONIAL MORPHOLOGIES.
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                ESCHERICHIA COLI
                                |
   AMPICILLIN------------  =>32 R
   AMPICILLIN/SULBACTAM--  =>32 R
   CEFAZOLIN-------------    16 I
   CEFEPIME--------------   <=1 S
   CEFTAZIDIME-----------   <=1 S
   CEFTRIAXONE-----------   <=1 S
   CEFUROXIME------------    16 I
   CIPROFLOXACIN---------   =>4 R
   GENTAMICIN------------   <=1 S
   MEROPENEM-------------<=0.25 S
   NITROFURANTOIN--------  <=16 S
   PIPERACILLIN---------- =>128 R
   PIPERACILLIN/TAZO-----     8 S
   TOBRAMYCIN------------   <=1 S
   TRIMETHOPRIM/SULFA----   <=1 S
   Blood culture:
         STAPHYLOCOCCUS, COAGULASE NEGATIVE.
   _________________________________________________________
                                STAPHYLOCOCCUS, COAGULASE NEGATIVE
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------<=0.25 S
   TETRACYCLINE----------     4 S
   VANCOMYCIN------------   <=1 S
   BAL culture:
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                STAPH AUREUS COAG +
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------   =>4 R
   RIFAMPIN-------------- <=0.5 S
   TETRACYCLINE----------   <=1 S
   TRIMETHOPRIM/SULFA---- <=0.5 S
   VANCOMYCIN------------   <=1 S
   [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY
   {STAPHYLOCOCCUS, COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE
   NEGATIVE}; Aerobic Bottle Gram Stain-FINAL; Anaerobic Bottle Gram
   Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {ESCHERICHIA COLI}
   INPATIENT
   Assessment and Plan
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: likely SIRS, continued hypotension on pressors (vasopressin
   and phenylephrine), infectious source likely MRSA pneumonia vs E. coli
   urosepsis
    - currently on meropenem and vancomycin. Vancomycin seems appropriate
   for MRSA (day 1 = [**10-14**]). E.coli in urine most sensitive to [**Last Name (un) 614**], also
   quite sensitive to ceftriaxone and ceftazidime. Could consider
   switching to ceftriaxone.
    - continue pressors to maintain MAP > 65
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   - continue to trend lacate now 2.8 from peak of 5.8 on [**10-14**]
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    -continue AC vent
 attempt transition to pressure support with goal
   TVol 300
   - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - as per renal, not a great candidate for CVVH b/c multiple pressors
   and critically ill. Patient had expressed that she would not want to be
   on HD longterm. Will discuss with family option of dialysis, but
   unlikely to be of great utility and unlikely to be a bridge to better
   prognosis.
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes with digoxin to improve
   atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - Nutrition Consult: continue current tube feeds and decrease goal rate
   to 30 cc/hr
   - Renal consult: patient is not a good candidate for CVVH given poor
   prognosis, multiple critical issues and pressor requirements
   - Flagyl discontinued
   -BAL grew MRSA
   -blood cx coag negative staph
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-14**] 08:45 AM
   Vancomycin - [**2181-10-14**] 08:00 PM
   Metronidazole - [**2181-10-16**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.6 mcg/Kg/min
   Other ICU medications:
   Fentanyl - [**2181-10-17**] 03:19 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-17**] 07:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 37.1
C (98.8
   HR: 133 (112 - 133) bpm
   BP: 98/65(77) {81/59(67) - 126/85(98)} mmHg
   RR: 15 (14 - 28) insp/min
   SpO2: 96%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 11 (5 - 21)mmHg
   Total In:
                                                                  1,966 mL
                                                                    340 mL
   PO:
   TF:
                                                                    150 mL
                                                                    211 mL
   IVF:
                                                                  1,496 mL
                                                                    129 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                     55 mL
                                                                    390 mL
   Urine:
                                                                     55 mL
                                                                     20 mL
   NG:
   Stool:
   Drains:
                                                                     70 mL
   Balance:
                                                                  1,911 mL
                                                                    -50 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Set): 300 (300 - 300) mL
   Vt (Spontaneous): 412 (410 - 492) mL
   PS : 14 cmH2O
   RR (Set): 28
   RR (Spontaneous): 13
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 20 cmH2O
   Plateau: 18 cmH2O
   SpO2: 96%
   ABG: 7.32/28/106/15/-10
   Ve: 5.1 L/min
   PaO2 / FiO2: 212
   Physical Examination
   General Appearance: No acute distress
   Eyes / Conjunctiva: icteric
   Head, Ears, Nose, Throat: Endotracheal tube, OG tube
   Cardiovascular: (S1: No(t) Normal), (S2: No(t) Normal), irregularly
   irregular, tachycardic
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Rhonchorous: )
   Abdominal: Soft, No(t) Non-tender, No(t) Bowel sounds present,
   hypoactive bowel sounds
   Extremities: Right lower extremity edema: 3+, Left lower extremity
   edema: 3+
   Skin:  Not assessed, Jaundice
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Sedated,
   Tone: Not assessed
   Labs / Radiology
   159 K/uL
   9.8 g/dL
   152 mg/dL
   3.1 mg/dL
   15 mEq/L
   3.9 mEq/L
   57 mg/dL
   107 mEq/L
   137 mEq/L
   29.9 %
   18.7 K/uL
        [image002.jpg]
                             [**2181-10-15**]  12:41 PM
                             [**2181-10-15**]  03:16 PM
                             [**2181-10-15**]  03:42 PM
                             [**2181-10-15**]  06:31 PM
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
   WBC
   20.7
   18.7
   Hct
   36.3
   29.9
   Plt
   334
   159
   Cr
   2.4
   2.8
   3.1
   TropT
   0.11
   0.11
   TCO2
   17
   17
   17
   16
   17
   15
   15
   Glucose
   133
   118
   113
   152
   Other labs: PT / PTT / INR:37.9/51.1/3.9, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:912/880, Alk Phos / T Bili:693/20.2,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:486 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:6.4 mg/dL
   Imaging: U/S liver/gallbladder:
   IMPRESSION:
   Patent flow identified within the portal vein and hepatic veins on
   doppler
   son[**Name (NI) **].
   CXR ([**10-16**]):
   In comparison with the study of [**10-15**], there is continued
   enlargement of the cardiac silhouette with bibasilar opacification
   consistent
   with volume loss and pleural effusions. Patchy opacification in the
   left mid
   lung zone is again seen, worrisome for pneumonia. Monitoring support
   devices
   remain in place.
   Microbiology:    URINE CULTURE (Preliminary):
         ESCHERICHIA COLI.    >100,000 ORGANISMS/ML..
            PRESUMPTIVE IDENTIFICATION OF TWO COLONIAL MORPHOLOGIES.
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                ESCHERICHIA COLI
                                |
   AMPICILLIN------------  =>32 R
   AMPICILLIN/SULBACTAM--  =>32 R
   CEFAZOLIN-------------    16 I
   CEFEPIME--------------   <=1 S
   CEFTAZIDIME-----------   <=1 S
   CEFTRIAXONE-----------   <=1 S
   CEFUROXIME------------    16 I
   CIPROFLOXACIN---------   =>4 R
   GENTAMICIN------------   <=1 S
   MEROPENEM-------------<=0.25 S
   NITROFURANTOIN--------  <=16 S
   PIPERACILLIN---------- =>128 R
   PIPERACILLIN/TAZO-----     8 S
   TOBRAMYCIN------------   <=1 S
   TRIMETHOPRIM/SULFA----   <=1 S
   Blood culture:
         STAPHYLOCOCCUS, COAGULASE NEGATIVE.
   _________________________________________________________
                                STAPHYLOCOCCUS, COAGULASE NEGATIVE
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------<=0.25 S
   TETRACYCLINE----------     4 S
   VANCOMYCIN------------   <=1 S
   BAL culture:
                                 SENSITIVITIES: MIC expressed in MCG/ML
   _________________________________________________________
                                STAPH AUREUS COAG +
                                |
   ERYTHROMYCIN----------   =>8 R
   GENTAMICIN------------ <=0.5 S
   LEVOFLOXACIN----------   =>8 R
   OXACILLIN-------------   =>4 R
   RIFAMPIN-------------- <=0.5 S
   TETRACYCLINE----------   <=1 S
   TRIMETHOPRIM/SULFA---- <=0.5 S
   VANCOMYCIN------------   <=1 S
   [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-PRELIMINARY
   {STAPHYLOCOCCUS, COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE
   NEGATIVE}; Aerobic Bottle Gram Stain-FINAL; Anaerobic Bottle Gram
   Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-PRELIMINARY {ESCHERICHIA COLI}
   INPATIENT
   Assessment and Plan
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: likely SIRS, continued hypotension on pressors (vasopressin
   and phenylephrine), infectious source likely MRSA pneumonia vs E. coli
   urosepsis
    - currently on meropenem and vancomycin. Vancomycin seems appropriate
   for MRSA (day 1 = [**10-14**]). E.coli in urine most sensitive to [**Last Name (un) 614**], also
   quite sensitive to ceftriaxone and ceftazidime. Could consider
   switching to ceftriaxone.
    - continue pressors to maintain MAP > 65
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   - continue to trend lacate now 2.8 from peak of 5.8 on [**10-14**]
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    -continue AC vent
 attempt transition to pressure support with goal
   TVol 300
   - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s:  recent abdominal CT and US shows normal appearing
   biliary tree but would require further evaluation with MRCP / ERCP to
   ensure no obstruction
 LFT
s continue to remain elevated likely
   representing component of superimposed shock liver given poor distal
   perfusion.
   - liver recs: MRCP
 patient unable to undergo this exam as she has a
   pacer
   - f/u hepatitis serologies, AMA, anti-Sm, [**Doctor First Name **]
 HBV neg., HAV neg., HCV
   neg., [**Doctor First Name **] neg., AMA pending
   - coags continue to trend up with stable fibrinogen, HCT and platelets
 likely representing hepatic injury
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - as per renal, not a great candidate for CVVH b/c multiple pressors
   and critically ill. Patient had expressed that she would not want to be
   on HD longterm. Will discuss with family option of dialysis, but
   unlikely to be of great utility and unlikely to be a bridge to better
   prognosis.
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt currently in afib with RVR. Will hold off on
   giving nodal blocker at this time given tenous nature of BP.
   - hold metoprolol for now given hypotension
   - hold coumadin given coagulopathy
   - attempt to rate control if BP stabilizes with digoxin to improve
   atrial kick
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 81-year-old woman admitted with sepsis, acute respiratory failure, and metabolic acidosis. She has a complex medical history, including liver function abnormalities, and is currently receiving broad-spectrum antibiotics for suspected MRSA pneumonia and E. coli urosepsis.

The patient's current condition is characterized by:

1. Respiratory failure: She has a large pleural effusion and underlying MRSA pneumonia, requiring mechanical ventilation.
2. Sepsis: She has a positive blood culture for coag-negative staph, which is likely a contaminant. The patient is receiving meropenem and vancomycin, with a plan to consider switching to ceftriaxone if E. coli is the primary pathogen.
3. Metabolic acidosis: Her lactate levels are trending down, and she is receiving broad-spectrum antibiotics and pressors to improve distal perfusion.
4. Acute kidney injury: She has a low urine output and is not a candidate for continuous venovenous hemofiltration (CVVH) due to multiple pressors and critical illness.
5. Hepatic dysfunction: Her liver function tests (LFTs) are elevated, likely due to superimposed shock liver caused by poor distal perfusion.
6. Atrial fibrillation: She is in atrial fibrillation with rapid ventricular response, and her blood pressure is being closely monitored to avoid hypotension.
7. Diastolic heart failure: She has a history of diastolic heart failure, and her blood pressure is being carefully managed to avoid further deterioration.

Potential medical complications that can arise include:

1. Respiratory failure: The patient's respiratory status can deteriorate further, leading to increased respiratory support or mechanical ventilation.
2. Sepsis: The patient's sepsis can worsen, leading to organ dysfunction and potentially life-threatening complications.
3. Acute kidney injury: The patient's kidney function can continue to decline, requiring renal replacement therapy or hemodialysis.
4. Hepatic dysfunction: The patient's liver function can deteriorate further, leading to coagulopathy, bleeding, or liver failure.
5. Cardiac complications: The patient's atrial fibrillation can worsen, leading to stroke or cardiac arrest.
6. Infection: The patient is at risk of developing secondary infections, particularly in the respiratory, urinary, or bloodstream.
7. Malnutrition: The patient's nutritional status can worsen, leading to further complications and decreased quality of life.

Given the patient's complex medical condition and multiple organ dysfunction, close monitoring and aggressive management of her symptoms are essential to prevent further deterioration and improve her chances of recovery."
174373.0,234940,2181-10-18 07:09:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - weened to single pressor, phenylephrine only
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   - patient in afib with RVR all morning, given 500 cc bolus with no
   effect
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   General: NAD, sedated
   Lungs: CTA anterolateral fields
   Heart: irregular, tachycardic, no MRG
   Abdomen: soft, ND, ABS
   Extremities:  diffuse anasarca, weeping skin, echymosis bil. lower
   ext., WWP
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - d/w pharmacy digoxin dosing given recent load, level and anuric
   renal failure
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - d/w family goals of care, possible CMO with extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - f/u pharmacy recommendations for digoxin dosing
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - weened to single pressor, phenylephrine only
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   - patient in afib with RVR all morning, given 500 cc bolus with no
   effect
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   General: NAD, sedated
   Lungs: CTA anterolateral fields
   Heart: irregular, tachycardic, no MRG
   Abdomen: soft, ND, ABS
   Extremities:  diffuse anasarca, weeping skin, echymosis bil. lower
   ext., WWP
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - d/w pharmacy digoxin dosing given recent load, level and anuric
   renal failure
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - d/w family goals of care, possible CMO with extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - f/u pharmacy recommendations for digoxin dosing
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the patient is an 81-year-old female admitted to the ICU with progressive painless jaundice, hypotension, and hypothermia, likely representing sepsis. The patient has a complex medical condition with multiple organ dysfunction.

Potential medical complications that can arise from the patient's condition include:

1. Sepsis-related organ failure: The patient's sepsis can lead to organ failure, including renal failure, respiratory failure, and hepatic failure.
2. Septic shock: The patient's septic shock requires pressor support, and there is a risk of further deterioration in her condition.
3. Respiratory failure: The patient's respiratory failure is complicated by her large effusion and underlying MRSA pneumonia, which may require invasive ventilation and consideration of extrubation.
4. Acute kidney injury: The patient's acute kidney injury is likely hemodynamic in origin due to poor perfusion, and there is a risk of further deterioration in her renal function.
5. Metabolic acidosis: The patient's metabolic acidosis is likely due to lactic acidosis evolving in her septic condition, and there is a risk of further deterioration in her acid-base balance.
6. Atrial fibrillation: The patient's atrial fibrillation is complicated by her RVR and digoxin load, and there is a risk of further arrhythmias.
7. Diastolic heart failure: The patient's diastolic heart failure is complicated by her hypotension and anuria, and there is a risk of further deterioration in her cardiac function.
8. Intrahepatic cholestasis: The patient's intrahepatic cholestasis is complicated by her elevated LFTs, and there is a risk of further deterioration in her liver function.
9. Coagulopathy: The patient's coagulopathy is complicated by her elevated INR and the need to hold anticoagulation therapy, and there is a risk of further bleeding.
10. Pressure ulcers: The patient's prolonged stay in the ICU and her anasarca increase her risk of developing pressure ulcers.

To address these potential complications, the patient's care should be focused on managing her sepsis, optimizing her fluid and electrolyte balance, and addressing her respiratory, renal, and hepatic dysfunction. Additionally, the patient's family should be involved in goal-setting and decision-making regarding her care."
174373.0,234940,2181-10-18 07:09:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - weened to single pressor, phenylephrine only
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   General: NAD, sedated
   Lungs: CTA anterolateral fields
   Heart: irregular, tachycardic, no MRG
   Abdomen: soft, ND, ABS
   Extremities:  diffuse anasarca, weeping skin, echymosis bil. lower
   ext., WWP
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - d/w pharmacy digoxin dosing given recent load, level and anuric
   renal failure
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - f/u pharmacy recommendations for digoxin dosing
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - weened to single pressor, phenylephrine only
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   General: NAD, sedated
   Lungs: CTA anterolateral fields
   Heart: irregular, tachycardic, no MRG
   Abdomen: soft, ND, ABS
   Extremities:  diffuse anasarca, weeping skin, echymosis bil. lower
   ext., WWP
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - d/w pharmacy digoxin dosing given recent load, level and anuric
   renal failure
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - f/u pharmacy recommendations for digoxin dosing
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, I summarize the patient's condition as follows:

The patient is an 81-year-old female with progressive painless jaundice for two weeks, admitted with hypotension and hypothermia, likely representing sepsis. She has multiple comorbidities, including MRSA pneumonia, E. Coli and Enterococcus urinary tract infections, and atrial fibrillation. The patient is receiving pressor support with phenylephrine and broad-spectrum antibiotics, including meropenem and vancomycin.

The patient's vital signs are:

* Temperature: 36.4C (97.5F)
* Heart rate: 116 bpm
* Blood pressure: 90/51 mmHg
* Respiratory rate: 16 breaths per minute
* SpO2: 94%

The patient has significant laboratory abnormalities, including:

* Elevated liver enzymes (ALT, AST, and alkaline phosphatase)
* Elevated bilirubin
* Anemia (hemoglobin 10.5 g/dL)
* Thrombocytopenia (platelet count 23.8 K/uL)
* Elevated lactate levels (2.8 mmol/L)

The patient's imaging studies show:

* Asymmetric airspace opacification in the left perihilar region on chest X-ray
* Bilateral pleural effusions
* Positive urine culture for E. Coli and Enterococcus
* Positive blood culture for MRSA

The patient's medical conditions and potential complications include:

* Septic shock
* Hypoxic respiratory failure
* Acute renal failure
* Metabolic acidosis
* Atrial fibrillation
* Diastolic heart failure
* Anasarca and electrolyte imbalance

Based on the patient's condition, potential medical complications that can arise include:

* Continued septic shock and organ dysfunction
* Progression of respiratory failure and need for mechanical ventilation
* Acute kidney injury and potential need for renal replacement therapy
* Metabolic acidosis and lactic acidosis
* Atrial fibrillation and potential for stroke or cardiac arrest
* Diastolic heart failure and potential for cardiac decompensation
* Anasarca and electrolyte imbalance, potentially leading to cardiac arrhythmias or cardiac arrest

The patient's code status is DNR/DNI, and her disposition is ICU."
174373.0,234940,2181-10-18 07:09:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - patient transitioned to PSV all day
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - d/w pharmacy digoxin dosing given recent load, level and anuric
   renal failure
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - f/u pharmacy recommendations for digoxin dosing
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - patient transitioned to PSV all day
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - d/w pharmacy digoxin dosing given recent load, level and anuric
   renal failure
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - f/u pharmacy recommendations for digoxin dosing
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old female admitted to the ICU with progressive painless jaundice, hypotension, and hypothermia, likely representing sepsis. The patient has a complex medical condition with multiple potential medical complications.

Potential medical complications that can arise from the patient's condition include:

1. Septic shock: The patient is currently in septic shock, which can lead to organ dysfunction, including cardiac, respiratory, and renal failure.
2. MRSA pneumonia: The patient has a diagnosis of MRSA pneumonia, which can lead to respiratory failure, sepsis, and mortality.
3. Urosepsis: The patient has a urinary tract infection with E. coli and Enterococcus, which can lead to sepsis and organ dysfunction.
4. Acute renal failure: The patient has acute renal failure, which can lead to electrolyte imbalances, acidosis, and death.
5. Metabolic acidosis: The patient has metabolic acidosis, which can lead to organ dysfunction, including cardiac and respiratory failure.
6. Atrial fibrillation: The patient has atrial fibrillation, which can lead to cardiac complications, including heart failure and stroke.
7. Diastolic heart failure: The patient has diastolic heart failure, which can lead to cardiac complications, including heart failure and death.
8. Anasarca: The patient has anasarca, which can lead to respiratory failure and death.
9. Intrahepatic cholestasis: The patient has intrahepatic cholestasis, which can lead to liver failure and death.

To manage these potential medical complications, the patient is receiving broad-spectrum antibiotics, pressors, and other supportive care measures. The patient's code status is DNR/DNI, indicating that the patient's family has chosen to withhold cardiopulmonary resuscitation (CPR) in the event of cardiac arrest."
174373.0,234940,2181-10-18 07:09:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - weened to single pressor, phenylephrine only
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   - patient in afib with RVR all morning, given 500 cc bolus with no
   effect
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   General: NAD, sedated
   Lungs: CTA anterolateral fields
   Heart: irregular, tachycardic, no MRG
   Abdomen: soft, ND, ABS
   Extremities:  diffuse anasarca, weeping skin, echymosis bil. lower
   ext., WWP
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - d/w family goals of care, possible CMO with extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w family concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy but
   may start if INR continues to trend down
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yo female with progressive painless jaundice x two
   weeks now presenting with hypotension and hypothermia likely
   representing sepsis in the setting of MRSA + sputum and E.Coli and
   Enterococcus + urine.
   24 Hour Events:
   - patient loaded with digoxin with level this morning 1.6
   - weened to single pressor, phenylephrine only
   - still waiting to discuss with family CVVH and goals of care
   - vanco level this morning  18.4
   - patient in afib with RVR all morning, given 500 cc bolus with no
   effect
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-17**] 10:00 AM
   Infusions:
   Phenylephrine - 1 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-18**] 06:39 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.4
C (97.5
   HR: 116 (99 - 134) bpm
   BP: 90/51(65) {79/47(61) - 122/81(96)} mmHg
   RR: 16 (12 - 20) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 7 (7 - 13)mmHg
   Total In:
                                                                    947 mL
                                                                    304 mL
   PO:
   TF:
                                                                    384 mL
                                                                    198 mL
   IVF:
                                                                    564 mL
                                                                     26 mL
   Blood products:
   Total out:
                                                                    548 mL
                                                                      0 mL
   Urine:
                                                                     68 mL
   NG:
   Stool:
   Drains:
                                                                    110 mL
   Balance:
                                                                    399 mL
                                                                    304 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 449 (306 - 449) mL
   PS : 14 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 68
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.32/31/91/16/-8
   Ve: 8.5 L/min
   PaO2 / FiO2: 182
   Physical Examination
   General: NAD, sedated
   Lungs: CTA anterolateral fields
   Heart: irregular, tachycardic, no MRG
   Abdomen: soft, ND, ABS
   Extremities:  diffuse anasarca, weeping skin, echymosis bil. lower
   ext., WWP
   Labs / Radiology
   153 K/uL
   10.5 g/dL
   205 mg/dL
   3.0 mg/dL
   16 mEq/L
   3.4 mEq/L
   67 mg/dL
   107 mEq/L
   137 mEq/L
   32.1 %
   23.8 K/uL
        [image002.jpg]
                             [**2181-10-15**]  11:27 PM
                             [**2181-10-16**]  02:45 AM
                             [**2181-10-16**]  02:53 AM
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
   WBC
   20.7
   18.7
   23.8
   Hct
   36.3
   29.9
   32.1
   Plt
   [**Telephone/Fax (3) 10255**]
   Cr
   2.8
   3.1
   3.0
   TropT
   0.11
   TCO2
   16
   17
   15
   15
   17
   17
   17
   Glucose
   118
   113
   152
   205
   Other labs: PT / PTT / INR:25.6/41.8/2.5, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:640/567, Alk Phos / T Bili:739/20.6,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:2.8 mmol/L, Albumin:2.0 g/dL, LDH:491 IU/L, Ca++:8.1 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.1 mg/dL
   Imaging:
   - CXR [**10-17**]: persistent  asymmetric airspace opacification in left
   perihilar region, slightly improved aeration at right base, continued
   bilateral pleural effusions
   Micro:
   - urine [**10-13**]: + E. Coli and Enterococcus
   - BAL [**10-13**]: + MRSA
   - blood [**2094-10-14**]: pending
   - urine [**10-15**]: pending
   Assessment and Plan
   81 yof with progressive painless jaundice x 2 weeks admitted with
   hypotension and hypothermia likely representing sepsis.
   # Shock: continued septic shock requiring pressor (phenylephrine)
   support with MRSA pneumonia vs. urosepsis as infective source.
    - continue meropenem and vancomycin to cover MRSA, E.Coli and
   Enterococcus pending most recent sensitivities
    - continue pressors to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
    - f/u surveillance cultures and sensitivities
    - consider re-siting lines if additional surveillance blood Cx are
   pos. Blood cultures with coag negative staph are likely contaminant.
   #Hypoxic Respiratory failure: patient with large effusion and
   underlying MRSA pneumonia
    - continue pressure support ventilation with goal TVol 300
 RSBI 68
   and FIO2/PaO2 = 182
    - d/w family goals of care, possible CMO with extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
   - f/u d/w family concerning CVVH and bridge to HD long term
   # Metabolic Acidosis: Likely due to lactic acidosis evolving in septic
   patient. Lactate trending down now with broad spectrum antibiotics and
   adequate MAPs
   - continue to trend ABG
   - continue to trend lactate
   - continue pressors to improve distal perfusion
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - hold metoprolol for now given continued hypotension
   - continue to trend INR now 2.5
 hold coumadin given coagulopathy but
   may start if INR continues to trend down
   # Diastolic Heart Failure: Holding BB and lasix given hemodynamic
   instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none- bruising with boots, no heparin from bleeding)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-18**] 03:24 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old female admitted to the ICU with progressive painless jaundice for two weeks, presenting with hypotension and hypothermia likely representing sepsis. The patient has multiple medical conditions, including:

1. Sepsis: The patient is in septic shock, requiring pressor support with phenylephrine, and has a high risk of developing multiple organ dysfunction syndrome (MODS).
2. MRSA pneumonia: The patient has a positive BAL for MRSA, and the CXR shows persistent asymmetric airspace opacification in the left perihilar region, suggesting a possible source of infection.
3. Urosepsis: The patient has a positive urine culture for E. Coli and Enterococcus, which may be a contributing factor to the septic shock.
4. Acute renal failure: The patient's creatinine is elevated, and the patient is at risk of developing chronic kidney disease (CKD) due to poor perfusion.
5. Metabolic acidosis: The patient has a metabolic acidosis, likely due to lactic acidosis evolving in the septic patient.
6. Atrial fibrillation: The patient has atrial fibrillation with rapid ventricular response (RVR) and is receiving digoxin to control the heart rate.
7. Diastolic heart failure: The patient has diastolic heart failure, which may be exacerbated by the septic shock and poor perfusion.
8. Anasarca: The patient has diffuse anasarca, which may be contributing to the patient's hypotension and poor perfusion.

Potential medical complications that may arise include:

1. MODS: The patient is at high risk of developing MODS due to the septic shock, which may lead to further organ dysfunction and poor outcomes.
2. Cardiac complications: The patient's atrial fibrillation and diastolic heart failure may lead to cardiac complications, such as arrhythmias, heart failure, and decreased cardiac output.
3. Renal complications: The patient's acute renal failure may progress to CKD, which may require long-term dialysis and impact the patient's quality of life.
4. Respiratory complications: The patient's hypoxic respiratory failure may lead to further respiratory complications, such as pneumonia, respiratory failure, and the need for mechanical ventilation.
5. Gastrointestinal complications: The patient's anasarca and poor perfusion may lead to gastrointestinal complications, such as nausea, vomiting, and bowel obstruction.
6. Infection: The patient's septic shock and positive cultures may lead to further infections, such as pneumonia, urinary tract infections, and bloodstream infections.

Based on the patient's condition, it is essential to continue broad-spectrum antibiotics to cover MRSA, E. Coli, and Enterococcus, and to monitor the patient's response to treatment. The patient's digoxin and pressors should be continued to control the atrial fibrillation and maintain blood pressure. The patient's electrolytes should be repleted as needed, and the patient's nutritional needs should be met through enteral nutrition. The patient's family should be counseled on the patient's condition and the need for continued ICU care."
174373.0,234940,2181-10-19 06:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with a h/o atrial fibrillation diastolic heart
   failure, s/p cholecystectomy, and hospitalization for ESBL Klebsiella
   UTI ([**2181-9-26**]) transferred from [**Hospital1 608**] for work-up of LFT's. Per OSH
   records patient noted to be jaundiced while in rehab on [**2181-10-2**]. Her AP
   at that time was 568, AST 198, ALT 300 and TBili 5.58. She underwent
   abdominal u/s on [**10-7**] normal liver and bilateral pleural effusions. On
   [**10-11**] she had CT Abd at [**Hospital3 364**] Hosp as an outpt that showed
   normal liver, spleen, pancreas and bilateral pleural effusions. On
   admission to [**Hospital1 608**] her AP was 1206 and bili 15.9. Patient transferred
   to [**Hospital1 19**] for further work-up of her LFT abnormalities in sepsis with
   urine and lung sources.
   24 Hour Events:
   - patient in afib with RVR throughout yesterday - treated with 500cc
   bolus without effect - later improved with boluses of fentanyl
   - patient tachycardic to 140 with hypotension to 70/40 at 0300, given
   additional 500cc bolus for CVP of [**9-3**] with some response
   - [**Location (un) 630**] Organ Bank contact[**Name (NI) **] for screening - they deferred
   - patient tachycardic but improved c boluses of fentanyl
   - renal recs: check urine sediment in am, if family thinks permanent hd
   is acceptable will do cvvh, otherwise not
   - wound care: consulted but still needs to see patient
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-18**] 08:15 AM
   Vancomycin - [**2181-10-18**] 08:00 PM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-19**] 06:31 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 35.9
C (96.7
   HR: 132 (117 - 155) bpm
   BP: 104/63(78) {79/47(59) - 146/96(114)} mmHg
   RR: 20 (16 - 28) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 8 (4 - 16)mmHg
   Total In:
                                                                  2,002 mL
                                                                    722 mL
   PO:
   TF:
                                                                    725 mL
                                                                    197 mL
   IVF:
                                                                    836 mL
                                                                    526 mL
   Blood products:
   Total out:
                                                                     45 mL
                                                                      4 mL
   Urine:
                                                                     45 mL
                                                                      4 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,957 mL
                                                                    718 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 472 (385 - 500) mL
   PS : 14 cmH2O
   RR (Spontaneous): 22
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 88
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.38/27/86.[**Numeric Identifier 143**]/15/-7
   Ve: 6.8 L/min
   PaO2 / FiO2: 174
   Physical Examination
   General: NAD, intubated, unresponsive, off sedation
   Heart: irregular, tachycardic, no MRG
   Lungs: coarse breath sounds bilateral anterolateral fields
   Abdomen: soft, ND, ABS
   Extremities: 4+ peripheral edema, weeping skin, WWP, CR < 1s
   Labs / Radiology
   91 K/uL
   9.5 g/dL
   189 mg/dL
   3.3 mg/dL
   15 mEq/L
   3.6 mEq/L
   74 mg/dL
   109 mEq/L
   138 mEq/L
   29.1 %
   18.0 K/uL
        [image002.jpg]
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
   WBC
   18.7
   23.8
   18.0
   Hct
   29.9
   32.1
   29.1
   Plt
   159
   153
   91
   Cr
   3.1
   3.0
   3.3
   TCO2
   15
   15
   17
   17
   17
   16
   17
   Glucose
   152
   205
   189
   Other labs: PT / PTT / INR:21.3/40.5/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.7 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.4 mg/dL
   Microbiology:
   - urine [**10-13**]
 E. Coli and Enterococcus
   - urine [**10-15**]
 negative
   - blood  [**10-13**]
 S. epidermidis
   - blood 9/21 and [**10-16**]
 pending
   - BAL [**10-13**] - MRSA
   Imaging:
   - CXR [**10-18**]: asymmetric edema vs. pneumonia, unchanged bilateral pleural
   effusions, distended stomach requiring OG tube to be advanced 5-7 cm
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - continue PSV with goal of [**11-3**] and consider SBT
 d/w family
   possible CMO with trial of extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - f/u urine sediment
   - f/u d/w family concerning CVVH and bridge to long term HD to define
   goals of care
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: none
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-19**] 05:45 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with a h/o atrial fibrillation diastolic heart
   failure, s/p cholecystectomy, and hospitalization for ESBL Klebsiella
   UTI ([**2181-9-26**]) transferred from [**Hospital1 608**] for work-up of LFT's. Per OSH
   records patient noted to be jaundiced while in rehab on [**2181-10-2**]. Her AP
   at that time was 568, AST 198, ALT 300 and TBili 5.58. She underwent
   abdominal u/s on [**10-7**] normal liver and bilateral pleural effusions. On
   [**10-11**] she had CT Abd at [**Hospital3 364**] Hosp as an outpt that showed
   normal liver, spleen, pancreas and bilateral pleural effusions. On
   admission to [**Hospital1 608**] her AP was 1206 and bili 15.9. Patient transferred
   to [**Hospital1 19**] for further work-up of her LFT abnormalities in sepsis with
   urine and lung sources.
   24 Hour Events:
   - patient in afib with RVR throughout yesterday - treated with 500cc
   bolus without effect - later improved with boluses of fentanyl
   - patient tachycardic to 140 with hypotension to 70/40 at 0300, given
   additional 500cc bolus for CVP of [**9-3**] with some response
   - [**Location (un) 630**] Organ Bank contact[**Name (NI) **] for screening - they deferred
   - patient tachycardic but improved c boluses of fentanyl
   - renal recs: check urine sediment in am, if family thinks permanent hd
   is acceptable will do cvvh, otherwise not
   - wound care: consulted but still needs to see patient
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-18**] 08:15 AM
   Vancomycin - [**2181-10-18**] 08:00 PM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-19**] 06:31 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 35.9
C (96.7
   HR: 132 (117 - 155) bpm
   BP: 104/63(78) {79/47(59) - 146/96(114)} mmHg
   RR: 20 (16 - 28) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 8 (4 - 16)mmHg
   Total In:
                                                                  2,002 mL
                                                                    722 mL
   PO:
   TF:
                                                                    725 mL
                                                                    197 mL
   IVF:
                                                                    836 mL
                                                                    526 mL
   Blood products:
   Total out:
                                                                     45 mL
                                                                      4 mL
   Urine:
                                                                     45 mL
                                                                      4 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,957 mL
                                                                    718 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 472 (385 - 500) mL
   PS : 14 cmH2O
   RR (Spontaneous): 22
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 88
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.38/27/86.[**Numeric Identifier 143**]/15/-7
   Ve: 6.8 L/min
   PaO2 / FiO2: 174
   Physical Examination
   General: NAD, intubated, unresponsive, off sedation
   Heart: irregular, tachycardic, no MRG
   Lungs: coarse breath sounds bilateral anterolateral fields
   Abdomen: soft, ND, ABS
   Extremities: 4+ peripheral edema, weeping skin, WWP, CR < 1s
   Labs / Radiology
   91 K/uL
   9.5 g/dL
   189 mg/dL
   3.3 mg/dL
   15 mEq/L
   3.6 mEq/L
   74 mg/dL
   109 mEq/L
   138 mEq/L
   29.1 %
   18.0 K/uL
        [image002.jpg]
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
   WBC
   18.7
   23.8
   18.0
   Hct
   29.9
   32.1
   29.1
   Plt
   159
   153
   91
   Cr
   3.1
   3.0
   3.3
   TCO2
   15
   15
   17
   17
   17
   16
   17
   Glucose
   152
   205
   189
   Other labs: PT / PTT / INR:21.3/40.5/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.7 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.4 mg/dL
   Microbiology:
   - urine [**10-13**]
 E. Coli and Enterococcus
   - urine [**10-15**]
 negative
   - blood  [**10-13**]
 S. epidermidis
   - blood 9/21 and [**10-16**]
 pending
   - BAL [**10-13**] - MRSA
   Imaging:
   - CXR [**10-18**]: asymmetric edema vs. pneumonia, unchanged bilateral pleural
   effusions, distended stomach requiring OG tube to be advanced 5-7 cm
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - continue PSV with goal of [**11-3**] and consider SBT
 d/w family
   possible CMO with trial of extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - f/u urine sediment
   - f/u d/w family concerning CVVH and bridge to long term HD to define
   goals of care
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: none
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-19**] 05:45 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old female with a history of atrial fibrillation, diastolic heart failure, and a recent cholecystectomy. She was hospitalized for an ESBL Klebsiella UTI and was transferred to the ICU for further work-up of her LFT abnormalities.

The patient's current condition is as follows:

* She is intubated and mechanically ventilated with a CPAP/PSV mode.
* She has a heart rate of 132 bpm with atrial fibrillation and RVR.
* Her blood pressure is 104/63 mmHg with a central venous pressure (CVP) of 8 mmHg.
* She has a total bilirubin level of 15.9 mg/dL and a liver function test (LFT) panel showing elevated AST, ALT, and alkaline phosphatase levels.
* She has a white blood cell count of 18.7 K/uL and a platelet count of 159 K/uL.
* She has a creatinine level of 3.1 mg/dL and a blood urea nitrogen (BUN) level of 15 mg/dL.
* She has a pending BAL culture showing MRSA.
* She has a CXR showing asymmetric edema vs. pneumonia, unchanged bilateral pleural effusions, and a distended stomach requiring an OG tube.

The patient's medical conditions and potential complications include:

1. Intrahepatic cholestasis with sepsis from urinary or lung source.
2. Septic shock requiring vasopressin support.
3. Hypoxic respiratory failure with bilateral large effusions and underlying MRSA pneumonia.
4. Acute renal failure likely due to poor perfusion.
5. Atrial fibrillation with RVR.
6. Diffuse anasarca with weeping skin and significant risk of skin sloughing.
7. Diastolic heart failure.

The patient's treatment plan includes:

1. Continue meropenem (E. coli) and vancomycin (Enterococcus and MRSA).
2. Continue pressor to maintain MAP > 65.
3. Continue digoxin 0.0625 mg/day for atrial fibrillation.
4. Continue PSV with a goal of weaning by [**11-3**] and consider SBT.
5. Continue vancomycin for MRSA pneumonia.
6. Trend LFTs and consider ERCP if the patient becomes more stable.
7. Renally dose all medications.
8. F/u urine sediment and consider CVVH and bridge to long-term HD to define goals of care.
9. Consider restarting anticoagulation for atrial fibrillation.
10. F/u wound care recommendations.

The patient's code status is DNR/DNI, and her disposition is ICU care."
174373.0,234940,2181-10-19 06:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with a h/o atrial fibrillation diastolic heart
   failure, s/p cholecystectomy, and hospitalization for ESBL Klebsiella
   UTI ([**2181-9-26**]) transferred from [**Hospital1 608**] for work-up of LFT's. Per OSH
   records patient noted to be jaundiced while in rehab on [**2181-10-2**]. Her AP
   at that time was 568, AST 198, ALT 300 and TBili 5.58. She underwent
   abdominal u/s on [**10-7**] normal liver and bilateral pleural effusions. On
   [**10-11**] she had CT Abd at [**Hospital3 364**] Hosp as an outpt that showed
   normal liver, spleen, pancreas and bilateral pleural effusions. On
   admission to [**Hospital1 608**] her AP was 1206 and bili 15.9. Patient transferred
   to [**Hospital1 19**] for further work-up of her LFT abnormalities in sepsis with
   urine and lung sources.
   24 Hour Events:
   - patient in afib with RVR throughout yesterday - treated with 500cc
   bolus without effect - later improved with boluses of fentanyl
   - patient tachycardic to 140 with hypotension to 70/40 at 0300, given
   additional 500cc bolus for CVP of [**9-3**] with some response
   - [**Location (un) 630**] Organ Bank contact[**Name (NI) **] for screening - they deferred
   - patient tachycardic but improved c boluses of fentanyl
   - renal recs: check urine sediment in am, if family thinks permanent hd
   is acceptable will do cvvh, otherwise not
   - wound care: consulted but still needs to see patient
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-18**] 08:15 AM
   Vancomycin - [**2181-10-18**] 08:00 PM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-19**] 06:31 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 35.9
C (96.7
   HR: 132 (117 - 155) bpm
   BP: 104/63(78) {79/47(59) - 146/96(114)} mmHg
   RR: 20 (16 - 28) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 8 (4 - 16)mmHg
   Total In:
                                                                  2,002 mL
                                                                    722 mL
   PO:
   TF:
                                                                    725 mL
                                                                    197 mL
   IVF:
                                                                    836 mL
                                                                    526 mL
   Blood products:
   Total out:
                                                                     45 mL
                                                                      4 mL
   Urine:
                                                                     45 mL
                                                                      4 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,957 mL
                                                                    718 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 472 (385 - 500) mL
   PS : 14 cmH2O
   RR (Spontaneous): 22
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 88
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.38/27/86.[**Numeric Identifier 143**]/15/-7
   Ve: 6.8 L/min
   PaO2 / FiO2: 174
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   91 K/uL
   9.5 g/dL
   189 mg/dL
   3.3 mg/dL
   15 mEq/L
   3.6 mEq/L
   74 mg/dL
   109 mEq/L
   138 mEq/L
   29.1 %
   18.0 K/uL
        [image002.jpg]
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
   WBC
   18.7
   23.8
   18.0
   Hct
   29.9
   32.1
   29.1
   Plt
   159
   153
   91
   Cr
   3.1
   3.0
   3.3
   TCO2
   15
   15
   17
   17
   17
   16
   17
   Glucose
   152
   205
   189
   Other labs: PT / PTT / INR:21.3/40.5/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.7 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.4 mg/dL
   Microbiology:
   - urine [**10-13**]
 E. Coli and Enterococcus
   - urine [**10-15**]
 negative
   - blood  [**10-13**]
 S. epidermidis
   - blood 9/21 and [**10-16**]
 pending
   - BAL [**10-13**] - MRSA
   Imaging:
   - CXR [**10-18**]: asymmetric edema vs. pneumonia, unchanged bilateral pleural
   effusions, distended stomach requiring OG tube to be advanced 5-7 cm
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressors to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - continue PSV and consider SBT
 d/w family possible CMO with trial
   of extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 and dosed per levels
   - f/u lytes
   - f/u d/w family concerning CVVH and bridge to long term HD to define
   goals of care
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: none
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-19**] 05:45 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with a h/o atrial fibrillation diastolic heart
   failure, s/p cholecystectomy, and hospitalization for ESBL Klebsiella
   UTI ([**2181-9-26**]) transferred from [**Hospital1 608**] for work-up of LFT's. Per OSH
   records patient noted to be jaundiced while in rehab on [**2181-10-2**]. Her AP
   at that time was 568, AST 198, ALT 300 and TBili 5.58. She underwent
   abdominal u/s on [**10-7**] normal liver and bilateral pleural effusions. On
   [**10-11**] she had CT Abd at [**Hospital3 364**] Hosp as an outpt that showed
   normal liver, spleen, pancreas and bilateral pleural effusions. On
   admission to [**Hospital1 608**] her AP was 1206 and bili 15.9. Patient transferred
   to [**Hospital1 19**] for further work-up of her LFT abnormalities in sepsis with
   urine and lung sources.
   24 Hour Events:
   - patient in afib with RVR throughout yesterday - treated with 500cc
   bolus without effect - later improved with boluses of fentanyl
   - patient tachycardic to 140 with hypotension to 70/40 at 0300, given
   additional 500cc bolus for CVP of [**9-3**] with some response
   - [**Location (un) 630**] Organ Bank contact[**Name (NI) **] for screening - they deferred
   - patient tachycardic but improved c boluses of fentanyl
   - renal recs: check urine sediment in am, if family thinks permanent hd
   is acceptable will do cvvh, otherwise not
   - wound care: consulted but still needs to see patient
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Metronidazole - [**2181-10-16**] 08:00 AM
   Meropenem - [**2181-10-18**] 08:15 AM
   Vancomycin - [**2181-10-18**] 08:00 PM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-19**] 06:31 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 35.9
C (96.7
   HR: 132 (117 - 155) bpm
   BP: 104/63(78) {79/47(59) - 146/96(114)} mmHg
   RR: 20 (16 - 28) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Height: 62 Inch
    CVP: 8 (4 - 16)mmHg
   Total In:
                                                                  2,002 mL
                                                                    722 mL
   PO:
   TF:
                                                                    725 mL
                                                                    197 mL
   IVF:
                                                                    836 mL
                                                                    526 mL
   Blood products:
   Total out:
                                                                     45 mL
                                                                      4 mL
   Urine:
                                                                     45 mL
                                                                      4 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,957 mL
                                                                    718 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 472 (385 - 500) mL
   PS : 14 cmH2O
   RR (Spontaneous): 22
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 88
   PIP: 20 cmH2O
   SpO2: 94%
   ABG: 7.38/27/86.[**Numeric Identifier 143**]/15/-7
   Ve: 6.8 L/min
   PaO2 / FiO2: 174
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   91 K/uL
   9.5 g/dL
   189 mg/dL
   3.3 mg/dL
   15 mEq/L
   3.6 mEq/L
   74 mg/dL
   109 mEq/L
   138 mEq/L
   29.1 %
   18.0 K/uL
        [image002.jpg]
                             [**2181-10-16**]  01:10 PM
                             [**2181-10-16**]  06:06 PM
                             [**2181-10-17**]  03:56 AM
                             [**2181-10-17**]  01:44 PM
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
   WBC
   18.7
   23.8
   18.0
   Hct
   29.9
   32.1
   29.1
   Plt
   159
   153
   91
   Cr
   3.1
   3.0
   3.3
   TCO2
   15
   15
   17
   17
   17
   16
   17
   Glucose
   152
   205
   189
   Other labs: PT / PTT / INR:21.3/40.5/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.7 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.4 mg/dL
   Microbiology:
   - urine [**10-13**]
 E. Coli and Enterococcus
   - urine [**10-15**]
 negative
   - blood  [**10-13**]
 S. epidermidis
   - blood 9/21 and [**10-16**]
 pending
   - BAL [**10-13**] - MRSA
   Imaging:
   - CXR [**10-18**]: asymmetric edema vs. pneumonia, unchanged bilateral pleural
   effusions, distended stomach requiring OG tube to be advanced 5-7 cm
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressors to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - continue PSV and consider SBT
 d/w family possible CMO with trial
   of extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 and dosed per levels
   - f/u lytes
   - f/u d/w family concerning CVVH and bridge to long term HD to define
   goals of care
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:  NovaSource Renal (Full) - [**2181-10-16**] 01:00 PM 30 mL/hour
   Glycemic Control:
   Lines:
   20 Gauge - [**2181-10-13**] 05:24 PM
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: none
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Code status: DNR / DNI
   Disposition: ICU
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-19**] 05:45 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old woman with a history of atrial fibrillation, diastolic heart failure, and previous hospitalization for an ESBL Klebsiella UTI. She was transferred to the ICU for further evaluation of liver function abnormalities and sepsis.

The patient's current condition is complicated by:

1. Intrahepatic cholestasis with elevated liver enzymes (AST, ALT, and AP) and bilirubin levels.
2. Sepsis of unknown origin, with possible sources from the urinary or lung tract.
3. Atrial fibrillation with rapid ventricular response (RVR) and worsening renal function.
4. Hypoxic respiratory failure with bilateral large pleural effusions and underlying MRSA pneumonia.
5. Acute renal failure, likely hemodynamic in origin due to poor perfusion.
6. Diastolic heart failure, with holding of beta blockers and lasix due to hemodynamic instability.
7. Diffuse anasarca with weeping skin and significant risk of skin sloughing.
8. Intra-abdominal hypertension, with a distended stomach requiring OG tube advancement.
9. Coagulopathy, with an INR of 2.0 and a possible need for anticoagulation.
10. Malnutrition, with a recent start of NovaSource Renal (Full) nutrition.

Potential medical complications that can arise from these conditions include:

1. Worsening liver function and cholestasis.
2. Progression of sepsis to multi-organ failure.
3. Development of cardiac arrhythmias or cardiac arrest.
4. Acute respiratory distress syndrome (ARDS) or respiratory failure.
5. Renal failure or acute kidney injury.
6. Skin breakdown or pressure ulcers.
7. Intra-abdominal hypertension or compartment syndrome.
8. Coagulopathy or bleeding complications.
9. Malnutrition or inadequate nutrition.
10. Increased risk of infection, including MRSA pneumonia.

The patient's code status is DNR/DNI, and her disposition is ICU. The plan of care includes continued treatment for sepsis, atrial fibrillation, and respiratory failure, as well as management of liver function, renal function, and coagulopathy."
174373.0,234940,2181-10-20 06:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   -patient in continued afib with RVR given bolus of fentanyl and then
   fluids with HCO3 for low CVP
   -family discussion choose no CVVH but still NOT CMO
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-19**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.3 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-20**] 06:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.9
C (98.4
   HR: 111 (110 - 143) bpm
   BP: 112/60(79) {88/47(58) - 137/84(102)} mmHg
   RR: 23 (19 - 27) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (6 - 14)mmHg
   Total In:
                                                                  1,911 mL
                                                                    375 mL
   PO:
   TF:
                                                                    636 mL
                                                                    200 mL
   IVF:
                                                                  1,145 mL
                                                                    116 mL
   Blood products:
   Total out:
                                                                    896 mL
                                                                     14 mL
   Urine:
                                                                     66 mL
                                                                     14 mL
   NG:
                                                                    110 mL
   Stool:
   Drains:
   Balance:
                                                                  1,015 mL
                                                                    361 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 375 (321 - 404) mL
   PS : 10 cmH2O
   RR (Spontaneous): 23
   PEEP: 8 cmH2O
   FiO2: 50%
   RSBI: 82
   PIP: 21 cmH2O
   SpO2: 98%
   ABG: 7.32/30/154/17/-9
   Ve: 12 L/min
   PaO2 / FiO2: 308
   Physical Examination
   Gen: intubated
   CV: irregularly irregular
   Resp: Rhonchorous b/l
   Abd: distended, nontender, hypoactive BS
   Ext: anasarcous, skin is jaundiced, bruising b/l in LE
   Labs / Radiology
   73 K/uL
   10.1 g/dL
   138 mg/dL
   3.3 mg/dL
   17 mEq/L
   3.6 mEq/L
   82 mg/dL
   110 mEq/L
   138 mEq/L
   29.8 %
   18.7 K/uL
        [image002.jpg]
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
   WBC
   23.8
   18.0
   18.7
   Hct
   32.1
   29.1
   29.8
   Plt
   153
   91
   73
   Cr
   3.0
   3.3
   3.3
   TCO2
   17
   17
   16
   17
   15
   16
   16
   Glucose
   [**Telephone/Fax (3) 10308**]38
   Other labs: PT / PTT / INR:21.4/39.1/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.7 mg/dL
   Imaging: cxr ([**2181-10-19**])
   Increasing perihilar opacification in the left lung is probably due to
   resolving edema or redistribution of pleural fluid since pneumonia
   should not
   clear that quickly. Substantial bibasilar opacification remains and
   could be
   atelectasis or pneumonia. Moderate right pleural effusion stable. Heart
   size
   normal. ET tube, right internal jugular line are in standard
   placements,
   unchanged. The transvenous right ventricular lead, which is inclined
   upward is unchanged in position and a nasogastric tube passes into the
   stomach and
   out of view.
   Microbiology: [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING
   INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL {STAPHYLOCOCCUS,
   COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE NEGATIVE}; Aerobic Bottle
   Gram Stain-FINAL; Anaerobic Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-FINAL {ESCHERICHIA COLI, ENTEROCOCCUS
   SP.} INPATIENT
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - continue PSV with goal of [**11-1**] and consider SBT
 d/w family
   possible CMO with trial of extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-20**] 12:04 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   -patient in continued afib with RVR given bolus of fentanyl and then
   fluids with HCO3 for low CVP
   -family discussion choose no CVVH but still NOT CMO
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-19**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.3 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-20**] 06:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.9
C (98.4
   HR: 111 (110 - 143) bpm
   BP: 112/60(79) {88/47(58) - 137/84(102)} mmHg
   RR: 23 (19 - 27) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (6 - 14)mmHg
   Total In:
                                                                  1,911 mL
                                                                    375 mL
   PO:
   TF:
                                                                    636 mL
                                                                    200 mL
   IVF:
                                                                  1,145 mL
                                                                    116 mL
   Blood products:
   Total out:
                                                                    896 mL
                                                                     14 mL
   Urine:
                                                                     66 mL
                                                                     14 mL
   NG:
                                                                    110 mL
   Stool:
   Drains:
   Balance:
                                                                  1,015 mL
                                                                    361 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 375 (321 - 404) mL
   PS : 10 cmH2O
   RR (Spontaneous): 23
   PEEP: 8 cmH2O
   FiO2: 50%
   RSBI: 82
   PIP: 21 cmH2O
   SpO2: 98%
   ABG: 7.32/30/154/17/-9
   Ve: 12 L/min
   PaO2 / FiO2: 308
   Physical Examination
   Gen: intubated
   CV: irregularly irregular
   Resp: Rhonchorous b/l
   Abd: distended, nontender, hypoactive BS
   Ext: anasarcous, skin is jaundiced, bruising b/l in LE
   Labs / Radiology
   73 K/uL
   10.1 g/dL
   138 mg/dL
   3.3 mg/dL
   17 mEq/L
   3.6 mEq/L
   82 mg/dL
   110 mEq/L
   138 mEq/L
   29.8 %
   18.7 K/uL
        [image002.jpg]
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
   WBC
   23.8
   18.0
   18.7
   Hct
   32.1
   29.1
   29.8
   Plt
   153
   91
   73
   Cr
   3.0
   3.3
   3.3
   TCO2
   17
   17
   16
   17
   15
   16
   16
   Glucose
   [**Telephone/Fax (3) 10308**]38
   Other labs: PT / PTT / INR:21.4/39.1/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.7 mg/dL
   Imaging: cxr ([**2181-10-19**])
   Increasing perihilar opacification in the left lung is probably due to
   resolving edema or redistribution of pleural fluid since pneumonia
   should not
   clear that quickly. Substantial bibasilar opacification remains and
   could be
   atelectasis or pneumonia. Moderate right pleural effusion stable. Heart
   size
   normal. ET tube, right internal jugular line are in standard
   placements,
   unchanged. The transvenous right ventricular lead, which is inclined
   upward is unchanged in position and a nasogastric tube passes into the
   stomach and
   out of view.
   Microbiology: [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING
   INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL {STAPHYLOCOCCUS,
   COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE NEGATIVE}; Aerobic Bottle
   Gram Stain-FINAL; Anaerobic Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-FINAL {ESCHERICHIA COLI, ENTEROCOCCUS
   SP.} INPATIENT
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - continue PSV with goal of [**11-1**] and consider SBT
 d/w family
   possible CMO with trial of extubation
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-20**] 12:04 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 81-year-old male who has been admitted to the ICU with sepsis, acute renal failure, atrial fibrillation, and respiratory failure. He has a history of intrahepatic cholestasis and sepsis from a urinary or lung source. He is currently receiving vasopressin support for septic shock and is being treated with meropenem and vancomycin for MRSA pneumonia. His renal function is worsening, and he is experiencing acidosis, metabolic. He has also developed respiratory failure, which is likely due to bilateral large effusions and underlying MRSA pneumonia.

Potential Medical Complications:

1. Worsening Renal Function: The patient's renal function is already compromised, and further deterioration may lead to end-stage renal disease or require renal replacement therapy.
2. Respiratory Failure: The patient's respiratory failure may worsen if his bilateral large effusions are not drained or if his underlying MRSA pneumonia is not effectively treated.
3. Sepsis: The patient is already experiencing septic shock, and further progression of his sepsis may lead to organ dysfunction or failure.
4. Atrial Fibrillation: The patient's atrial fibrillation may worsen if his digoxin therapy is not effective or if his underlying cardiac condition is not managed properly.
5. Skin Complications: The patient's diffuse anasarca and weeping skin may lead to skin sloughing or infection, which could further compromise his condition.
6. Liver Dysfunction: The patient's intrahepatic cholestasis may worsen if his liver function is not managed properly, leading to further complications such as coagulopathy or encephalopathy.
7. Electrolyte Imbalance: The patient's electrolyte imbalance may worsen if his fluid and electrolyte management is not properly managed, leading to cardiac arrhythmias or muscle weakness.
8. Infection: The patient is at risk for developing further infections, particularly in his urinary or respiratory tracts, which could further complicate his condition.

Recommendations:

1. Continue vasopressin support for septic shock and monitor the patient's hemodynamic status closely.
2. Continue meropenem and vancomycin therapy for MRSA pneumonia and consider adding other antibiotics if necessary.
3. Monitor the patient's renal function closely and consider initiating renal replacement therapy if necessary.
4. Consider draining the patient's bilateral large effusions to improve his respiratory function.
5. Continue digoxin therapy for atrial fibrillation and monitor the patient's cardiac status closely.
6. Manage the patient's skin complications with wound care and consider using topical antibiotics or dressings to prevent infection.
7. Monitor the patient's liver function closely and consider initiating therapy for intrahepatic cholestasis if necessary.
8. Monitor the patient's electrolyte imbalance closely and consider administering electrolyte supplements or other medications as necessary."
174373.0,234940,2181-10-20 06:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   -patient in continued afib with RVR given bolus of fentanyl and then
   fluids with HCO3 for low CVP
   -family discussion choose no CVVH but still NOT CMO
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-19**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.3 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-20**] 06:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.9
C (98.4
   HR: 111 (110 - 143) bpm
   BP: 112/60(79) {88/47(58) - 137/84(102)} mmHg
   RR: 23 (19 - 27) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (6 - 14)mmHg
   Total In:
                                                                  1,911 mL
                                                                    375 mL
   PO:
   TF:
                                                                    636 mL
                                                                    200 mL
   IVF:
                                                                  1,145 mL
                                                                    116 mL
   Blood products:
   Total out:
                                                                    896 mL
                                                                     14 mL
   Urine:
                                                                     66 mL
                                                                     14 mL
   NG:
                                                                    110 mL
   Stool:
   Drains:
   Balance:
                                                                  1,015 mL
                                                                    361 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 375 (321 - 404) mL
   PS : 10 cmH2O
   RR (Spontaneous): 23
   PEEP: 8 cmH2O
   FiO2: 50%
   RSBI: 82
   PIP: 21 cmH2O
   SpO2: 98%
   ABG: 7.32/30/154/17/-9
   Ve: 12 L/min
   PaO2 / FiO2: 308
   Physical Examination
   Gen: intubated
   CV: irregularly irregular
   Resp: Rhonchorous b/l
   Abd: distended, nontender, hypoactive BS
   Ext: anasarcous, skin is jaundiced, bruising b/l in LE
   Labs / Radiology
   73 K/uL
   10.1 g/dL
   138 mg/dL
   3.3 mg/dL
   17 mEq/L
   3.6 mEq/L
   82 mg/dL
   110 mEq/L
   138 mEq/L
   29.8 %
   18.7 K/uL
         [image002.jpg]
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
   WBC
   23.8
   18.0
   18.7
   Hct
   32.1
   29.1
   29.8
   Plt
   153
   91
   73
   Cr
   3.0
   3.3
   3.3
   TCO2
   17
   17
   16
   17
   15
   16
   16
   Glucose
   [**Telephone/Fax (3) 10308**]38
   Other labs: PT / PTT / INR:21.4/39.1/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.7 mg/dL
   Imaging: cxr ([**2181-10-19**])
   Increasing perihilar opacification in the left lung is probably due to
   resolving edema or redistribution of pleural fluid since pneumonia
   should not
   clear that quickly. Substantial bibasilar opacification remains and
   could be
   atelectasis or pneumonia. Moderate right pleural effusion stable. Heart
   size
   normal. ET tube, right internal jugular line are in standard
   placements,
   unchanged. The transvenous right ventricular lead, which is inclined
   upward is unchanged in position and a nasogastric tube passes into the
   stomach and
   out of view.
   Microbiology: [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING
   INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL {STAPHYLOCOCCUS,
   COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE NEGATIVE}; Aerobic Bottle
   Gram Stain-FINAL; Anaerobic Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-FINAL {ESCHERICHIA COLI, ENTEROCOCCUS
   SP.} INPATIENT
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - will attempt SBT today; did well on 0/5
   - no plans for [**Female First Name (un) 217**] at this time
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-20**] 12:04 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   -patient in continued afib with RVR given bolus of fentanyl and then
   fluids with HCO3 for low CVP
   -family discussion choose no CVVH but still NOT CMO
   Patient unable to provide history: Sedated
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-19**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Phenylephrine - 0.3 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-20**] 06:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.9
C (98.4
   HR: 111 (110 - 143) bpm
   BP: 112/60(79) {88/47(58) - 137/84(102)} mmHg
   RR: 23 (19 - 27) insp/min
   SpO2: 98%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (6 - 14)mmHg
   Total In:
                                                                  1,911 mL
                                                                    375 mL
   PO:
   TF:
                                                                    636 mL
                                                                    200 mL
   IVF:
                                                                  1,145 mL
                                                                    116 mL
   Blood products:
   Total out:
                                                                    896 mL
                                                                     14 mL
   Urine:
                                                                     66 mL
                                                                     14 mL
   NG:
                                                                    110 mL
   Stool:
   Drains:
   Balance:
                                                                  1,015 mL
                                                                    361 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 375 (321 - 404) mL
   PS : 10 cmH2O
   RR (Spontaneous): 23
   PEEP: 8 cmH2O
   FiO2: 50%
   RSBI: 82
   PIP: 21 cmH2O
   SpO2: 98%
   ABG: 7.32/30/154/17/-9
   Ve: 12 L/min
   PaO2 / FiO2: 308
   Physical Examination
   Gen: intubated
   CV: irregularly irregular
   Resp: Rhonchorous b/l
   Abd: distended, nontender, hypoactive BS
   Ext: anasarcous, skin is jaundiced, bruising b/l in LE
   Labs / Radiology
   73 K/uL
   10.1 g/dL
   138 mg/dL
   3.3 mg/dL
   17 mEq/L
   3.6 mEq/L
   82 mg/dL
   110 mEq/L
   138 mEq/L
   29.8 %
   18.7 K/uL
         [image002.jpg]
                             [**2181-10-17**]  03:05 PM
                             [**2181-10-18**]  04:25 AM
                             [**2181-10-18**]  04:53 AM
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
   WBC
   23.8
   18.0
   18.7
   Hct
   32.1
   29.1
   29.8
   Plt
   153
   91
   73
   Cr
   3.0
   3.3
   3.3
   TCO2
   17
   17
   16
   17
   15
   16
   16
   Glucose
   [**Telephone/Fax (3) 10308**]38
   Other labs: PT / PTT / INR:21.4/39.1/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:580/346, Alk Phos / T Bili:744/19.5,
   Amylase / Lipase:243/383, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.0 g/dL, LDH:405 IU/L, Ca++:7.8 mg/dL,
   Mg++:2.6 mg/dL, PO4:4.7 mg/dL
   Imaging: cxr ([**2181-10-19**])
   Increasing perihilar opacification in the left lung is probably due to
   resolving edema or redistribution of pleural fluid since pneumonia
   should not
   clear that quickly. Substantial bibasilar opacification remains and
   could be
   atelectasis or pneumonia. Moderate right pleural effusion stable. Heart
   size
   normal. ET tube, right internal jugular line are in standard
   placements,
   unchanged. The transvenous right ventricular lead, which is inclined
   upward is unchanged in position and a nasogastric tube passes into the
   stomach and
   out of view.
   Microbiology: [**2181-10-16**]  BLOOD CULTURE Blood Culture, Routine-PENDING
   INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-15**]  URINE URINE CULTURE-FINAL INPATIENT
   [**2181-10-15**]  BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT
   [**2181-10-14**]  Blood (CMV AB) CMV IgG ANTIBODY-FINAL; CMV IgM
   ANTIBODY-FINAL INPATIENT
   [**2181-10-13**]  BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; RESPIRATORY
   CULTURE-FINAL {STAPH AUREUS COAG +} INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL INPATIENT
   [**2181-10-13**]  BLOOD CULTURE Blood Culture, Routine-FINAL {STAPHYLOCOCCUS,
   COAGULASE NEGATIVE, STAPHYLOCOCCUS, COAGULASE NEGATIVE}; Aerobic Bottle
   Gram Stain-FINAL; Anaerobic Bottle Gram Stain-FINAL INPATIENT
   [**2181-10-13**]  MRSA SCREEN MRSA SCREEN-FINAL {POSITIVE FOR METHICILLIN
   RESISTANT STAPH AUREUS} INPATIENT
   [**2181-10-13**]  URINE URINE CULTURE-FINAL {ESCHERICHIA COLI, ENTEROCOCCUS
   SP.} INPATIENT
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
    - continue digoxin 0.0625 mg / day per pharmacy
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - will attempt SBT today; did well on 0/5
   - no plans for [**Female First Name (un) 217**] at this time
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-20**] 12:04 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (none)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, Daily wake up, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male with intrahepatic cholestasis and sepsis from a urinary or lung source, continuing to have atrial fibrillation with right ventricular failure and worsening renal function. He is experiencing hypotension, hypoxia, and respiratory failure, and has a high risk of skin sloughing due to diffuse anasarca. He has a history of liver function abnormalities, acidosis, and impaired skin integrity.

Potential Medical Complications:

1. Sepsis: The patient is at high risk for sepsis due to his underlying infections, including MRSA pneumonia and urosepsis.
2. Acute Renal Failure: The patient's worsening renal function may lead to acute renal failure, which could require further interventions such as CVVH.
3. Atrial Fibrillation: The patient's atrial fibrillation may lead to further complications, such as stroke or heart failure.
4. Respiratory Failure: The patient's respiratory failure may worsen, requiring further interventions such as mechanical ventilation.
5. Skin Complications: The patient's diffuse anasarca and weeping skin increase the risk of skin sloughing, which could lead to further complications.
6. Liver Failure: The patient's liver function abnormalities may worsen, leading to liver failure.
7. Cardiovascular Complications: The patient's hypotension and diastolic heart failure may lead to further cardiovascular complications, such as cardiogenic shock.
8. Infection: The patient's underlying infections may spread to other areas of the body, leading to further complications.
9. Metabolic Acidosis: The patient's metabolic acidosis may worsen, leading to further complications.
10. Coagulopathy: The patient's coagulopathy may worsen, leading to further bleeding complications.

Recommendations:

1. Continue antibiotics and antifungals as prescribed.
2. Monitor the patient's renal function closely and consider further interventions such as CVVH if necessary.
3. Continue to monitor the patient's atrial fibrillation and consider restarting anticoagulation.
4. Monitor the patient's respiratory function closely and consider further interventions such as mechanical ventilation if necessary.
5. Monitor the patient's skin closely and consider further interventions such as wound care if necessary.
6. Monitor the patient's liver function closely and consider further interventions such as ERCP if necessary.
7. Consider restarting anticoagulation for atrial fibrillation.
8. Consider fentanyl boluses to treat atrial fibrillation with right ventricular failure.
9. Continue to hold beta blockers and Lasix due to hemodynamic instability.
10. Continue to replete electrolytes as necessary."
174373.0,234940,2181-10-21 07:20:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   -Switched digoxin to NG
   -attempted SBT-->did well, good sats, but tired out and became
   tachypnic, gas not great. put back on old settings
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-20**] 09:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-21**] 07:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 104 (103 - 136) bpm
   BP: 104/53(71) {80/44(56) - 153/71(101)} mmHg
   RR: 22 (21 - 32) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 7 (6 - 61)mmHg
   Total In:
                                                                  1,369 mL
                                                                    331 mL
   PO:
   TF:
                                                                    721 mL
                                                                    216 mL
   IVF:
                                                                    487 mL
                                                                    115 mL
   Blood products:
   Total out:
                                                                    159 mL
                                                                     90 mL
   Urine:
                                                                    159 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,210 mL
                                                                    241 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 380 (345 - 392) mL
   PS : 10 cmH2O
   RR (Spontaneous): 26
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 123
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.34/28/103/13/-8
   Ve: 9 L/min
   PaO2 / FiO2: 206
   Physical Examination
   gen: intubated, jaundiced
   cv: rrr
   resp: cta anteriorly
   abd: soft
   ext: edematous
   Labs / Radiology
   59 K/uL
   9.9 g/dL
   172 mg/dL
   3.3 mg/dL
   13 mEq/L
   3.5 mEq/L
   87 mg/dL
   111 mEq/L
   139 mEq/L
   30.0 %
   18.6 K/uL
        [image002.jpg]
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
   WBC
   18.0
   18.7
   18.6
   Hct
   29.1
   29.8
   30.0
   Plt
   91
   73
   59
   Cr
   3.3
   3.3
   3.3
   TCO2
   16
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:4.7 mg/dL
   Microbiology: URINE CULTURE-FINAL {ESCHERICHIA COLI s to [**Last Name (un) 614**],
   ENTEROCOCCUS SP s to vanc
   MRSA from resp cultures
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - will attempt SBT today; did well on 0/5
   - no plans for [**Female First Name (un) 217**] at this time
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
    # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (no dvt ppx)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   -Switched digoxin to NG
   -attempted SBT-->did well, good sats, but tired out and became
   tachypnic, gas not great. put back on old settings
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-20**] 09:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-21**] 07:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 104 (103 - 136) bpm
   BP: 104/53(71) {80/44(56) - 153/71(101)} mmHg
   RR: 22 (21 - 32) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 7 (6 - 61)mmHg
   Total In:
                                                                  1,369 mL
                                                                    331 mL
   PO:
   TF:
                                                                    721 mL
                                                                    216 mL
   IVF:
                                                                    487 mL
                                                                    115 mL
   Blood products:
   Total out:
                                                                    159 mL
                                                                     90 mL
   Urine:
                                                                    159 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,210 mL
                                                                    241 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 380 (345 - 392) mL
   PS : 10 cmH2O
   RR (Spontaneous): 26
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 123
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.34/28/103/13/-8
   Ve: 9 L/min
   PaO2 / FiO2: 206
   Physical Examination
   gen: intubated, jaundiced
   cv: rrr
   resp: cta anteriorly
   abd: soft
   ext: edematous
   Labs / Radiology
   59 K/uL
   9.9 g/dL
   172 mg/dL
   3.3 mg/dL
   13 mEq/L
   3.5 mEq/L
   87 mg/dL
   111 mEq/L
   139 mEq/L
   30.0 %
   18.6 K/uL
        [image002.jpg]
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
   WBC
   18.0
   18.7
   18.6
   Hct
   29.1
   29.8
   30.0
   Plt
   91
   73
   59
   Cr
   3.3
   3.3
   3.3
   TCO2
   16
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:4.7 mg/dL
   Microbiology: URINE CULTURE-FINAL {ESCHERICHIA COLI s to [**Last Name (un) 614**],
   ENTEROCOCCUS SP s to vanc
   MRSA from resp cultures
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - will attempt SBT today; did well on 0/5
   - no plans for [**Female First Name (un) 217**] at this time
    - continue vancomycin for MRSA pneumonia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
    # Acute renal failure- likely hemodynamic in origin do to poor
   perfusion
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (no dvt ppx)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male admitted to the ICU with intrahepatic cholestasis and sepsis from an unknown source. He has developed atrial fibrillation, acute renal failure, and respiratory failure. He is receiving vasopressin for septic shock and has MRSA pneumonia. His laboratory results show elevated liver enzymes, metabolic acidosis, and hypocalcemia. He is on mechanical ventilation and has a nasogastric tube.

Potential Medical Complications:

1. Continued septic shock: The patient's septic shock is likely to continue, and his vasopressor support may need to be adjusted or increased.
2. Worsening renal function: The patient's acute renal failure may worsen, and he may require renal replacement therapy.
3. Respiratory failure: The patient's respiratory failure may worsen, and he may require more aggressive respiratory support.
4. MRSA pneumonia: The patient's MRSA pneumonia may worsen, and he may require more aggressive antibiotic therapy.
5. Intrahepatic cholestasis: The patient's intrahepatic cholestasis may worsen, and he may require further management of his liver function.
6. Atrial fibrillation: The patient's atrial fibrillation may worsen, and he may require more aggressive anticoagulation therapy.
7. Skin integrity: The patient's skin integrity may worsen, and he may require more aggressive wound care management.
8. Diastolic heart failure: The patient's diastolic heart failure may worsen, and he may require more aggressive management of his cardiac function.

Recommendations:

1. Continue to monitor the patient's vital signs and laboratory results closely.
2. Adjust the patient's vasopressor support as needed to maintain adequate blood pressure.
3. Consider increasing the patient's fluid administration to help improve his renal function.
4. Consider adding more aggressive respiratory support, such as high-frequency oscillatory ventilation (HFOV), to help improve the patient's respiratory function.
5. Consider adding more aggressive antibiotic therapy for the patient's MRSA pneumonia.
6. Consider further management of the patient's liver function, such as ERCP, if his intrahepatic cholestasis worsens.
7. Consider more aggressive anticoagulation therapy for the patient's atrial fibrillation.
8. Consider more aggressive wound care management for the patient's skin integrity.
9. Consider more aggressive management of the patient's diastolic heart failure, such as increasing his diuretic therapy."
174373.0,234940,2181-10-21 07:20:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   -Switched digoxin to NG
   -attempted SBT yesterday-->did well, good sats, but tired out and
   became tachypnic, gas not great. put back on old settings
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-20**] 09:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-21**] 07:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 104 (103 - 136) bpm
   BP: 104/53(71) {80/44(56) - 153/71(101)} mmHg
   RR: 22 (21 - 32) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 7 (6 - 61)mmHg
   Total In:
                                                                  1,369 mL
                                                                    331 mL
   PO:
   TF:
                                                                    721 mL
                                                                    216 mL
   IVF:
                                                                    487 mL
                                                                    115 mL
   Blood products:
   Total out:
                                                                    159 mL
                                                                     90 mL
   Urine:
                                                                    159 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,210 mL
                                                                    241 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 380 (345 - 392) mL
   PS : 10 cmH2O
   RR (Spontaneous): 26
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 123
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.34/28/103/13/-8
   Ve: 9 L/min
   PaO2 / FiO2: 206
   Physical Examination
   gen: intubated, jaundiced
   cv: rrr
   resp: cta anteriorly
   abd: soft
   ext: anasarca
   Labs / Radiology
   59 K/uL
   9.9 g/dL
   172 mg/dL
   3.3 mg/dL
   13 mEq/L
   3.5 mEq/L
   87 mg/dL
   111 mEq/L
   139 mEq/L
   30.0 %
   18.6 K/uL
        [image002.jpg]
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
   WBC
   18.0
   18.7
   18.6
   Hct
   29.1
   29.8
   30.0
   Plt
   91
   73
   59
   Cr
   3.3
   3.3
   3.3
   TCO2
   16
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:4.7 mg/dL
   Microbiology: URINE CULTURE-FINAL {ESCHERICHIA COLI s to [**Last Name (un) 614**],
   ENTEROCOCCUS SP s to vanc
   MRSA from resp cultures
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - no sbt today as rsbi 123
   - continue vancomycin for MRSA pneumonia
   -pulm edema seems stable despite no UOP.
    # Acute renal failure- likely ATN due to poor perfusion. Cr does not
   appear to be rising
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharmacy. Will check level
   this morning. Could consider dc dig as does not seem to be helping her
   rate at all
   - continue to trend INR now 2.0
 could consider restarting
   anticoagulation for atrial fibrillation
   - fentanyl boluses seem to help inconsistently
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (no dvt ppx)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR (chemical code ok)
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   -Switched digoxin to NG
   -attempted SBT yesterday-->did well, good sats, but tired out and
   became tachypnic, gas not great. put back on old settings
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-20**] 09:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-21**] 07:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 104 (103 - 136) bpm
   BP: 104/53(71) {80/44(56) - 153/71(101)} mmHg
   RR: 22 (21 - 32) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 7 (6 - 61)mmHg
   Total In:
                                                                  1,369 mL
                                                                    331 mL
   PO:
   TF:
                                                                    721 mL
                                                                    216 mL
   IVF:
                                                                    487 mL
                                                                    115 mL
   Blood products:
   Total out:
                                                                    159 mL
                                                                     90 mL
   Urine:
                                                                    159 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,210 mL
                                                                    241 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 380 (345 - 392) mL
   PS : 10 cmH2O
   RR (Spontaneous): 26
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 123
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.34/28/103/13/-8
   Ve: 9 L/min
   PaO2 / FiO2: 206
   Physical Examination
   gen: intubated, jaundiced
   cv: rrr
   resp: cta anteriorly
   abd: soft
   ext: anasarca
   Labs / Radiology
   59 K/uL
   9.9 g/dL
   172 mg/dL
   3.3 mg/dL
   13 mEq/L
   3.5 mEq/L
   87 mg/dL
   111 mEq/L
   139 mEq/L
   30.0 %
   18.6 K/uL
        [image002.jpg]
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
   WBC
   18.0
   18.7
   18.6
   Hct
   29.1
   29.8
   30.0
   Plt
   91
   73
   59
   Cr
   3.3
   3.3
   3.3
   TCO2
   16
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:4.7 mg/dL
   Microbiology: URINE CULTURE-FINAL {ESCHERICHIA COLI s to [**Last Name (un) 614**],
   ENTEROCOCCUS SP s to vanc
   MRSA from resp cultures
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - no sbt today as rsbi 123
   - continue vancomycin for MRSA pneumonia
   -pulm edema seems stable despite no UOP.
    # Acute renal failure- likely ATN due to poor perfusion. Cr does not
   appear to be rising
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharmacy. Will check level
   this morning. Could consider dc dig as does not seem to be helping her
   rate at all
   - continue to trend INR now 2.0
 could consider restarting
   anticoagulation for atrial fibrillation
   - fentanyl boluses seem to help inconsistently
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (no dvt ppx)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR (chemical code ok)
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old female admitted to the ICU with intrahepatic cholestasis and sepsis from a urinary or lung source, complicated by atrial fibrillation, acute renal failure, respiratory failure, and hypothermia. She has a history of liver function abnormalities and has developed bilateral large effusions, MRSA pneumonia, and anasarca. She is receiving vasopressin support for septic shock and is being treated with meropenem and vancomycin for suspected urinary and lung infections.

Potential Medical Complications:

1. Worsening of septic shock: The patient's septic shock may worsen due to the ongoing infection and inadequate perfusion, leading to further organ dysfunction.
2. Acute kidney injury: The patient's acute kidney injury may progress to chronic kidney disease or require dialysis, which could impact her overall prognosis.
3. Respiratory failure: The patient's respiratory failure may worsen due to the underlying lung disease and lack of spontaneous breathing, leading to further respiratory distress.
4. Atrial fibrillation: The patient's atrial fibrillation may persist or worsen, leading to further cardiac complications, such as stroke or heart failure.
5. Skin integrity issues: The patient's anasarca and weeping skin may lead to skin sloughing and further complications, such as sepsis or organ failure.
6. Liver function abnormalities: The patient's liver function abnormalities may worsen, leading to further liver damage or failure.
7. Nutritional deficiencies: The patient's anasarca and lack of oral intake may lead to nutritional deficiencies, which could impact her overall health and recovery.
8. Infection control issues: The patient's ongoing infections and lack of spontaneous breathing may lead to further infection control issues, such as ventilator-associated pneumonia.

Given the patient's complex medical condition, close monitoring and aggressive management are necessary to prevent further complications and improve her overall prognosis."
174373.0,234940,2181-10-21 07:20:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   -Switched digoxin to NG
   -attempted SBT-->did well, good sats, but tired out and became
   tachypnic, gas not great. put back on old settings
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-20**] 09:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-21**] 07:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 104 (103 - 136) bpm
   BP: 104/53(71) {80/44(56) - 153/71(101)} mmHg
   RR: 22 (21 - 32) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 7 (6 - 61)mmHg
   Total In:
                                                                  1,369 mL
                                                                    331 mL
   PO:
   TF:
                                                                    721 mL
                                                                    216 mL
   IVF:
                                                                    487 mL
                                                                    115 mL
   Blood products:
   Total out:
                                                                    159 mL
                                                                     90 mL
   Urine:
                                                                    159 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,210 mL
                                                                    241 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 380 (345 - 392) mL
   PS : 10 cmH2O
   RR (Spontaneous): 26
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 123
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.34/28/103/13/-8
   Ve: 9 L/min
   PaO2 / FiO2: 206
   Physical Examination
   gen: intubated, jaundiced
   cv: rrr
   resp: cta anteriorly
   abd: soft
   ext: anasarca
   Labs / Radiology
   59 K/uL
   9.9 g/dL
   172 mg/dL
   3.3 mg/dL
   13 mEq/L
   3.5 mEq/L
   87 mg/dL
   111 mEq/L
   139 mEq/L
   30.0 %
   18.6 K/uL
        [image002.jpg]
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
   WBC
   18.0
   18.7
   18.6
   Hct
   29.1
   29.8
   30.0
   Plt
   91
   73
   59
   Cr
   3.3
   3.3
   3.3
   TCO2
   16
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:4.7 mg/dL
   Microbiology: URINE CULTURE-FINAL {ESCHERICHIA COLI s to [**Last Name (un) 614**],
   ENTEROCOCCUS SP s to vanc
   MRSA from resp cultures
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - no sbt today as rsbi 123
   - continue vancomycin for MRSA pneumonia
   -pulm edema seems stable despite no UOP.
    # Acute renal failure- likely ATN due to poor perfusion. Cr does not
   appear
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (no dvt ppx)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   -Switched digoxin to NG
   -attempted SBT-->did well, good sats, but tired out and became
   tachypnic, gas not great. put back on old settings
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-18**] 08:00 PM
   Meropenem - [**2181-10-20**] 09:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-21**] 07:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.9
   Tcurrent: 36.6
C (97.9
   HR: 104 (103 - 136) bpm
   BP: 104/53(71) {80/44(56) - 153/71(101)} mmHg
   RR: 22 (21 - 32) insp/min
   SpO2: 99%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 7 (6 - 61)mmHg
   Total In:
                                                                  1,369 mL
                                                                    331 mL
   PO:
   TF:
                                                                    721 mL
                                                                    216 mL
   IVF:
                                                                    487 mL
                                                                    115 mL
   Blood products:
   Total out:
                                                                    159 mL
                                                                     90 mL
   Urine:
                                                                    159 mL
                                                                     90 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,210 mL
                                                                    241 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 380 (345 - 392) mL
   PS : 10 cmH2O
   RR (Spontaneous): 26
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 123
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: 7.34/28/103/13/-8
   Ve: 9 L/min
   PaO2 / FiO2: 206
   Physical Examination
   gen: intubated, jaundiced
   cv: rrr
   resp: cta anteriorly
   abd: soft
   ext: anasarca
   Labs / Radiology
   59 K/uL
   9.9 g/dL
   172 mg/dL
   3.3 mg/dL
   13 mEq/L
   3.5 mEq/L
   87 mg/dL
   111 mEq/L
   139 mEq/L
   30.0 %
   18.6 K/uL
        [image002.jpg]
                             [**2181-10-18**]  01:16 PM
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
   WBC
   18.0
   18.7
   18.6
   Hct
   29.1
   29.8
   30.0
   Plt
   91
   73
   59
   Cr
   3.3
   3.3
   3.3
   TCO2
   16
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:4.7 mg/dL
   Microbiology: URINE CULTURE-FINAL {ESCHERICHIA COLI s to [**Last Name (un) 614**],
   ENTEROCOCCUS SP s to vanc
   MRSA from resp cultures
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 RENAL FAILURE, ACUTE (ACUTE RENAL FAILURE, ARF)
 RESPIRATORY FAILURE, ACUTE (NOT ARDS/[**Doctor Last Name 11**])
 SEPSIS, SEVERE (WITH ORGAN DYSFUNCTION)
 ACIDOSIS, METABOLIC
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 HYPOTHERMIA
 .H/O ACIDOSIS, RESPIRATORY
 .H/O LIVER FUNCTION ABNORMALITIES
 HYPOTENSION (NOT SHOCK)
 IMPAIRED SKIN INTEGRITY
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and worsening renal function.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Enterococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
    - no sbt today as rsbi 123
   - continue vancomycin for MRSA pneumonia
   -pulm edema seems stable despite no UOP.
    # Acute renal failure- likely ATN due to poor perfusion. Cr does not
   appear
   - renally dose all meds
 vancomycin 500 q day and dosed per levels
   - family/patient would not want CVVH, however not CMO at this point
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - continue digoxin 0.0625 daily for afib per pharamcy
   - continue to trend INR now 2.0
 consider restarting anticoagulation
   for atrial fibrillation
   - consider fentanyl boluses to treat a. fib RVR
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT: (no dvt ppx)
   Stress ulcer: PPI
   VAP: HOB elevation, Mouth care, RSBI
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male with intrahepatic cholestasis and sepsis from a urinary or lung source, with ongoing atrial fibrillation and worsening renal function. He is currently in septic shock requiring vasopressin support, with MRSA pneumonia and urosepsis as potential sources of infection. He has acute renal failure, likely due to poor perfusion, and elevated liver function tests. He is also experiencing hypoxemic respiratory failure, with bilateral large effusions and underlying MRSA pneumonia.

Potential medical complications:

1. Worsening septic shock: The patient's septic shock is ongoing, and there is a risk of further deterioration if not managed properly.
2. Acute kidney injury (AKI): The patient's acute renal failure is likely due to poor perfusion, and there is a risk of further deterioration if not managed properly.
3. Respiratory failure: The patient's hypoxemic respiratory failure is ongoing, and there is a risk of further deterioration if not managed properly.
4. Infection: The patient has MRSA pneumonia and urosepsis as potential sources of infection, and there is a risk of further complications if not managed properly.
5. Liver dysfunction: The patient's liver function tests are elevated, and there is a risk of further liver dysfunction if not managed properly.
6. Skin complications: The patient has diffuse anasarca with weeping skin and significant risk of skin sloughing, which may lead to further complications.
7. Cardiovascular complications: The patient has atrial fibrillation and may be at risk for further cardiovascular complications, such as heart failure or arrhythmias.
8. Neurological complications: The patient is at risk for neurological complications, such as sepsis-induced encephalopathy or stroke, due to his underlying septic shock and respiratory failure.

Recommendations:

1. Continue vasopressin support to maintain mean arterial pressure (MAP) > 65.
2. Continue meropenem and vancomycin to treat MRSA pneumonia and urosepsis.
3. Continue renal dose adjustment of medications.
4. Monitor the patient's liver function tests and consider ERCP if the patient becomes more stable.
5. Consider restarting anticoagulation for atrial fibrillation.
6. Monitor the patient's skin for signs of skin sloughing and provide wound care recommendations as needed.
7. Continue to manage the patient's respiratory failure with CPAP/PSV and consider non-invasive ventilation if necessary.
8. Monitor the patient's neurological status and consider imaging studies if neurological symptoms develop."
174373.0,234940,2181-10-22 07:15:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   - continued progressive thrombocytopenia [**Medical Record Number 10338**] - 59
   - 52
   - continued afib with RVR in setting of digoxin, treated with fluid
   bolus with marginal improvement, treated with fentanyl increase with
   marginal response
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-21**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-22**] 03:38 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-22**] 06:59 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 36.1
C (96.9
   HR: 126 (105 - 143) bpm
   BP: 123/67(88) {84/45(57) - 130/70(93)} mmHg
   RR: 19 (14 - 26) insp/min
   SpO2: 99%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 8 (5 - 11)mmHg
   Total In:
                                                                  1,485 mL
                                                                    315 mL
   PO:
   TF:
                                                                    720 mL
                                                                    206 mL
   IVF:
                                                                    615 mL
                                                                    110 mL
   Blood products:
   Total out:
                                                                    145 mL
                                                                     55 mL
   Urine:
                                                                    145 mL
                                                                     55 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,340 mL
                                                                    260 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 378 (373 - 444) mL
   PS : 10 cmH2O
   RR (Spontaneous): 18
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: ///14/
   Ve: 7 L/min
   Physical Examination
   General: NAD, opens eyes to name, does not follow commands
   Lungs: coarse crackles bilateral
   Heart: irregular and tachycardic, no MRG
   Abdomen: soft, ND, hypoactive BS
   Extremities: diffuse anasarca with weeping skin
   Labs / Radiology
   52 K/uL
   9.8 g/dL
   171 mg/dL
   4.1 mg/dL
   14 mEq/L
   3.3 mEq/L
   93 mg/dL
   112 mEq/L
   139 mEq/L
   30.3 %
   16.8 K/uL
        [image002.jpg]
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
   WBC
   18.0
   18.7
   18.6
   16.8
   Hct
   29.1
   29.8
   30.0
   30.3
   Plt
   91
   73
   59
   52
   Cr
   3.3
   3.3
   3.3
   4.1
   TCO2
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   171
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:5.0 mg/dL
   Imaging
   - CXR [**10-21**]: worsening L airspace opacifications c/w evolving pneumonia
   with moderate L and small R layering effusions
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration
   - continue to trend platelet counts transfusing with goal > 50,000
   - consider HIT Ig and pulling central line
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider discontinuing digoxin as no improvement in afib with RVR s/p
   load
   - fentanyl boluses seem to help inconsistently
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   - continued progressive thrombocytopenia [**Medical Record Number 10338**] - 59
   - 52
   - continued afib with RVR in setting of digoxin, treated with fluid
   bolus with marginal improvement, treated with fentanyl increase with
   marginal response
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-21**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-22**] 03:38 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-22**] 06:59 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 36.1
C (96.9
   HR: 126 (105 - 143) bpm
   BP: 123/67(88) {84/45(57) - 130/70(93)} mmHg
   RR: 19 (14 - 26) insp/min
   SpO2: 99%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 8 (5 - 11)mmHg
   Total In:
                                                                  1,485 mL
                                                                    315 mL
   PO:
   TF:
                                                                    720 mL
                                                                    206 mL
   IVF:
                                                                    615 mL
                                                                    110 mL
   Blood products:
   Total out:
                                                                    145 mL
                                                                     55 mL
   Urine:
                                                                    145 mL
                                                                     55 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,340 mL
                                                                    260 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 378 (373 - 444) mL
   PS : 10 cmH2O
   RR (Spontaneous): 18
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: ///14/
   Ve: 7 L/min
   Physical Examination
   General: NAD, opens eyes to name, does not follow commands
   Lungs: coarse crackles bilateral
   Heart: irregular and tachycardic, no MRG
   Abdomen: soft, ND, hypoactive BS
   Extremities: diffuse anasarca with weeping skin
   Labs / Radiology
   52 K/uL
   9.8 g/dL
   171 mg/dL
   4.1 mg/dL
   14 mEq/L
   3.3 mEq/L
   93 mg/dL
   112 mEq/L
   139 mEq/L
   30.3 %
   16.8 K/uL
        [image002.jpg]
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
   WBC
   18.0
   18.7
   18.6
   16.8
   Hct
   29.1
   29.8
   30.0
   30.3
   Plt
   91
   73
   59
   52
   Cr
   3.3
   3.3
   3.3
   4.1
   TCO2
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   171
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:5.0 mg/dL
   Imaging
   - CXR [**10-21**]: worsening L airspace opacifications c/w evolving pneumonia
   with moderate L and small R layering effusions
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration
   - continue to trend platelet counts transfusing with goal > 50,000
   - consider HIT Ig and pulling central line
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider discontinuing digoxin as no improvement in afib with RVR s/p
   load
   - fentanyl boluses seem to help inconsistently
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following medical complications are potential concerns:

1. Septic Shock: The patient continues to experience septic shock, which is a life-threatening condition that requires prompt and aggressive treatment. The patient's vasopressor support and antibiotics need to be continued and monitored closely.
2. Acute Renal Failure: The patient's anuric renal failure is likely to progress to chronic kidney disease if not managed promptly. The patient's creatinine level is rising, and the doctor has considered CVVH and HD, but the family has declined long-term GOC.
3. Thrombocytopenia: The patient's platelet count is rapidly dropping, which increases the risk of bleeding. The doctor has considered HIT, synthetic dysfunction, and splenic sequestration as potential causes and is planning to transfuse with a goal of >50,000 platelets.
4. Intrahepatic Cholestasis: The patient's liver function tests (LFTs) are abnormal, and the doctor is considering ERCP if the patient becomes more stable.
5. Atrial Fibrillation: The patient's atrial fibrillation is persistent, and the doctor is considering discontinuing digoxin as it has not improved the patient's condition.
6. Skin Complications: The patient has diffuse anasarca with weeping skin, which increases the risk of skin sloughing. The doctor has recommended wound care and will follow up with recommendations.
7. Diastolic Heart Failure: The patient's diastolic heart failure is likely to worsen if not managed promptly. The doctor is holding beta-blockers and Lasix due to hemodynamic instability.
8. Malnutrition: The patient is at risk of malnutrition due to anuria and diffuse anasarca. The doctor has recommended tube feeds and will continue to monitor the patient's nutritional status.
9. Infection: The patient has MRSA pneumonia, and the doctor is continuing antibiotics. The patient also has E. coli and Enterococcus infections, which need to be managed promptly to prevent further complications.
10. Hemodynamic Instability: The patient's hemodynamic instability is a concern, and the doctor is monitoring the patient's vital signs closely to adjust treatment accordingly.

In summary, the patient is at risk of multiple medical complications, including septic shock, acute renal failure, thrombocytopenia, intrahepatic cholestasis, atrial fibrillation, skin complications, diastolic heart failure, malnutrition, infection, and hemodynamic instability. The doctor needs to continue to monitor the patient's condition closely and adjust treatment accordingly to prevent further complications and improve the patient's outcome."
174373.0,234940,2181-10-22 07:15:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   - continued progressive thrombocytopenia [**Medical Record Number 10338**] - 59
   - 52
   - continued afib with RVR in setting of digoxin, treated with fluid
   bolus with marginal improvement, treated with fentanyl increase with
   marginal response
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-21**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-22**] 03:38 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-22**] 06:59 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 36.1
C (96.9
   HR: 126 (105 - 143) bpm
   BP: 123/67(88) {84/45(57) - 130/70(93)} mmHg
   RR: 19 (14 - 26) insp/min
   SpO2: 99%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 8 (5 - 11)mmHg
   Total In:
                                                                  1,485 mL
                                                                    315 mL
   PO:
   TF:
                                                                    720 mL
                                                                    206 mL
   IVF:
                                                                    615 mL
                                                                    110 mL
   Blood products:
   Total out:
                                                                    145 mL
                                                                     55 mL
   Urine:
                                                                    145 mL
                                                                     55 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,340 mL
                                                                    260 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 378 (373 - 444) mL
   PS : 10 cmH2O
   RR (Spontaneous): 18
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: ///14/
   Ve: 7 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   52 K/uL
   9.8 g/dL
   171 mg/dL
   4.1 mg/dL
   14 mEq/L
   3.3 mEq/L
   93 mg/dL
   112 mEq/L
   139 mEq/L
   30.3 %
   16.8 K/uL
        [image002.jpg]
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
   WBC
   18.0
   18.7
   18.6
   16.8
   Hct
   29.1
   29.8
   30.0
   30.3
   Plt
   91
   73
   59
   52
   Cr
   3.3
   3.3
   3.3
   4.1
   TCO2
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   171
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:5.0 mg/dL
   Imaging
   - CXR [**10-21**]: worsening L airspace opacifications c/w evolving pneumonia
   with moderate L and small R layering effusions
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration
   - continue to trend platelet counts transfusing with goal > 50,000
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider discontinuing digoxin as no improvement in afib with RVR s/p
   load
   - fentanyl boluses seem to help inconsistently
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   - continued progressive thrombocytopenia [**Medical Record Number 10338**] - 59
   - 52
   - continued afib with RVR in setting of digoxin, treated with fluid
   bolus with marginal improvement, treated with fentanyl increase with
   marginal response
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-21**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-22**] 03:38 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-22**] 06:59 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 36.1
C (96.9
   HR: 126 (105 - 143) bpm
   BP: 123/67(88) {84/45(57) - 130/70(93)} mmHg
   RR: 19 (14 - 26) insp/min
   SpO2: 99%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 8 (5 - 11)mmHg
   Total In:
                                                                  1,485 mL
                                                                    315 mL
   PO:
   TF:
                                                                    720 mL
                                                                    206 mL
   IVF:
                                                                    615 mL
                                                                    110 mL
   Blood products:
   Total out:
                                                                    145 mL
                                                                     55 mL
   Urine:
                                                                    145 mL
                                                                     55 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,340 mL
                                                                    260 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 378 (373 - 444) mL
   PS : 10 cmH2O
   RR (Spontaneous): 18
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: ///14/
   Ve: 7 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   52 K/uL
   9.8 g/dL
   171 mg/dL
   4.1 mg/dL
   14 mEq/L
   3.3 mEq/L
   93 mg/dL
   112 mEq/L
   139 mEq/L
   30.3 %
   16.8 K/uL
        [image002.jpg]
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
   WBC
   18.0
   18.7
   18.6
   16.8
   Hct
   29.1
   29.8
   30.0
   30.3
   Plt
   91
   73
   59
   52
   Cr
   3.3
   3.3
   3.3
   4.1
   TCO2
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   171
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:5.0 mg/dL
   Imaging
   - CXR [**10-21**]: worsening L airspace opacifications c/w evolving pneumonia
   with moderate L and small R layering effusions
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration
   - continue to trend platelet counts transfusing with goal > 50,000
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider discontinuing digoxin as no improvement in afib with RVR s/p
   load
   - fentanyl boluses seem to help inconsistently
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male admitted to the ICU with grossly abnormal liver function tests (LFTs) in the setting of sepsis from a urinary tract infection (UTI) and MRSA pneumonia. He is anuric and has ongoing atrial fibrillation with rapid ventricular response (AFib with RVR). He has a rapidly dropping platelet count, and his creatinine has risen to 4.1 mg/dL, indicating acute renal failure.

Potential Medical Complications:

1. Septic Shock: The patient's ongoing septic shock requires vasopressin support, and his creatinine level is rising, indicating poor perfusion.
2. Acute Renal Failure: The patient's creatinine level has risen to 4.1 mg/dL, indicating acute renal failure. CVVH and HD are being considered, but the family has concerns about long-term GOC.
3. Thrombocytopenia: The patient's platelet count is rapidly dropping, and synthetic dysfunction, HIT, and splenic sequestration are being considered.
4. Intrahepatic Cholestasis: The patient's LFTs are abnormal, and AST/ALT are trending down, while AP/LDH and TBili remain constant, indicating intrahepatic cholestasis or obstructive picture.
5. Atrial Fibrillation: The patient is in AFib with RVR, and digoxin load has been given, but there is no improvement. Fentanyl boluses seem to help inconsistently.
6. Diastolic Heart Failure: The patient has diastolic heart failure, and beta-blockers and lasix are being held due to hemodynamic instability.
7. Skin Complications: The patient has diffuse anasarca with weeping skin and significant risk of skin sloughing.
8. Respiratory Failure: The patient has ongoing hypoxic respiratory failure due to bilateral large effusions and underlying MRSA pneumonia.

Recommendations:

1. Continue antibiotics and vasopressin support for septic shock.
2. Consider CVVH and HD for acute renal failure, but discuss with the family about long-term GOC.
3. Monitor platelet count and consider transfusions with a goal of > 50,000.
4. Continue to trend LFTs and consider ERCP if the patient becomes more stable.
5. Discontinue digoxin and consider other treatments for atrial fibrillation.
6. Hold beta-blockers and lasix due to hemodynamic instability and consider other treatments for diastolic heart failure.
7. Provide wound care recommendations for skin complications.
8. Continue to monitor respiratory status and consider adjusting ventilation settings as necessary."
174373.0,234940,2181-10-22 07:15:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   - continued progressive thrombocytopenia [**Medical Record Number 10338**] - 59
   - 52
   - continued afib with RVR in setting of digoxin, treated with fluid
   bolus with marginal improvement, treated with fentanyl increase with
   marginal response
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-21**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-22**] 03:38 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-22**] 06:59 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 36.1
C (96.9
   HR: 126 (105 - 143) bpm
   BP: 123/67(88) {84/45(57) - 130/70(93)} mmHg
   RR: 19 (14 - 26) insp/min
   SpO2: 99%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 8 (5 - 11)mmHg
   Total In:
                                                                  1,485 mL
                                                                    315 mL
   PO:
   TF:
                                                                    720 mL
                                                                    206 mL
   IVF:
                                                                    615 mL
                                                                    110 mL
   Blood products:
   Total out:
                                                                    145 mL
                                                                     55 mL
   Urine:
                                                                    145 mL
                                                                     55 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,340 mL
                                                                    260 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 378 (373 - 444) mL
   PS : 10 cmH2O
   RR (Spontaneous): 18
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: ///14/
   Ve: 7 L/min
   Physical Examination
   General: NAD, opens eyes to name, does not follow commands
   Lungs: coarse crackles bilateral
   Heart: irregular and tachycardic, no MRG
   Abdomen: soft, ND, hypoactive BS
   Extremities: diffuse anasarca with weeping skin
   Labs / Radiology
   52 K/uL
   9.8 g/dL
   171 mg/dL
   4.1 mg/dL
   14 mEq/L
   3.3 mEq/L
   93 mg/dL
   112 mEq/L
   139 mEq/L
   30.3 %
   16.8 K/uL
        [image002.jpg]
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
   WBC
   18.0
   18.7
   18.6
   16.8
   Hct
   29.1
   29.8
   30.0
   30.3
   Plt
   91
   73
   59
   52
   Cr
   3.3
   3.3
   3.3
   4.1
   TCO2
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   171
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:5.0 mg/dL
   Imaging
   - CXR [**10-21**]: worsening L airspace opacifications c/w evolving pneumonia
   with moderate L and small R layering effusions
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration, drug induced
   - continue to trend platelets
   - consider antibiotic holiday with daily re-addition to evaluate for
   drug induced thrombocytopenia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider increasing digoxin as no improvement in afib with RVR s/p
   load
 will titrate to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   - continued progressive thrombocytopenia [**Medical Record Number 10338**] - 59
   - 52
   - continued afib with RVR in setting of digoxin, treated with fluid
   bolus with marginal improvement, treated with fentanyl increase with
   marginal response
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-21**] 08:00 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-22**] 03:38 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-22**] 06:59 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.5
   Tcurrent: 36.1
C (96.9
   HR: 126 (105 - 143) bpm
   BP: 123/67(88) {84/45(57) - 130/70(93)} mmHg
   RR: 19 (14 - 26) insp/min
   SpO2: 99%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 78 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 8 (5 - 11)mmHg
   Total In:
                                                                  1,485 mL
                                                                    315 mL
   PO:
   TF:
                                                                    720 mL
                                                                    206 mL
   IVF:
                                                                    615 mL
                                                                    110 mL
   Blood products:
   Total out:
                                                                    145 mL
                                                                     55 mL
   Urine:
                                                                    145 mL
                                                                     55 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,340 mL
                                                                    260 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 378 (373 - 444) mL
   PS : 10 cmH2O
   RR (Spontaneous): 18
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 70
   PIP: 16 cmH2O
   SpO2: 99%
   ABG: ///14/
   Ve: 7 L/min
   Physical Examination
   General: NAD, opens eyes to name, does not follow commands
   Lungs: coarse crackles bilateral
   Heart: irregular and tachycardic, no MRG
   Abdomen: soft, ND, hypoactive BS
   Extremities: diffuse anasarca with weeping skin
   Labs / Radiology
   52 K/uL
   9.8 g/dL
   171 mg/dL
   4.1 mg/dL
   14 mEq/L
   3.3 mEq/L
   93 mg/dL
   112 mEq/L
   139 mEq/L
   30.3 %
   16.8 K/uL
        [image002.jpg]
                             [**2181-10-19**]  03:27 AM
                             [**2181-10-19**]  04:04 AM
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
   WBC
   18.0
   18.7
   18.6
   16.8
   Hct
   29.1
   29.8
   30.0
   30.3
   Plt
   91
   73
   59
   52
   Cr
   3.3
   3.3
   3.3
   4.1
   TCO2
   17
   15
   16
   16
   17
   16
   Glucose
   189
   148
   138
   172
   171
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.3 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:7.7 mg/dL,
   Mg++:2.5 mg/dL, PO4:5.0 mg/dL
   Imaging
   - CXR [**10-21**]: worsening L airspace opacifications c/w evolving pneumonia
   with moderate L and small R layering effusions
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration, drug induced
   - continue to trend platelets
   - consider antibiotic holiday with daily re-addition to evaluate for
   drug induced thrombocytopenia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider increasing digoxin as no improvement in afib with RVR s/p
   load
 will titrate to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-21**] 04:01 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided medical progress note, the patient is an 81-year-old male with a history of atrial fibrillation and diastolic heart failure, admitted with grossly abnormal liver function tests (LFTs) in the setting of sepsis from a urinary tract infection (UTI) and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. The patient is anuric and has undergone fluid resuscitation with marginal improvement.

The patient's current condition is as follows:

* Hemodynamic monitoring: The patient's mean arterial pressure (MAP) is 123/67 mmHg, and his central venous pressure (CVP) is 8 mmHg.
* Respiratory support: The patient is receiving continuous positive airway pressure (CPAP) and positive end-expiratory pressure (PEEP) through an endotracheal tube.
* Cardiovascular status: The patient is in atrial fibrillation with rapid ventricular response (RVR), and his digoxin load has been ineffective in controlling his heart rate.
* Renal function: The patient is anuric and has rising creatinine levels, indicating acute renal failure.
* Liver function: The patient's LFTs are abnormal, with elevations in aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP).
* Coagulation status: The patient has thrombocytopenia, with a platelet count of 59.
* Infections: The patient has sepsis from a urinary or lung source, and is receiving meropenem and vancomycin antibiotics.

Potential medical complications that may arise include:

* Septic shock: The patient's sepsis may progress to septic shock, requiring further vasopressor support and possible invasive hemodynamic monitoring.
* Acute kidney injury: The patient's anuria and rising creatinine levels indicate acute kidney injury, which may require further interventions such as continuous renal replacement therapy (CRRT) or hemodialysis.
* Intrahepatic cholestasis: The patient's abnormal LFTs may be indicative of intrahepatic cholestasis, which may require further evaluation and management.
* Thrombocytopenia: The patient's rapidly dropping platelet count may indicate synthetic dysfunction, heparin-induced thrombocytopenia (HIT), splenic sequestration, or drug-induced thrombocytopenia.
* Skin sloughing: The patient's diffuse anasarca and weeping skin may increase the risk of skin sloughing, which may require further wound care and management.
* Atrial fibrillation: The patient's atrial fibrillation with RVR may require further management, including increasing digoxin doses or considering other antiarrhythmic medications.

In conclusion, the patient is a complex case requiring close monitoring and management of his multiple medical conditions. Further evaluation and management are needed to address the patient's sepsis, acute kidney injury, intrahepatic cholestasis, thrombocytopenia, skin sloughing, and atrial fibrillation."
174373.0,234940,2181-10-23 06:32:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   General: NAD, opens eyes to name but unable to follow commands
   Lungs: diffuse crackles unchanged from prior
   Heart: irregular, tachycardic
   Abdomen: soft, NTND, no masses
   Extremities: jaundice, 4+ peripheral edema with weeping skin
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Imaging
   - CXR [**10-22**]: improving airspace opacities in left mid and lower lung
   which may be do to improving pneumonia, dense opacification in right
   perihilar and retrocardiac area and bilateral pleural effusions
   unchanged
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   General: NAD, opens eyes to name but unable to follow commands
   Lungs: diffuse crackles unchanged from prior
   Heart: irregular, tachycardic
   Abdomen: soft, NTND, no masses
   Extremities: jaundice, 4+ peripheral edema with weeping skin
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Imaging
   - CXR [**10-22**]: improving airspace opacities in left mid and lower lung
   which may be do to improving pneumonia, dense opacification in right
   perihilar and retrocardiac area and bilateral pleural effusions
   unchanged
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old male admitted with sepsis, urinary tract infection (UTI), and MRSA pneumonia, resulting in anuric renal failure, atrial fibrillation, and diastolic heart failure. The patient has a history of atrial fibrillation and diastolic heart failure.

The patient's current vital signs are:

* Temperature: 36.1C (96.9F)
* Heart rate: 94 bpm (94-137 bpm)
* Blood pressure: 107/53 mmHg (71-143/96 mmHg)
* Respiratory rate: 20 inspirations per minute (16-29 inspirations per minute)
* Oxygen saturation: 100%

The patient's laboratory results show:

* White blood cell count: 18.7 K/uL
* Hemoglobin: 9.5 g/dL
* Platelet count: 73 K/uL
* Creatinine: 4.5 mg/dL
* Liver function tests (LFTs): elevated AST/ALT, alkaline phosphatase, and total bilirubin
* Blood cultures: negative for E. coli and Enterococcus on 9/21
* Urine culture: E. coli and Enterococcus on 10/13
* BAL culture: MRSA on 10/13

The patient's imaging studies show:

* Chest X-ray (CXR) on 10/22: improving airspace opacities in the left mid and lower lung, dense opacification in the right perihilar and retrocardiac area, and bilateral pleural effusions

The patient's plan includes:

* Continuing broad-spectrum antibiotics (meropenem and vancomycin) for sepsis and pneumonia
* Maintaining vasopressin support to maintain mean arterial pressure (MAP) > 65 mmHg
* Limiting intravenous fluids (IVF) in the setting of anuric renal failure
* Continuing to monitor and trend platelet counts
* Considering CVVH and HD for acute renal failure
* Reconsulting the liver to evaluate continued LFT abnormalities
* Considering MRCP to evaluate for CBD obstruction in the setting of elevated alkaline phosphatase and total bilirubin

Potential medical complications that can arise include:

1. Worsening sepsis and septic shock
2. Progressive renal failure and need for dialysis
3. Development of liver failure and coagulopathy
4. Cardiac arrhythmias and decreased cardiac output
5. Respiratory failure and need for mechanical ventilation
6. Skin sloughing and infection
7. Thrombocytopenia and bleeding diathesis
8. Intra-abdominal hypertension and compartment syndrome
9. Cerebral edema and neurological complications
10. Malignant hypertension and hypertensive crisis

It is essential to closely monitor the patient's condition and adjust the treatment plan accordingly to prevent or mitigate these potential complications."
174373.0,234940,2181-10-23 06:32:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Imaging
   - CXR [**10-22**]: improving airspace opacities in left mid and lower lung
   which may be do to improving pneumonia, dense opacification in right
   perihilar and retrocardiac area and bilateral pleural effusions
   unchanged
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Imaging
   - CXR [**10-22**]: improving airspace opacities in left mid and lower lung
   which may be do to improving pneumonia, dense opacification in right
   perihilar and retrocardiac area and bilateral pleural effusions
   unchanged
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following summary and potential medical complications are identified:

Summary:

The patient is an 81-year-old man with a history of atrial fibrillation, diastolic heart failure, and intrahepatic cholestasis. He was admitted with grossly abnormal LFTs and sepsis from a urinary tract infection (UTI) and MRSA pneumonia. The patient is currently anuric and has been treated with vasopressin, meropenem, and vancomycin. He has developed thrombocytopenia, elevated LFTs, and atrial fibrillation with rapid ventricular response.

Potential Medical Complications:

1. Septic Shock: The patient's septic shock state may worsen if the underlying infections are not effectively treated, leading to further organ dysfunction and potentially life-threatening complications.
2. Acute Renal Failure: The patient's anuric renal failure may progress to chronic renal failure if not managed appropriately, leading to electrolyte imbalances, acidosis, and increased risk of cardiovascular events.
3. Hepatic Failure: The patient's intrahepatic cholestasis may worsen if not managed, leading to fulminant hepatic failure and potentially life-threatening complications.
4. Cardiovascular Complications: The patient's atrial fibrillation with rapid ventricular response may increase the risk of stroke, cardiac arrest, and cardiovascular mortality.
5. Respiratory Failure: The patient's MRSA pneumonia may worsen, leading to respiratory failure and potentially life-threatening complications.
6. Thrombocytopenia: The patient's thrombocytopenia may worsen if not managed, leading to increased risk of bleeding and potentially life-threatening complications.
7. Skin Complications: The patient's diffuse anasarca and weeping skin may increase the risk of skin sloughing, infections, and potentially life-threatening complications.
8. Malnutrition: The patient's anuric renal failure and inability to tolerate oral intake may lead to malnutrition and potentially life-threatening complications.
9. Electrolyte Imbalances: The patient's anuric renal failure may lead to electrolyte imbalances, including hyperkalemia, hypocalcemia, and hypomagnesemia, which may worsen if not managed.
10. Infections: The patient's septic shock state and anuric renal failure may increase the risk of secondary infections, including ventilator-associated pneumonia and central line-associated bloodstream infections.

Based on this analysis, it is essential to continue aggressive management of the patient's septic shock, acute renal failure, and intrahepatic cholestasis, while also addressing the potential complications listed above."
174373.0,234940,2181-10-23 06:32:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration, drug induced
   - continue to trend platelets
   - consider antibiotic holiday with daily re-addition to evaluate for
   drug induced thrombocytopenia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider increasing digoxin as no improvement in afib with RVR s/p
   load
 will titrate to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration, drug induced
   - continue to trend platelets
   - consider antibiotic holiday with daily re-addition to evaluate for
   drug induced thrombocytopenia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider increasing digoxin as no improvement in afib with RVR s/p
   load
 will titrate to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old individual admitted to the ICU with intrahepatic cholestasis and sepsis from a urinary or lung source. The patient is experiencing:

1. Septic shock: The patient requires vasopressin support to maintain a mean arterial pressure (MAP) above 65 mmHg, and the source of infection is suspected to be MRSA pneumonia or urosepsis.
2. Hypoxic respiratory failure: The patient has bilateral large effusions and underlying MRSA pneumonia, which is not improving despite antibiotics.
3. Acute renal failure: The patient has anuric renal failure, likely due to acute tubular necrosis (ATN) caused by poor perfusion, with a rising creatinine level.
4. Thrombocytopenia: The patient's platelet count is rapidly dropping, and consideration is being given to synthetic dysfunction, heparin-induced thrombocytopenia (HIT), splenic sequestration, or drug-induced thrombocytopenia.
5. Elevated liver function tests (LFTs): The patient's AST and ALT are trending down, while AP and LDH remain constant, suggesting intrahepatic cholestasis or obstructive picture.
6. Atrial fibrillation: The patient is in atrial fibrillation with rapid ventricular response (RVR), which is being managed with digoxin.
7. Skin: The patient has diffuse anasarca with weeping skin and a significant risk of skin sloughing.
8. Diastolic heart failure: The patient is experiencing hemodynamic instability, and beta-blockers and Lasix are being held.

Potential medical complications that can arise from these conditions include:

1. Worsening septic shock: The patient's septic shock may worsen if the source of infection is not effectively treated, leading to further organ dysfunction and increased mortality.
2. Respiratory failure: The patient's hypoxic respiratory failure may progress to respiratory arrest if not managed effectively, leading to further morbidity and mortality.
3. Renal failure: The patient's acute renal failure may progress to end-stage renal disease if not managed effectively, leading to further morbidity and mortality.
4. Thrombocytopenia: The patient's thrombocytopenia may worsen if not managed effectively, leading to increased risk of bleeding and hemorrhage.
5. Liver failure: The patient's elevated LFTs may indicate liver failure, which can lead to further organ dysfunction and increased mortality.
6. Cardiac arrhythmias: The patient's atrial fibrillation may worsen, leading to further cardiac arrhythmias and decreased cardiac output.
7. Skin complications: The patient's skin anasarca may worsen, leading to skin sloughing and increased risk of infection.
8. Diastolic heart failure: The patient's diastolic heart failure may worsen, leading to further cardiac dysfunction and decreased cardiac output."
174373.0,234940,2181-10-23 06:32:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   General: NAD, opens eyes to name but unable to follow commands
   Lungs: diffuse crackles unchanged from prior
   Heart: irregular, tachycardic
   Abdomen: soft, NTND, no masses
   Extremities: jaundice, 4+ peripheral edema with weeping skin
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Imaging
   - CXR [**10-22**]: improving airspace opacities in left mid and lower lung
   which may be do to improving pneumonia, dense opacification in right
   perihilar and retrocardiac area and bilateral pleural effusions
   unchanged
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care this evening once family arrives
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   General: NAD, opens eyes to name but unable to follow commands
   Lungs: diffuse crackles unchanged from prior
   Heart: irregular, tachycardic
   Abdomen: soft, NTND, no masses
   Extremities: jaundice, 4+ peripheral edema with weeping skin
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Imaging
   - CXR [**10-22**]: improving airspace opacities in left mid and lower lung
   which may be do to improving pneumonia, dense opacification in right
   perihilar and retrocardiac area and bilateral pleural effusions
   unchanged
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care this evening once family arrives
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male with a history of atrial fibrillation, diastolic heart failure, and sepsis due to urinary tract infection (UTI) and MRSA pneumonia. He is anuric and has undergone vasopressor support for septic shock. The patient has undergone various interventions, including antibiotic therapy, vasopressor support, and fluid management. His condition is complicated by intrahepatic cholestasis, thrombocytopenia, and elevated liver function tests (LFTs).

Potential Medical Complications:

1. Continued septic shock: The patient's septic shock state requires ongoing vasopressor support, and the possibility of MRSA pneumonia or urosepsis as the infective source remains a concern.
2. Acute renal failure: The patient's anuric renal failure is likely due to acute tubular necrosis (ATN) secondary to poor perfusion, and further deterioration of renal function is possible.
3. Thrombocytopenia: The patient's platelet count has stabilized, but the possibility of drug-induced thrombocytopenia remains, and further monitoring is necessary.
4. Intrahepatic cholestasis: The patient's LFTs remain abnormal, and the possibility of CBD obstruction or intrahepatic cholestasis persists, requiring further evaluation and management.
5. Atrial fibrillation: The patient's atrial fibrillation requires ongoing rate control, and the possibility of digoxin toxicity remains.
6. Skin complications: The patient's diffuse anasarca and weeping skin increase the risk of skin sloughing and require close monitoring and wound care.
7. Diastolic heart failure: The patient's diastolic heart failure requires ongoing management, and the possibility of further decompensation remains.
8. Electrolyte imbalance: The patient's anuria and diffuse anasarca increase the risk of electrolyte imbalance, requiring close monitoring and repletion as needed.

Overall, the patient's condition is complex and requires ongoing close monitoring and management to prevent further complications and deterioration."
174373.0,234940,2181-10-23 06:32:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration, drug induced
   - continue to trend platelets
   - consider antibiotic holiday with daily re-addition to evaluate for
   drug induced thrombocytopenia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider increasing digoxin as no improvement in afib with RVR s/p
   load
 will titrate to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now anuric.
   24 Hour Events:
   -family meeting: treatment options discussed and possibility of CMO
   introduced, family to discuss
   -digoxin increased to 0.125 mg with HR response now low 100's
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Meropenem - [**2181-10-22**] 08:00 AM
   Vancomycin - [**2181-10-22**] 08:30 AM
   Infusions:
   Vasopressin - 2.4 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-23**] 04:02 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-23**] 06:32 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.3
C (99.1
   Tcurrent: 36.1
C (96.9
   HR: 94 (94 - 137) bpm
   BP: 107/53(71) {92/46(61) - 143/70(96)} mmHg
   RR: 20 (16 - 29) insp/min
   SpO2: 100%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
    CVP: 10 (10 - 10)mmHg
   Total In:
                                                                  1,918 mL
                                                                    288 mL
   PO:
   TF:
                                                                    720 mL
                                                                    196 mL
   IVF:
                                                                  1,118 mL
                                                                     92 mL
   Blood products:
   Total out:
                                                                    140 mL
                                                                     45 mL
   Urine:
                                                                    140 mL
                                                                     45 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,778 mL
                                                                    243 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 333 (333 - 487) mL
   PS : 10 cmH2O
   RR (Spontaneous): 29
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI Deferred: RR >35
   PIP: 16 cmH2O
   SpO2: 100%
   ABG: 7.35/27/119/14/-8
   Ve: 9.5 L/min
   PaO2 / FiO2: 238
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary or lung
   source, continuing a. fib with RVR and continued anuric renal failure.
   # Shock: continued septic shock requiring vasopressin support with MRSA
   pneumonia vs. urosepsis as infective source.
    - continue meropenem (E.Coli) and vancomycin (Entrococcus and MRSA)
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.1
   - continue to renally dose all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: rapidly dropping platelet count [**Medical Record Number 10339**] - 59
 52.  Considerations include synthetic dysfunction, HIT,
   splenic sequestration, drug induced
   - continue to trend platelets
   - consider antibiotic holiday with daily re-addition to evaluate for
   drug induced thrombocytopenia
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver
    - continue to trend LFT
s and consider ERCP if patient becomes more
   stable
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   load
   - consider increasing digoxin as no improvement in afib with RVR s/p
   load
 will titrate to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability.
    # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
   ICU Care
   Nutrition:
   NovaSource Renal (Full) - [**2181-10-22**] 07:59 AM 30 mL/hour
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old male with a history of atrial fibrillation and diastolic heart failure, who was admitted with grossly abnormal liver function tests (LFTs) in the setting of sepsis from a urinary tract infection (UTI) and MRSA pneumonia, and is now anuric.

The patient's current condition is complicated by:

1. Sepsis: The patient has ongoing septic shock requiring vasopressin support, with MRSA pneumonia and UTI as potential sources of infection.
2. Respiratory failure: The patient has bilateral large effusions and underlying MRSA pneumonia, which may be contributing to his hypoxic respiratory failure.
3. Acute renal failure: The patient has rising creatinine levels and is anuric, likely due to ATN caused by poor perfusion.
4. Thrombocytopenia: The patient's platelet count is rapidly dropping, and consideration should be given to synthetic dysfunction, HIT, splenic sequestration, and drug-induced thrombocytopenia.
5. Elevated LFTs: The patient's LFTs are abnormal, with AST and ALT trending down, while AP and LDH remain constant, indicating intrahepatic cholestasis or obstructive picture.
6. Atrial fibrillation: The patient is in atrial fibrillation with RVR, and consideration should be given to increasing digoxin as no improvement in afib with RVR has been seen.
7. Skin issues: The patient has diffuse anasarca with weeping skin and significant risk of skin sloughing.
8. Diastolic heart failure: The patient's hemodynamic instability precludes the use of beta-blockers and lasix.
9. Fluid and electrolyte management: The patient has anuria and diffuse anasarca, and repletion of electrolytes is necessary.
10. Potential complications: The patient is at risk for developing further complications, including DVT, stress ulcer, and VAP.

The patient's treatment plan includes:

1. Continuing antibiotics for MRSA pneumonia and UTI.
2. Maintaining vasopressin support to maintain MAP > 65.
3. Limiting IVF in the setting of anuric renal failure.
4. Renally dosing all medications.
5. Considering CVVH and HD, but not c/w long-term GOC per family.
6. Trending platelets and considering antibiotic holiday to evaluate for drug-induced thrombocytopenia.
7. Continuing to trend LFTs and considering ERCP if the patient becomes more stable.
8. Titrating digoxin to effect for atrial fibrillation.
9. Providing wound care recommendations for skin issues.
10. Holding IVF and repleting electrolytes as necessary.

The patient's code status is DNR/DNI, and his disposition is unclear."
174373.0,234940,2181-10-24 06:13:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   General: NAD
   Lungs: light crackles bilateral
   Heart: irregular, normal rate, no MRG
   Abdomen: soft, ND
   Extremities: diffuse anasarca, weeping skin, WWP, DP 2+
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   General: NAD
   Lungs: light crackles bilateral
   Heart: irregular, normal rate, no MRG
   Abdomen: soft, ND
   Extremities: diffuse anasarca, weeping skin, WWP, DP 2+
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male with a history of atrial fibrillation and diastolic heart failure, admitted with grossly abnormal liver function tests (LFTs) and sepsis from a urinary tract infection (UTI) and MRSA pneumonia. He has developed anuric renal failure and is currently in septic shock requiring vasopressin support. He has also developed thrombocytopenia, elevated LFTs, and atrial fibrillation with rapid ventricular response (RVR).

Potential Medical Complications:

1. Continued septic shock: The patient's septic shock state may worsen if not properly managed, leading to organ dysfunction and failure.
2. Acute kidney injury (AKI): The patient's anuric renal failure may progress to AKI, requiring urgent dialysis.
3. Thrombocytopenia: The patient's thrombocytopenia may worsen if not managed promptly, leading to bleeding complications.
4. Intrahepatic cholestasis: The patient's elevated LFTs may indicate ongoing intrahepatic cholestasis, which may worsen if not addressed.
5. Atrial fibrillation: The patient's atrial fibrillation may worsen if not managed with anticoagulation and rate control, leading to stroke or cardiac arrhythmias.
6. Skin breakdown: The patient's diffuse anasarca and weeping skin may lead to skin breakdown and sloughing, requiring prompt wound care.
7. Respiratory failure: The patient's hypoxic respiratory failure may worsen if not managed with mechanical ventilation and oxygen therapy.
8. Cardiac arrest: The patient's septic shock and atrial fibrillation may increase the risk of cardiac arrest, requiring prompt recognition and management.

Recommendations:

1. Continue broad-spectrum antibiotics to cover E. coli, Enterococcus, and MRSA.
2. Maintain vasopressin support to manage septic shock.
3. Monitor and manage thrombocytopenia with platelet transfusions and consideration of alternative antibiotics.
4. Consider MRCP to evaluate for CBD obstruction and transjugular liver biopsy to investigate intrahepatic cholestasis.
5. Manage atrial fibrillation with anticoagulation and rate control.
6. Provide prompt wound care to prevent skin breakdown and sloughing.
7. Continue mechanical ventilation and oxygen therapy to manage respiratory failure.
8. Monitor the patient's cardiac status closely to prevent cardiac arrest."
174373.0,234940,2181-10-24 06:13:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care this evening once family arrives
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care this evening once family arrives
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male with a history of intrahepatic cholestasis and sepsis from a urinary and/or lung source, currently in a septic shock state requiring vasopressin support. The patient has developed anuric renal failure, bilateral large effusions, and MRSA pneumonia. The patient is also experiencing thrombocytopenia, elevated liver function tests, atrial fibrillation, and diffuse anasarca.

Potential Medical Complications:

1. Worsening of septic shock: The patient's septic shock state may continue to deteriorate, leading to organ failure and increased mortality risk.
2. Renal failure: The patient's anuric renal failure may progress, requiring dialysis and increasing the risk of complications such as electrolyte imbalances and acidosis.
3. Respiratory failure: The patient's hypoxic respiratory failure may worsen, requiring mechanical ventilation and increasing the risk of ventilator-associated pneumonia and other respiratory complications.
4. Thrombocytopenia: The patient's thrombocytopenia may continue to worsen, increasing the risk of bleeding complications.
5. Liver failure: The patient's elevated liver function tests may indicate liver failure, which could lead to coagulopathy, encephalopathy, and increased mortality risk.
6. Skin sloughing: The patient's diffuse anasarca and weeping skin may lead to skin sloughing, increasing the risk of infection and wound complications.
7. Cardiovascular instability: The patient's atrial fibrillation and diastolic heart failure may lead to cardiovascular instability, increasing the risk of cardiac arrest and mortality.
8. Nutritional deficiencies: The patient's anuria and diffuse anasarca may lead to nutritional deficiencies, increasing the risk of malnutrition and related complications.

Recommendations:

1. Continue to monitor the patient's vital signs and laboratory values closely to detect any changes in his condition.
2. Adjust antibiotics and vasopressor therapy as necessary to optimize treatment of septic shock and MRSA pneumonia.
3. Consider dialysis to manage anuric renal failure and electrolyte imbalances.
4. Monitor the patient's respiratory status closely and consider mechanical ventilation if necessary.
5. Continue to monitor the patient's platelet count and consider platelet transfusions if necessary.
6. Consider liver function tests and imaging studies to evaluate the cause of elevated liver function tests.
7. Implement wound care recommendations to manage skin sloughing and prevent infection.
8. Monitor the patient's cardiovascular status closely and consider adjusting therapy as necessary to manage atrial fibrillation and diastolic heart failure.
9. Ensure the patient is receiving adequate nutrition and consider tube feeds if necessary.
10. Consider consulting with a specialist, such as a nephrologist or a gastroenterologist, to optimize treatment of the patient's renal and liver failure."
174373.0,234940,2181-10-24 06:13:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the patient is an 81-year-old male with a history of atrial fibrillation and diastolic heart failure, admitted with grossly abnormal liver function tests (LFTs) in the setting of sepsis from a urinary tract infection (UTI) and MRSA pneumonia. The patient is currently in anuric renal failure and has a prolonged QT interval.

The patient's vital signs are stable, with a temperature of 36.8C, heart rate of 99 bpm, blood pressure of 116/60 mmHg, and oxygen saturation of 97% on 50% FiO2. The patient is receiving vasopressin support for septic shock and has a central line and arterial line in place.

The patient's laboratory results show:

* Elevated liver enzymes (ALT/AST) with a trend towards normalization
* Elevated bilirubin levels
* Elevated creatinine levels (4.5 mg/dL) with anuria
* Thrombocytopenia (platelet count 73 x 10^9/L)
* Elevated white blood cell count (18.7 x 10^9/L)
* Elevated lactate levels (1.1 mmol/L)

The patient's imaging studies show:

* No new imaging studies performed
* Old microbiology results show E. coli and Enterococcus in the urine and MRSA in the bronchoalveolar lavage (BAL)

The patient's medical and family history is significant for atrial fibrillation, diastolic heart failure, and a history of liver disease.

The patient's assessment and plan include:

* Continued broad-spectrum antibiotics for sepsis and pneumonia
* Pressor support for septic shock
* Limitation of intravenous fluids in the setting of anuric renal failure
* Consideration of continuous renal replacement therapy (CRRT) or hemodialysis (HD)
* Monitoring of platelet count and consideration of platelet transfusions
* Investigation of elevated liver enzymes and bilirubin levels
* Consideration of MRCP or transjugular liver biopsy to evaluate for obstructive liver disease

Potential medical complications that can arise include:

* Continued septic shock and multi-organ dysfunction
* Progression of anuric renal failure to chronic kidney disease
* Development of liver failure or cirrhosis
* Increased risk of bleeding due to thrombocytopenia
* Increased risk of skin sloughing and maceration due to anasarca and poor wound care
* Potential for cardiac arrhythmias due to atrial fibrillation and electrolyte imbalances
* Potential for respiratory failure due to pneumonia and underlying lung disease."
174373.0,234940,2181-10-24 06:13:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   General: NAD
   Lungs: light crackles bilateral
   Heart: irregular, normal rate, no MRG
   Abdomen: soft, ND
   Extremities: diffuse anasarca, weeping skin, WWP, DP 2+
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
   ------ Protected Section ------
   Critical Care
   After family discussion made CMO and extubated. We are maintaining
   comfort with iv morphine. No evidence of breathlessness or pain.
   Time spent 35 min
   Critically ill
   ------ Protected Section Addendum Entered By:[**Initials (NamePattern4) **] [**Last Name (NamePattern4) 56**] [**Last Name (NamePattern1) 37**], MD
   on:[**2181-10-24**] 19:06 ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   General: NAD
   Lungs: light crackles bilateral
   Heart: irregular, normal rate, no MRG
   Abdomen: soft, ND
   Extremities: diffuse anasarca, weeping skin, WWP, DP 2+
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
   ------ Protected Section ------
   Critical Care
   After family discussion made CMO and extubated. We are maintaining
   comfort with iv morphine. No evidence of breathlessness or pain.
   Time spent 35 min
   Critically ill
   ------ Protected Section Addendum Entered By:[**Initials (NamePattern4) **] [**Last Name (NamePattern4) 56**] [**Last Name (NamePattern1) 37**], MD
   on:[**2181-10-24**] 19:06 ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old male with a history of atrial fibrillation, diastolic heart failure, and sepsis due to urinary tract infection (UTI) and MRSA pneumonia. He is currently in an anuric renal failure and has been on vasopressin support due to septic shock.

The patient's current vital signs include a temperature of 36.8C, heart rate of 99 beats per minute, blood pressure of 116/60 mmHg, respiratory rate of 22 breaths per minute, and oxygen saturation of 97%. He is receiving mechanical ventilation with a CPAP/PSV mode, FiO2 of 50%, and PEEP of 5 cmH2O.

The patient's laboratory results show elevated levels of creatinine (4.5 mg/dL), lactate (1.1 mmol/L), and liver enzymes (ALT 143 IU/L, AST 156 IU/L, and alkaline phosphatase 912 IU/L). His platelet count is low (73 K/uL), and his white blood cell count is elevated (18.7 K/uL).

The patient's medical conditions include:

1. Intrahepatic cholestasis
2. Sepsis from urinary and/or lung source
3. Atrial fibrillation with RVR
4. Anuric renal failure
5. Thrombocytopenia
6. Elevated liver enzymes
7. MRSA pneumonia
8. Diffuse anasarca with weeping skin

The patient's plan of care includes:

1. Continuing broad-spectrum antibiotics (meropenem and vancomycin)
2. Maintaining vasopressin support to maintain mean arterial pressure (MAP) above 65 mmHg
3. Limiting intravenous fluids in setting of anuric renal failure
4. Considering CVVH and HD for renal replacement therapy
5. Trending platelet count and considering alternative antibiotics if necessary
6. Investigating intrahepatic cholestasis with MRCP or transjugular liver biopsy
7. Continuing air mattress and moisturizing skin to prevent maceration
8. Holding IV fluids and repleting electrolytes as needed
9. Maintaining comfort with IV morphine

Potential medical complications that can arise include:

1. Worsening of septic shock
2. Development of acute respiratory distress syndrome (ARDS)
3. Increased risk of skin sloughing
4. Progression of renal failure to end-stage renal disease
5. Development of liver failure
6. Increased risk of bleeding due to thrombocytopenia
7. Worsening of MRSA pneumonia
8. Development of Clostridioides difficile infection (CDI) due to antibiotic use."
174373.0,234940,2181-10-24 06:13:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   General: NAD
   Lungs: light crackles bilateral
   Heart: irregular, normal rate, no MRG
   Abdomen: soft, ND
   Extremities: diffuse anasarca, weeping skin, WWP, DP 2+
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   General: NAD
   Lungs: light crackles bilateral
   Heart: irregular, normal rate, no MRG
   Abdomen: soft, ND
   Extremities: diffuse anasarca, weeping skin, WWP, DP 2+
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male admitted to the ICU with grossly abnormal liver function tests (LFTs) in the setting of sepsis from a urinary tract infection (UTI) and MRSA pneumonia. He has developed anuric renal failure, and his condition has been complicated by atrial fibrillation with rapid ventricular response, thrombocytopenia, and elevated liver enzymes. The patient's family has requested no escalation of care, and it is likely that he will become a comfort measure-only (CMO) patient today.

Potential Medical Complications:

1. Continued septic shock state: The patient remains in septic shock, which requires ongoing vasopressor support. There is a risk of further deterioration in his condition if the sepsis is not effectively treated.
2. Anuric renal failure: The patient's anuric renal failure is likely to progress to chronic kidney disease if not managed effectively. There is a risk of acute kidney injury if the patient is not adequately hydrated.
3. Thrombocytopenia: The patient's thrombocytopenia is likely to worsen if the underlying cause is not identified and treated. There is a risk of bleeding if the platelet count drops further.
4. Elevated liver enzymes: The patient's elevated liver enzymes are likely to remain elevated until the underlying cause is identified and treated. There is a risk of liver damage if the enzymes remain elevated.
5. Skin breakdown: The patient's diffuse anasarca and weeping skin put him at risk of skin breakdown and sloughing. There is a risk of infection if the skin is not properly cared for.
6. Respiratory failure: The patient's hypoxic respiratory failure is likely to worsen if the underlying cause is not effectively treated. There is a risk of respiratory arrest if the patient's oxygenation status deteriorates further.
7. Cardiovascular instability: The patient's atrial fibrillation with rapid ventricular response puts him at risk of cardiovascular instability. There is a risk of cardiac arrest if the patient's heart rate or rhythm is not effectively managed.

Recommendations:

1. Continue to treat the patient's sepsis with broad-spectrum antibiotics and vasopressor support.
2. Manage the patient's anuric renal failure with fluid restriction and electrolyte management.
3. Monitor the patient's thrombocytopenia closely and consider platelet transfusions if the count drops further.
4. Identify and treat the underlying cause of the patient's elevated liver enzymes.
5. Provide proper skin care to prevent breakdown and sloughing.
6. Manage the patient's respiratory failure with oxygen therapy and mechanical ventilation as needed.
7. Monitor the patient's cardiovascular stability closely and adjust his medication regimen as needed."
174373.0,234940,2181-10-24 06:13:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   Microbiology
   - no new microbiology
   -
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care this evening once family arrives
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   Microbiology
   - no new microbiology
   -
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5
   - continue to renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
    - re-consult liver now to evaluate continued LFT abnormalities
 would
   recommend MRCP vs. transjugular biopsy but unsure if it would
   ultimately change patient management
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased digoxin dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - f/u wound care recommendations
   # Diastolic Heart Failure: continue holding BB and lasix given
   hemodynamic instability and renal failure.
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care this evening once family arrives
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 81-year-old male admitted to the ICU with grossly abnormal LFTs, sepsis from a UTI and MRSA pneumonia, and anuric renal failure. He has been receiving broad-spectrum antibiotics and vasopressin support for septic shock. His current condition includes atrial fibrillation with rapid ventricular response, diastolic heart failure, and diffuse anasarca with weeping skin. His laboratory results show elevated LFTs, thrombocytopenia, and acute renal failure with a rising creatinine level.

Potential Medical Complications:

1. Sepsis: The patient's septic shock state may continue to worsen if not adequately managed, leading to multi-organ failure.
2. Renal Failure: The patient's anuric renal failure may progress to chronic kidney disease or require dialysis if not managed properly.
3. Thrombocytopenia: The patient's thrombocytopenia may worsen if not managed, leading to bleeding complications.
4. Intrahepatic Cholestasis: The patient's intrahepatic cholestasis may worsen if not managed, leading to further liver damage.
5. Atrial Fibrillation: The patient's atrial fibrillation may worsen if not managed, leading to further cardiac complications.
6. Diastolic Heart Failure: The patient's diastolic heart failure may worsen if not managed, leading to further cardiac complications.
7. Skin Complications: The patient's diffuse anasarca and weeping skin may lead to skin sloughing and further complications.
8. Respiratory Failure: The patient's respiratory failure may worsen if not managed, leading to further respiratory complications.
9. Nutritional Deficiencies: The patient's anuria and diffuse anasarca may lead to nutritional deficiencies if not managed properly.
10. Electrolyte Imbalance: The patient's anuria and diffuse anasarca may lead to electrolyte imbalances if not managed properly.

Recommendations:

1. Continue to manage the patient's septic shock state with vasopressin support and broad-spectrum antibiotics.
2. Monitor the patient's renal function closely and consider dialysis if necessary.
3. Manage the patient's thrombocytopenia with platelet transfusions and consider switching from Meropenem to Daptomycin.
4. Monitor the patient's intrahepatic cholestasis and consider MRCP or transjugular biopsy to evaluate for CBD obstruction.
5. Manage the patient's atrial fibrillation with rate control and consider cardioversion.
6. Manage the patient's diastolic heart failure with diuretics and consider inotropic support.
7. Manage the patient's skin complications with wound care and consider covering the patient with a moisture barrier ointment.
8. Monitor the patient's respiratory function closely and consider adjusting ventilator settings as necessary.
9. Monitor the patient's nutritional status closely and consider tube feeds or parenteral nutrition if necessary.
10. Monitor the patient's electrolyte status closely and consider correcting imbalances if necessary."
174373.0,234940,2181-10-24 06:13:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 81 yof with h/o atrial fibrilation with diastolic HF
   admitted with grossly abnormal LFT's in setting sepsis from  UTI
   (E.coli and Entrococcus) and MRSA pneumonia, now in anuric renal
   failure.
   24 Hour Events:
   Family meeting yesterday: no more escelation of care, will likely
   become CMO today
   Wound care: moisture barrier ointment on skin to protect from
   maceration, first step mattress with low air loss
   Allergies:
   Keflex (Oral) (Cephalexin Monohydrate)
   Unknown;
   Bactrim (Oral) (Sulfamethoxazole/Trimethoprim)
   Unknown;
   Last dose of Antibiotics:
   Vancomycin - [**2181-10-22**] 08:30 AM
   Meropenem - [**2181-10-23**] 08:15 AM
   Infusions:
   Vasopressin - 1.5 units/hour
   Other ICU medications:
   Fentanyl - [**2181-10-24**] 03:16 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2181-10-24**] 06:12 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 99 (93 - 117) bpm
   BP: 116/60(77) {93/46(61) - 132/63(86)} mmHg
   RR: 22 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 82.3 kg (admission): 63.6 kg
   Height: 62 Inch
             Total In:
                                                                    898 mL
                                                                     58 mL
   PO:
             TF:
                                                                    491 mL
   IVF:
                                                                    406 mL
                                                                     58 mL
   Blood products:
   Total out:
                                                                    265 mL
                                                                     60 mL
   Urine:
                                                                    265 mL
                                                                     60 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    633 mL
                                                                     -2 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CPAP/PSV
   Vt (Spontaneous): 426 (351 - 450) mL
   PS : 10 cmH2O
   RR (Spontaneous): 21
   PEEP: 5 cmH2O
   FiO2: 50%
   RSBI: 53
   PIP: 16 cmH2O
   SpO2: 97%
   ABG: ////
   Ve: 9.2 L/min
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   74 K/uL
   9.5 g/dL
   141 mg/dL
   4.5 mg/dL
   14 mEq/L
   3.5 mEq/L
   102 mg/dL
   112 mEq/L
   139 mEq/L
   29.2 %
   16.3 K/uL
        [image002.jpg]
                             [**2181-10-19**]  02:24 PM
                             [**2181-10-19**]  05:05 PM
                             [**2181-10-20**]  03:30 AM
                             [**2181-10-20**]  04:04 AM
                             [**2181-10-20**]  08:39 AM
                             [**2181-10-20**]  04:05 PM
                             [**2181-10-21**]  04:34 AM
                             [**2181-10-22**]  04:09 AM
                             [**2181-10-23**]  04:03 AM
                             [**2181-10-23**]  04:32 AM
   WBC
   18.7
   18.6
   16.8
   16.3
   Hct
   29.8
   30.0
   30.3
   29.2
   Plt
   73
   59
   52
   74
   Cr
   3.3
   3.3
   4.1
   4.5
   TCO2
   15
   16
   16
   17
   16
   16
   Glucose
   148
   138
   172
   171
   144
   141
   Other labs: PT / PTT / INR:21.3/38.9/2.0, CK / CKMB /
   Troponin-T:100/5/0.11, ALT / AST:143/156, Alk Phos / T Bili:912/22.4,
   Amylase / Lipase:114/106, Differential-Neuts:90.0 %, Band:2.0 %,
   Lymph:6.0 %, Mono:1.0 %, Eos:0.0 %, Fibrinogen:514 mg/dL, Lactic
   Acid:1.1 mmol/L, Albumin:2.3 g/dL, LDH:331 IU/L, Ca++:8.2 mg/dL,
   Mg++:2.6 mg/dL, PO4:5.2 mg/dL
   Imaging
   - no new imaging
   New Microbiology
   - none
   Old Microbiology
   - urine [**10-13**]: E.coli  and Enterococcus (vancomycin)
   - BAL [**10-13**]: MRSA
   - urine and blood 9/21: negative
   Assessment and Plan
   81 yof with intrahepatic cholestasis and sepsis from urinary and / or
   lung source, continuing a.fib with RVR and continued anuric renal
   failure.
   # Shock: continued septic shock state requiring vasopressin support
   with MRSA pneumonia vs. urosepsis as infective source.
    - continue broad spectrum continue meropenem (E.Coli) and vancomycin
   (Entrococcus and MRSA) - started on [**10-14**]
    - continue pressor to maintain MAP > 65
   #Hypoxic Respiratory failure: patient with bilateral large effusions
   and underlying MRSA pneumonia and unchanged disease demonstrated by
   serial CXR
   - continue antibiotics as documented above
   - limit IVF in setting of anuric renal failure
    # Acute renal failure: likely ATN due to poor perfusion with rising
   Cr, now 4.5, remains 24.5 liters positive for [**Location **] continue renal dosing all medications
   - CVVH and HD considered, however not c/w longterm GOC per family
   # Thrombocytopenia: initially rapidly dropping platelet count with most
   recent level stabilized, likely representing drug induced
   thrombocytopenia.
   - continue to trend platelets
   - may consider pulling off Meropenum or  switching from Vancomycin to
   Daptomycin but difficult as patient still has septic shock physiology
   requiring pressors
   #  Elevated LFT
s: AST/ALT continue to trend down while AP/LDH and
   TBili continue to remain constant representing intrahepatic cholestasis
   or obstructive picture with now resolving component of shock liver.
   Liver suggested the next steps in investigating these abnormalities
   would include an MRCP to r/o obstruction or an transjugular liver
   biopsy.
    - consider MRCP to evaluate for CBD obstruction in setting of elevated
   AP and TB
 however patient has pacemaker
   #  Atrial Fibrillation: Pt continued in afib with RVR now s/p digoxin
   increased dose to 0.125
    - improved rate control on high digoxin dose
 continue to titrate
   digoxin dose to effect
   # Skin: diffuse anasarca with weeping skin and significant risk of skin
   sloughing
   - continue to moisturize skin to prevent maceration and continue air
   mattress
   # FEN: holding IVF given anuria with diffuse anasarca, replete
   electrolytes PRN, continue tube feeds
   # Access
 central line placed on [**10-13**], arterial line placed on [**10-13**]
   # Prophylaxis: HOB elevation, lansoprazole
   # Communication
 son
   # Code
 DNR
 family called and would like no escalation of care today
   with likely CMO and withdrawal of care today
   # Disposition
 ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Multi Lumen - [**2181-10-13**] 08:35 PM
   Arterial Line - [**2181-10-13**] 09:43 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: DNR / DNI
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 81-year-old individual with a history of atrial fibrillation and diastolic heart failure, who was admitted with grossly abnormal liver function tests (LFTs) in the setting of sepsis from a urinary tract infection (UTI) and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. The patient has developed anuric renal failure and is currently receiving vasopressin support for septic shock.

The patient's current vital signs are:

* Temperature: 36.8C (98.2F)
* Heart rate: 99 beats per minute (bpm)
* Blood pressure: 116/60 mmHg
* Respiratory rate: 22 breaths per minute
* Oxygen saturation: 97%

The patient's laboratory results show:

* White blood cell count: 18.7 x 10^9/L
* Hemoglobin: 9.5 g/dL
* Platelet count: 73 x 10^9/L
* Creatinine: 4.5 mg/dL
* Blood urea nitrogen: 14 mmol/L
* Lactic acid: 1.1 mmol/L
* Albumin: 2.3 g/dL
* Lactate dehydrogenase: 331 IU/L
* Calcium: 8.2 mg/dL
* Magnesium: 2.6 mg/dL
* Phosphate: 5.2 mg/dL

The patient's imaging studies show:

* No new imaging studies were performed.

The patient's microbiology results show:

* E. coli and Enterococcus in the urine
* MRSA in the bronchoalveolar lavage (BAL)
* Negative urine and blood cultures on 9/21

The patient's medical conditions include:

* Intrahepatic cholestasis
* Sepsis from urinary and/or lung source
* Atrial fibrillation with rapid ventricular response (RVR)
* Anuric renal failure
* Shock (septic shock)
* Hypoxic respiratory failure
* Thrombocytopenia
* Elevated liver function tests (LFTs)

The patient's plan includes:

* Continuing broad-spectrum antibiotics (meropenem and vancomycin)
* Continuing pressor support to maintain mean arterial pressure (MAP) > 65
* Limiting intravenous fluids (IVF) in the setting of anuric renal failure
* Considering continuous renal replacement therapy (CRRT) and hemodialysis (HD)
* Trending platelet counts and considering pulling off meropenem or switching to daptomycin
* Investigating elevated LFTs with an MRCP to rule out obstruction or a transjugular liver biopsy
* Continuing to titrate digoxin dose to effect
* Continuing to moisturize skin to prevent maceration and using an air mattress
* Holding IVF and repleting electrolytes as needed
* Continuing tube feeds

The patient's code status is DNR/DNI, and the family has requested no escalation of care today, with likely withdrawal of care today."
